Characterization and biosynthesis of mitochondrial proteins by Gibb, Graham Morton
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
CHARACTERIZATION AND BIOSYNTHESIS OF MITOCHONDRIAL PROTEINS
by
Graham Merton Gibb BSc
Thesis submitted for the degree of 
Doctor of Philosophy 
in the Faculty of Science 
University of Glasgow 
July, 1985
ProQuest Number: 10907127
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10907127
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
ACKNOWLEDGEMENTS
I should like to thank Professor Smellie, Professor Houslay and 
Professor Fewson for the use of the facilities in the Biochemistry 
Department, University of Glasgow, which enabled me to perform this 
research.
I am deeply indebted to Dr. J.G. Lindsay for consistent advice and 
encouragement throughout the course of my research project and during 
the many months of my thesis writing. I should also like to thank Dr. 
Lindsay for allowing me to occasionally succeed on the golf course when 
we have played a friendly game together. M/ gratitude to Dr. J. Kusel 
whose continual encouragement helped me through the difficult times in 
my project.
The laboratory staff of C35, which surprisingly changed little 
during the course of ny thesis, also deserve a special mention for 
providing, many good times during my prolonged stay in the laboratory.
In particular, Gordon Reid, George Clarkson, Anne Hunter, Anne Phelps, 
Andrew Lipka, Jeff Hodgson and my favourite teacher from the deep blue 
south, Olga De Marcucci.
Ity sincere thanks to the staff of the Medical Illustration Department 
for their expertise in preparing the art work of this thesis.
I must also egress my extreme gratitude to my parents who have 
given me the utmost support, advice and encouragement throughout the 
duration of my thesis. I should like to -thank my mother for undertaking 
the painstaking task of typing my thesis and spending many a long hour 
ensuring that its contents were in the correct order. My sister, Pamela, 
also deserves a mention for typing some of. the tables in this thesis.
Finally, but by no means least, I must acknowledge my late grand­
mother whose encouragement in the early years of my.research inspired and 
motivated me.
TO MY PARENTS
Research is the seeking of knowledge 
and the beginning of wisdom but the 
greatest asset is common sense.
LIST OF CONTENTS
Chapter One INTRODUCTION
1.1 The Mitochondrial Genome 1
1.1.1 Introduction 1
1.1.2 Genomic Organization of Mitochondrial ENA 1
1.1.3 Mitochondrial. Genetic Code 3
1.2 Distribution of Secretory Proteins 5
1.2.1 Historical Background 5
1.2.2 Sequence, and Structure of Signal Peptides 7
1.2.3 Mclecular Aspects of Secretory Protein Synthesis 8
1.3 Iirport of Proteins into Mitochondria 10
1.3.1 Introduction 10
1.3.2 Mechanism of Synthesis of Nuclear-Encoded 
Mitochondrial Proteins
12
1.3.3 Molecular Characteristics of Precursors 15
1.3.4 Receptors Involved in the Recognition and 
Binding of Mitochondrial Precursors
18
1.3.5 Translocation and Processing of Mitochondrial 
Precursors
21
1.3.5.1 Energy Dependence of Translocation 21
1.3.5.2 Properties of the Yeast Mitochondrial Matrix 
Protease
25
1.3.5.3 Processing of Mitochondrial Precursor Polypeptides 27
1.3.6 Assembly of Processed Proteins into Functional Units 31
1.4 Mitochondrial Phosphate Transport Protein 34
1.4.1 Introduction 34
1.4.2 Identification of the Protein 35
1.4.3 Purification Studies on the Phosphate Transport 
Protein
37
1.5 Rimarase or Rimarate Hydratase (EC 4.2.1.2) 39
1.5.1 Introduction 39
1.5.2 Conpartmentalization of Romarase 
General Aims
42
46
Chapter TWO MATERIALS AND METHODS
2.1 Materials 47
2.1.1 Biological. Materials 47
2.1.2 Chemicals for Polyacrylamide Gel Electrophoresis 47
2.1.3 Radiochemicals 48
2.1.4 Chemicals for Bluorography 48
2.1.5 Photographic Materials 48
2.1.6 Immunochemicals 49
2.1.7 Tissue Culture Materials 49
2.1.8 Chromatographic Media 50
2.1.9 Enzymes 50
2.1.10 General Chemicals 50
2.2 General Methods 51
2.2.1 Protein Estimations 51
2.2.2 Enzyme Assays 52
2.2.3 Radioiodination of Proteins 52
2.2.4 SDS-Polyacrylaraide Gel Electrophoresis 53
2.2.4.1 Preparation of Gels-Electrophoretic Conditions ^
2.2.4.2 Preparation of Protein Sanples for Electrophoresis 54
2.2.4.3 Staining of Protein(s) 54
2.2.4.4 Estimation of the Relative Malecular Mass of a 55
Protein
2.2.4.5 Autoradiography 55
2.2.4.6 FLuorography 56
2.2.5 Subcellular Fractionation Techniques 56
2.2.5.1 Isolation of Rat Liver Mitochondria 56
2.2.5.2 Preparation of Rat Liver Mitcplasts 57
2.2.5.3 Isolation of Subcellular Fractions from Cultured 58
Mammalian Cells
2.3 Immunological Techniques 59
2.3.1 Preparation of Antisera 59
2.3.2 Characterization of the Antisera 59
2.3.2.1 Immune-blotting 59
2.3.2.2 Preparation of. Cell lysate for Immune-Precipi- 61
tation Studies
2.3.2.3 Immune-Precipi tation 61
2.3.2.4 The Enzyme-linked Immunosorbant Assay 62
2.4 Tissue-Culture Techniques 63
2.4.1 Growth Media for Cell Lines 63
2.4.2 Routine Maintenance of Cells 63
2.5 Characterization of the Phosphate Transport 64
Protein
2.5.1 Measurement of Phosphate Transport by Passive 64
Isotonic Swelling
2.5.2 N-[2-^H]-ethylmaleimide Labelling of the 64
Phosphate Transport Protein
2.5.3 Performic Acid Oxidation of the Isolated Phosphate 65
Transport Protein
2.5.4 Amino Acid Analysis 66
Chapter Three PURIFICATION AND CHARACTERIZATION OF THE PHOSPHATE
TRANSPORT PROTEIN FROM RAT. LIVER MITOCHONDRIA
3.1 Introduction 67
3.2 Methods 68
3.2.1 Procedure(s) for the Purification of the Phosphate 68
Transport Protein from Rat Liver Mitochondria
3.2.2 Iodination of.Ooncanavalin A 70
3.2.3 Lectin Overlay Analysis of the Phosphate Transport 71
Protein
3.2.4 Preparation of SDS-Polyacrylamide Gradient Gels 71
3.3 Results and Discussion 72
3.3.1 SDS-Polyacrylamide Gel Electrophoresis Analysis 72
of the Isolated Phosphate Transport Protein
3.3.2 Lectin Overlay Analysis of the Phosphate Transport 74
Protein
3.3.3 SDS-Polyacrylamide Gradient Gel Electrophoresis 75
of the Purified Protein
3.3.4 Characterization of the Phosphate Transport Protein 78
3.3.4.1 Effect of N-ethylmaleimide on Phosphate Transport 78
into Isolated Mitochondria
3.3.4.2 N-[^H]-ethylmaleimide Labelling Studies of the 80
Phosphate Transport Protein
3.3.4.3 Immunological Studies 82
3.3.4.3.1 Effect of an Anti-Phosphate Transport Protein 82
Serum on Phosphate Transport
3.3.4.4 Amino Acid Analysis of the Phosphate Transport 84
Protein
Chapter Four CHARACTERIZ ATI ON OF ANTI SERA RAISED AGAINST THE 
PHOSPHATE TRANSPORT PROTEIN AND FUMARASE
4.1 Introduction 86
4.2 Methods 87
4.2.1 Subcellular Fractionation of Cultured Mammalian 87
Cells
4.3 Results 87
4.3.1 Determination of the Antibody litres of Antisera 88
to the Phosphate Transport Protein and Rimarase
4.3.2 Immune-blotting Analysis of the Phosphate Transport 88 
Protein Antiserum
4.3.3 Effect of Rimarase. Anti serum on Enzymic Activity 91
4.3.4 Immune-blot Analysis of Anti-Rimarase Serum 92
4.4 Discussion 94
4.4.1 Immune-replica Assay 95
4.4.2
4.4.3
Specificity of the Phosphate Transport Protein 
Antiserum
Specificity of the Rabbit, Polyclonal Antiserum 
to Pig Heart Ramarase
Chapter Five
5.1
5.2
5.2.1
5.2.2
5.3
5.3.1
5.3.2
5.3.3
5.3.4
5.4
5.4.1
5.4.2
5.4.3
BIOSYNTHETIC STUDIES ON FUMARASE AND THE PHOSPHATE 
TRANSPORT PROTEIN
Introduction
Methods
35L- [ S]-Methionine Labelling of Cultured Mammalian 
Cells
Accumulation of Mitochondrial Precursor Proteins 
in Yeast Cells
Results
Optimization of Growth Conditions
Optimization of Conditions for Accumulating 
Precursor Polypeptides
Mechanism of Synthesis of. Ramarase in Mammalian 
Culture Cells
Precursor Accumulation Studies in Yeast Cells 
Discussion
Optimization of Conditions for Studying Mito­
chondrial Precursors
Mechanism of Synthesis, of Ramarase in Cultured 
Mammalian Cells
Precursor Studies in Yeast Cells
Chapter Six 
6.1 
6.2 
6.3
A.
B.
GENERAL DISCUSSION
General Discussion
Update on Mitochondrial Biogenesis
Rature Work
Ramarase
Phosphate Transport Protein
References
Publications
96
101
104
106
106
107
108 
109 
112
115
117
120
120
124
131
136
139
143
143
145
146 
159
LIST OF FIGURES
, Genomic Organization of mammalian mitochondrial 
genomes.
Current picture of the initial events in secretory 
protein synthesis.
Scheme illustrating the steps involved in the 
synthesis, inport and assembly of the^-subunit of 
F^  ATPase.
1.3.2 'Two-step' inport and processing mechanism for
cytochromes c^  and
1.4.1 Transporters in mitochondria.
1.4.2 The effect of p-mercuribenzoate protection on the
specificity of labelling of the phosphate transport 
3system with N- [ H]-ethylmaleimide.
1.5.1 Tricarboxylic acid cycle.
3.3.1 (a) & (b) Lectin overlay analysis of the purified phosphate
transport protein from intact rat liver, mitochondria.
3.3.2 Standard. Curve of electrophoretic mobility of marker
proteins versus log subunit value.
3.3.3 (a) & (b) Lectin overlay analysis of the purified phosphate
transport protein from Triton X-100 (0.5% (v/v)) 
pre-extracted rat liver mitochondria.
1.1.1
1.2.1
1.3.1
3.3.4 Model of the mitochondrial phosphate carrier.
3.3.5 SDS-polyacrylamide gradient gel analysis 14-20%
(w/v) of purified phosphate transport protein from 
rat liver and beef heart mitochondria.
3.3.6 Postulated mechanism of mitochondrial swelling in
solutions of isotonic ammonium salts.
3.3.7 (a) & (b) Inhibition of mitochondrial swelling in isotonic
(NHj) 2® ^  medium in the presence of N-ethylmaleimide.
3
3.3.8 (a) (b) & (c) N-[ H]-ethylmaleimide labelling studies, of the
phosphate transport protein from rat liver mito­
chondria.
3.3.9 (a) & (b) Partial inhibition of phosphate uptake in rat liver
mitcplasts pre-incubated with a specific antiserum 
to the phosphate transport protein as measured by 
the NH4+-ion swelling technique.
4.3.1 (A) & (B) ELISA estimations of the antibody titres of phosphate
transport protein and fumarase antisera respectively.
4.3.2 Immune-replica analysis of purified phosphate trans­
port protein versus anti serum directed against the 
protein.
4.3.3 Immune-replica analysis of mammalian tissue-culture
cell extracts versus phosphate transport protein 
anti serum.
4.3.4 Effect of polyclonal, rabbit anti-fumarase serum
on purified enzymic activity.
Immune-replica analysis of purified pig heart 
fumarase versus anti-fumarase serum.
Immune-replica analysis of cultured mammalian cell 
extracts versus anti-fumarase serum.
Estimation of. fumarase and citrate synthetase 
activities in digitonin treated PK-15 cells.
i /
Immune-replica analysis of beef heart mitochondrial 
subfractions versus anti-fumarase serum.
The effect of pre-incubation time in (-) methionine
35(-) serum medium on the incorporation of [ S]-
methionine into BEL cell protein.
Time-course to measure the extent of incorporation 
35of [ S]-methionine into BKL cellular protein m  
(-) methionine and low methionine media.
A study of the effects of various inhibitory com­
pounds on the synthesis of mitochondrially-encoded 
proteins.
Time-course of the effect of 10pM PCCP on the
35incorporation of [ S]-methionine into total BEL 
cell proteins.
Immune-precipitation of fumarase from PK-15 and
35NBL-1 cells labelled overnight with [ S]-methionine.
Biosynthesis of fumarase in PK-15 cells labelled
35 . . .with [ S]-methionine in the presence of an inhibitor
of mitochondrial import.
Biosynthesis of fumarase in BKL cells labelled with 
35 .[ SJ-methionine in the presence of an. inhibitor 
of mitochondrial inport.
Effect of the uncoupler CCCP on.the growth of the 
rho mutant strain of S.cerevisiae.
Immune-replica analysis of the yeast rho" mutant 
strain treated, with increasing concentrations of 
CCCP (Ramarase anti serum).
Quantitation of precursor accumulation in yeast 
cells after growth in the presence of CCCP.
Immune-replica analysis of the yeast rho” mutant 
strain treated with increasing concentrations of 
CCCP (phosphate transport protein anti serum)
Immune-replica analysis of a yeast mitochondrial 
extract with phosphate transport protein anti serum-
Generation of two mENA species encoding the mito­
chondrial and cytosolic forms of fumarase.
Summary of the molecular and functional properties 
of proteins involved in secretory protein synthesis
Cytcplasmically-synthesised mitochondrial proteins
Summary of the mechanism(s) of inport of cytcplas­
mically- synthesised mitochondrial proteins
Molecular properties of rat liver mitochondrial 
and cytosolic fumarases
Conposition and volumes of solutions used to cast 
SDS-polyacrylamide gels
Gonposition and volumes of solutions used to cast 
SDS-polyacrylamide gradient gels (14-20% (w/v))
Comparison of the amino acid compositions of the 
rat liver and beef heart mitochondrial phosphate 
transport proteins
The effect of the conposition of labelling medium
35on the incorporation of [ S],-methionine into total
BEL cell protein
Functional assignment of mitochondrially-encoded 
BEL cell proteins
ABBREVIATIONS
The abbreviations used in this thesis are as given in 'Instructions 
to Authors' published by the Biochemical Journal (1985) with the 
following exceptions:
BSA - bovine serum albumin
CCCP - carbonyl cyanide m-chlorcphenylhydrazone
con A - concanavalin A
DMSO - dimethyl sulphoxide
DOC - sodium deoxycholate
DTNB - 5,5' dithio(bis)2-nitrobenzoic acid
DTT - dithiothreitol
FCCP - carbonyl cyanide 4-(trifluoromethoxy)phenyl-
hydrazone
Bio-gel HTP - hydroxylapatite
Leupeptin - acetyl-L-leucyl-L-leucyl-L-argininal
Mops - 4-morpholincprcpanesulfonic acid
NEAA - non-essential amino acids
OPD - o-phenylene diamine
OAA - oxaloacetic acid
PBS — phosphate buffered saline
PMSF - phenylmethylsulfony/fluoride
PPO - 2,5-diphenyloxazole
SDS - sodium dodecyl sulphate
TIMED - N,N,N',N'-tetramethylethylenediamine
TMPD - tetramethylphenylenediamine
Tween 20 - polyethylene sorbital mono-laureate
WGA - wheat germ agglutinin
SUMMARY
Mitochondria have their own very limited genetic system which codes 
for a few proteins of the inner membrane respiratory chain. As such, 
the bulk of mitochondrial proteins are nuclear encoded, synthesised in 
the cytoplasm on free ribosomes (in general as larger precursors) and 
subsequently iirported into the correct conpartment within the organelle.
We were particularly interested in studying two mitochondrial proteins 
with respect to this problem of biosynthesis and inport into the organelle.
The first of these proteins, the phosphate transport protein is an 
integral, inner transmembraneous protein of mitochondria which has a 
major role to play in energy metabolism in the cell. It had only been
partially characterized when we started to investigate it and as such this 
represented an interesting area of research. Purification of the phosphate 
transport protein from rat liver mitochondria was carried out by extraction 
in an 8% (v/v) Triton X-100 buffer and then adsorption chromatography on 
hydroxylapatite followed by Celite. SDS-polyacrylamide gel electrophoresis 
10% (w/v) demonstrated that the protein band was apparently homogeneous
when stained with Coomassie Blue and had an Mr of 34,000. However, when
. . 1 2 5this gel was overlayed with I-labelled concanavalm A to detect glyco­
proteins and exposed to autoradiography, numerous low and high Mr glyco­
protein contaminants could be visualized. To overcome this problem, 
mitochondria were pre-extracted with a 0.5% (v/v) Triton X-100 buffer 
prior to purification. This initial extraction solubilised about 80% 
of the mitochondrial protein and effected quantitative removal of the 
contaminants.
SDS-polyacrylamide gradient gel electrophoresis 14-20% (w/v) of the 
hydroxylapatite and Celite eluates revealed one major band of 34,000
when stained with Coomassie Blue. Densitometric scanning of the gel 
demonstrated that the protein was greater than 95% pure. This result 
was in marked contrast to the recent findings of several groups who have 
purified the phosphate transport protein from bovine and pig heart mito­
chondria, respectively. The hydroxylapatite eluates, when resolved on 
a similar gradient gel, demonstrated, four to five Goomassie Blue staining 
bands.
In order to identify the protein, the sulphydryl group sensitivity
of the phosphate transport protein was enployed. Labelling studies with 
3
N-[ H]-ethylmaleimide showed that only the 34,000 band was labelled 
in both the hydroxylapatite and, Celite fractions, when purified from rat 
liver mitochondria. This result was consistent with the known sulphydryl 
group sensitivity of the phosphate transport protein. Further confirmation 
has been provided by preliminary experiments with an anti serum directed 
against the 34,000 M protein. Partial inhibition of mitcplast swelling 
in isotonic ammonium phosphate buffer was achieved when mitcplasts were 
incubated with the specific antiserum.
Tto study the biosynthesis and import of this protein into mitochondria, 
in general, cultured mammalian cell lines were enployed. The rabbit, 
polyclonal antiserum raised against the 34,000 Mr band.proved to be un­
successful when testing its specificity by immune-blotting and later with 
the in vivo mitochondrial inport studies. Numerous polypeptides were 
observed when crude tissue-culture extracts were challenged with the anti­
phosphate transport protein serum and analysed by the immune-replica technique 
However, a preliminary experiment in the yeast rho” strain {p), which can 
accumulate large quantities of mitochondrial precursors in the presence of 
uncoupler, indicated that the protein was probably not. made as a . larger Mr 
precursor. The antiserum raised against the rat liver mitochondrial 
phosphate transport protein strongly cross-reacted with a yeast protein
of 29,000 under the above conditions. .In addition the identity of 
this cross-reacting yeast protein has been partially provided by the immune- 
replica technique, where the antiserum specifically recognised a protein 
of 29,000 Mr in a yeast mitochondrial extract.
The second protein of particular interest to us was the enzyme
fumarase. This enzyme has been shown to be located in the cell cytosol 
as well as in the mitochondrial matrix. In. the mitochondrial matrix, 
fumarase has a functional role to play in the operation of the 'citric 
acid cycle' and in the cell cytosol has an indirect role in the 'urea 
cycle', the tyrosine-oxidizing system and in purine biosynthesis. It 
has been reported in the literature that both forms of the enzyme are 
of the same Mr (subunit of 49,000). In studying the biosynthesis of
this enzyme, an additional problem to be overcome, is to determine the
mechanism by which this bimodal distribution occurs.
The pig heart enzyme, which had a purity of greater than 95%, was 
purchased from Sigma. A rabbit, polyclonal antiserum was raised against 
the protein, so that we could monitor the biosynthesis of the enzyme 
in vivo enploying cultured mammalian cells. Initially, the specificity 
of the polyclonal antiserum was tested in one of two ways:
(1) Enzymic activity was measured in the presence of the antiserum 
and resulted in a greater than 80% inhibition.
(2) Immune-blotting of the anti serum against various crude extracts,
125m  which the antigen-antibody conplexes formed were detected, with I- 
labelled protein A, showed that it was monospecific.. The crude extracts 
included beef heart submitochondrial fractions.
Tb determine which of the following mammalian tissue-culture cell 
lines to enploy for the in vivo biosynthetic studies, immune-blotting of
the antiserum against various crude cell extracts was carried out. The 
cell lines used were Buffalo rat liver (BEL), Pig kidney (PK-15) and Bovine 
kidney (NBL-1), respectively. All the crude cell extracts prepared from 
these cell lines cross-reacted specifically with the antiserum, although 
the PK-15 and NBL-1 cell extracts reacted most strongly. Additionally, 
in the case of BEL cells, the mitochondrial (Mr 45,000) and cytosolic 
fumarases (Mr 47,000) appeared to differ in value.
Initial studies to determine the mechanism of. synthesis of fumarase
were carried out by labelling PK-15 and NBL-1 cells overnight in the presence 
35of L-[ S]-methionine. Immune-precipi tation and subsequent detection 
by fluorography showed the presence of a band of M 47,000, corresponding 
to mature fumarase. Preliminary precursor experiments in which PK-15 
cells were labelled in the presence of the uncoupler PCCP (10pM), 
demonstrated the existence of two polypeptide bands which had M values 
of 47,000 and 51,000 respectively. The 47,000 Mr band is assumed to 
represent cytosolically-located fumarase whereas the 51,000 Mr polypeptide 
is the cytosolic precursor form of the mitochondrially-located fumarase, 
under the conditions enployed. When a similar experiment was performed 
in BEL cells, a single specific polypeptide of 47,000. could be immune- 
precipitated from the cell extract. This polypeptide was assumed to 
represent both cytoplasmically-located fumarase as well as the precursor 
form of the mitochondrial enzyme. In the absence of uncoupler two proteins 
with Mr values of 47,000 and 45,000 respectively, were recognised in a 
specific manner by the antiserum, confirming, the immune-replica data. 
Analogous examination of yeast {p  ) immune-blots,. to those employed with 
the phosphate transport protein, suggest the accumulation of a larger Mr 
precursor to fumarase when cells were grown for 1-2 generations in increasing 
uncou^l nn
Finally, the data obtained has enabled hypothetical pathways to be
put forward to explain the mechanism by which this enzyme becomes 
distributed between two cellular corpartments.
CHAPTER ONE
INTRODUCTION
1.1 THE MITOCHONDRIAL GENOME
1.1.1 Introduction
Mitochondria contain their own genetic system which is responsible 
for the synthesis of about 5% of the proteins found in the organelle. 
Additionally, the mitochondrial genome encodes all the riboscmal and 
transfer ENAs of its separate translation system. The mitochondrial 
genome is autonomously replicated and is expressed within the confines 
of the organelle. Each mitochondrion in a cell contains several 
copies of the closed circular DNA genome. The M^ value of the DNA
varies from species to species within a narrow range: between
6 6 10 x 10 in animal tissue and 70 x 10 in higher plants.
1.1.2 Genomic Organisation of Mitochondrial DNA
The conplete sequence and organisation of three mammalian 
mitochondrial genomes have recently been elucidated (Bibb et al.,
1981, Anderson et al., 1981; Anderson et al., 1982). They all show 
extreme economy in organisation, in that there are none or very few 
non-coding bases between adjacent genes (Fig. 1.1.1). It can be 
seen that the mammalian mitochondrial genome encodes two ribosomal 
RNA genes (12S and 16S) , 22 transfer RNA genes (tENA) and 13 protein- 
coding genes. Encoded on the heavy strand of the genome (H-strand) 
are the two ribosomal RNA genes, 14 tRNA genes and 12 of the 13 
protein-coding genes while the remaining eight tRNA genes and one 
protein-coding gene are expressed by the light strand (L-strand).
Protein products of known function have been assigned to five 
of the 13 reading frames. They were identified from the amino acid 
sequence of purified protein and by homology with DNA sequence of
Fig. 1.1.1
Genomic map of Mammalian Mitochondrial DNA
0H
MAMMALIAN
MITOCHONDRIAL
DNA
URF4L
& URF3
**■ URFA6L
The dotted areas represent tRNA genes designated by the single-letter 
amino acid code, with polarity given by the arrows. All protein coding 
genes are encoded on the H-strand (with counter clockwise polarity) , with 
the exception of URF6 which is encoded on the L strand.
COI, COII and COIII; cytochrome oxidase subunits I, II and III, Cyt b: 
cytochrome b, URF: unassigned reading frame, 0^ . and 0T: the origins
of H and L strand replication, respectively. (Reproduced from Clayton, 
1984).
known genes in other mitochondrial systems (Bibb et .al.y 1981,
Anderson et al., 1981, Thalenfeld and Tzagoloff, 1980, Macino and 
Tzagoloff, 1980; Nobrega and Tzagoloff, 1980). The remaining 
eight unidentified reading frames (URF) are highly conserved in 
bovine and human mitochondrial DMA (Anderson et al., 1981) , showing 
about 70% nucleotide and amino acid sequence homology. In addition, 
there is evidence of protein products corresponding to human mito­
chondrial DNA URFs 1, 3, 6 and A6L (Mariottini et al., 1983, Oliver 
et al., 1983; Ghomyn et al., 1983). It is therefore believed that 
most, if not all, of these reading frames represent genes for mammalian 
mitochondrial proteins. There is only one region of mammalian 
mitochondrial DNA of significant size which contains no open reading 
frames, the displacement loop (D-loqp). This region has been shown 
to contain the origin of heavy strand replication and sequences 
relevant to the promotion of RNA synthesis from each template strand 
(Montoya et al., 1982; Montoya et al., 1983).
In contrast, the yeast mitochondrial genome which is about five 
times the size of mammalian mitochondrial DNA, appears to be less 
economically organised. It codes for two ribosomal RNAs, 25 tRNAs 
and 16 proteins, 10 of which are of unassigned function at present.
The genomic organisation of the yeast mitochondrial DNA is different 
to that of its mammalian counterpart, as shown by the fact that the 
large (21S) and small (16S) ribosomal RNA genes are 25,000 base pairs 
apart on the genome. In addition, the majority of tRNA genes are 
clustered on the H-strand, near the large ribosomal gene.
Finally, several yeast genes have been shown to contain intervening 
sequences (introns) in their structure, a feature absent from mammalian 
mitochondrial genes. The large ribosomal RNA gene has been demon­
strated to contain one intervening sequence (Borst and Grivell, 1978)
which varies in length in different yeast strains. Cytochrome b 
gene in S.cerevisiae D273/10B contains two intron sequences (Nobrega 
and Tzagoloff, 1980) while evidence from Van Ommen et al. (1979), shows 
that this same gene in a different yeast strain contains four inter­
vening sequences.
It can clearly be seen from these examples that there are marked 
differences in the overall organisation of genes in various eukaryotic 
mitochondria, as well as in different strains of the same organism.
1.1.3 Mitochondrial Genetic Code
The genetic code which is invariant from viruses to man is not as 
originally thought universal. Mitochondria have their own version 
which is subject to variation in different organisms. Mammalian 
mitochondria read AGA and AGG as step signals rather than as codons 
for the amino acid arginine whereas in the mitochondria of Neurospora 
crassa (N.crassa) and Aspergillus nidulans (A.nidulans) these codons 
are translated as arginine. Additionally, mammalian mitochondria 
utilise the standard UAA as a termination codon.. In many human 
mitochondrial messengers this latter termination codon is generated 
from the primary transcript by polyadenylation, since the transcript 
ends in either U or UA. Mammalian and yeast mitochondria translate 
AUA as methionine rather than isoleucine whereas in N.crassa and 
A.nidulans it is translated as isoleucine. In addition, AUA and AUU 
can serve as start signals instead of AUG in mammalian mitochondria.
A further difference in the mitochondrial genetic code occurs in yeast 
which read the four codons beginning with CU as threonine rather than 
as leucine. Finally, to date the mitochondria of mammals, yeast, 
N.crassa and A.nidulans specify the amino acid tryptophan by the
'universal1 step codon UGA as well as by the usual UGG codon.
There are 61 codons in the mitochondrial genetic code which, 
according to the 'Wobble' hypothesis proposed by Crick in 1966, would 
require a minimum of 32 tENAs to decipher them all, using a G:U 'Wobble'. 
Contrary to this hypothesis, mammalian mitochondria and several other 
lower eukaryotes appear to require substantially fewer tENAs to read 
their entire genetic code. In the case of mammalian mitochondria 
only 22 tENAs are necessary to fulfil such a function. Each-of the 
22 tENAs in mammalian mitochondria is able to read a 'family' of either 
two or four synonymous codons. The tENAs for the two codon families 
seem to have conventional G:U 'Wobble' anticodons whereas the tENAs 
for four codon families have anticodons with a U in the 5' position. 
There are two possible mechanisms to explain the four codon families; 
either the U base , in the 5' position of the anticodon pairs with all 
four of the 3' codons or the anticodons read only the first two bases 
and ignore the last one, a hypothesis proposed by Lagerkvist (1978).
An interesting question is how some tENAs with U in the 'Wobble' 
position are held to reading two codons rather than four. In the 
mitochondria of yeast and N.crassa and in.many non-mitochondrial tENAs, 
such recognition is prevented by chemical modification of the 'Wobble'
U, but so far sequence analysis of mitochondrial tENAs in animals has 
not revealed any modification at this position.
The mammalian mitochondrial tENAs are also unusual in that most 
lack features common to all tENAs. The most extreme case is that of 
the tENA for serine which lacks the D arm (de Bruijn et al., 1980).
In general, mitochondrial tENAs are apparently stabilised by fewer 
tertiary interactions. These missing or different tertiary inter­
actions may mean that the mammalian mitochondrial tENAs have more 
freedom than cytoplasmic tRNAs reflecting a different interaction
with the ribosome.
1.2 Distribution of Secretory Proteins
1.2.1 Historical Background
Although the basic principles and molecular details of protein 
synthesis have long been established, one of the-most.intriguing problems 
to emerge in recent years has been to understand how newly-synthesised 
polypeptides, which are predominantly made in the cytosol, are distributed 
to their final locations in different sub-cellular cortpartments. The 
sub-cellular distribution of proteins.in a epkaryotic cell can conceptually 
be divided into two ’sorting1 events:
External §?ace 
Plasma Membrane 
Lysosomes
Nucleus 
Mitochondria 
Peroxisomes 
(Chloroplasts)
(Glyoxisomes)
The present understanding of the mechanisms involved in the trans­
port of polypeptides to the various sub-cellular conpartments owes a 
great deal to the studies performed on the synthesis of secretory 
proteins in eukaryotic cells. The initial evidence on the mode of 
synthesis of secretory proteins was provided by electron microscopy 
studies and the discovery (Palade, 1955) that animal cells contain
Membrane-
bound
Initiation of 
protein synthesis
"Primary 
sorting"
Free
Polysomes
"Secondary
sorting1'
membrane-bound ribosomes and ribosomes free in the cytoplasm. Sub­
sequently, various secretory proteins were shown to be synthesised on 
the bound ribosomes while cytoplasmic proteins were formed predominantly 
on free ribosomes (reviewed by Palade, 1975). This distribution 
suggested that secreted proteins might cross membranes as growing 
chains rather than after conpletion of synthesis. Such a mechanism 
was supported by the observation of Sabatini and Blobel (1970) who 
showed that microsomes protected nascent chains of secretory but not 
of cytoplasmic protein from proteolytic degradation. The concept 
that the growing polypeptide chain is translocated through the membrane 
of the endoplasmic reticulum during protein synthesis was then recognised. 
The attachment of bound polysomes to membranes via the amino-terminal 
region of the growing polypeptide chain was first shown by Milstein 
et al. (1972) in their studies on the translation of immunoglobulin 
light chain mRNA in a cell-free system. They showed that a larger 
precursor containing extra amino acids at the amino-terminus was 
synthesised in the rabbit reticulocyte lysate but not in the presence 
of microsomal membranes. In 1975 (a,b) , Blobel and Dobberstein 
presented the decisive experimental data which led to the formulation 
of the signal hypothesis with the following predictions:-
a) Initiation of translation of secretory proteins starts in the 
cytosol with the formation of an amino-terminal signal peptide that 
binds to the endoplasmic reticulum and initiates vectorial discharge 
of the growing polypeptide chain into the lumen of the endoplasmic 
reticulum.
b) Vectorial discharge must start before the chain reaches a
1 An/f v»*i ,^ 4-1 t r 1 4-/^  r-s v/^4"^■! r»r ti«n-4>/-•*/-i •» r-« / -«—■»—» .
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translational secretion).
c) Signal peptides are transient entities that are cleaved before 
chain termination.
1.2.2 Sequence and Structure of Signal Peptides
The signal hypothesis had a major iirpact on the development of 
this research area, leading to the determination of the sequences of 
numerous secretory proteins over the next few years. Initially, it 
was expected that the structure of signal peptides would be highly 
conserved, but this was found not to be the case, as these peptides 
varied in length from 15-30 amino acids (Kreil, 1981). There is 
little obvious homology among signal sequences, but closer examination 
reveals common primary structural features which may be crucial to the 
mechanism that leads proteins across membranes (Garnier et al., 1980).
In all transient signal sequences studied so far there is a central 
region of hydrophobic residues with a minimum length of 9 residues.
To demonstrate that translocation and processing of secretory proteins 
requires structural features determined by the primary amino acid 
sequence, Hortin and Boime (1980), investigated the effect of decreasing 
the hydrcphobicity within this region. They incorporated the leucine 
analogue,^ - hydroxyleucine into bovine preprolactin using a cell-free 
translational system and showed that the precursor was not processed 
to the mature protein, on addition of microsomal membranes.
Most signal peptides also contain residues with positively charged 
side chains, arginine and lysine, near the amino-terminus. Signal 
peptidase preferentially cleaves on the carboxyl-terminal side of the 
small, uncharged amino acids glycine, alanine, serine, cysteine and 
threonine, with alanine most commonly found.
In view of the lack of primary sequence homology among signal
peptides, attention was focused on the likely secondary structure 
of these sequences. In 1979, Austen employed enpirical methods to 
predict the secondary structure of a variety of secretory proteins 
including prohormones and immunoglobulins. There was a tendency 
forx-helix formation in the central hydrophobic region of the signal 
sequence. Recently determined sequences and structural predications 
(Austen and Ridd, 1981) have confirmed that the central portion of all 
signal peptides exhibit a high potential for forming x-helix and to 
a lesser degree, extended or sheet conformation. In many cases 
p -turns, which would be expected to break this structure, were 
predicted to occur with high frequency close to the protease cleavage 
sites. The information gained from these structural studies has led 
to the design and synthesis of a consensus signal sequence by Austen 
et al. (1984). They studied the in vitro processing of nascent 
pre-prolactin, pre-forms of pancreatic digestive enzymes and pre- 
placental lactogen by microsomal vesicles in the presence of this 
consensus peptide. This peptide was shown to inhibit, in a concen­
tration dependent manner, the processing of these secretory proteins.
It would, therefore, appear that it is the three-dimensional structure 
and not the amino acid sequence of the signal peptide which is important 
for correct location of the nascent secretory proteins.
1.2.3 Molecular Aspects of Secretory Protein Synthesis
In recent years much attention has been directed towards a more 
detailed understanding of the mechanisms by which the signal peptide 
interacts with the rough endoplasmic reticulum. Warren and Dobberstein 
(1978) reported that when rough microsomes from canine pancreas were 
washed with high salt concentrations they lost the capacity to trans­
locate nascent immunoglobulin light-chains in a cell-free translational 
system. On re-addition of the salt extract, the microsomes were able 
to translocate this protein. Subsequently, the factor removed from 
the rough microsomes was shown to be a protein complex of Mr 250,000 
(Walter and Blobel, 1980). It has a low affinity for ribosomes alone 
but a very high affinity for ribosomes synthesising secretory proteins. 
Addition of this protein conplex to a cell-free translation system 
synthesising bovine preprolactin, blocked its synthesis as soon as 
the nascent chain was long enough to be recognised as a putative 
secretory protein (Walter and Blobel, 1981). The block remained in 
effect until salt-washed microsomes were added to the system. In 
1982 Walter and Blobel illustrated that a 7S ENA species was also 
associated with this conplex and subsequently named it the 'signal- 
recognition particle1 (SRP). It functions by blocking translation of 
the nascent polypeptide chain and allows the protein to find the 
molecules required to mediate its membrane transfer.
Ihe next step in the transfer must involve a system for removing 
the translational block and permitting transfer to proceed. A 
conponent required for. the translocation of nascent secretory proteins 
was isolated from rough microsomes, using mild proteolysis in con­
junction with high salt (Meyer and Dobberstein, 1980). The salt 
extract prepared frcm rough microsomes by such treatment was capable 
of restoring translocating activity to inactive membrane vesicles. 
Subsequent purification yielded a polypeptide of Mr 60,000 which 
represented the cytcplasmic domain of a larger membrane protein. Tb 
further characterize the membrane-bound molecule, Meyer et al._ (1982a) 
raised antibodies to this polypeptide fragment. Immune-precipitation 
of solubilised, radiolabelled rough microsomal proteins, yielded a 
single polypeptide of M 72,000. On the basis of these findings, it
has been assumed to be the membrane SRP receptor. The protein functions 
by docking the SRP-ribosomal conplex to the rough endoplasmic reticulum 
membrane and was, therefore, called the 1docking-protein1 (Meyer et al., 
1982b). There is very little information with regard to the mechanism 
of attachment of ribosomes to the membrane of the endoplasmic reticulum 
although it appears to involve two proteins, ribcphorins I and II. 
Kreibich et al.. (1978) demonstrated that these two proteins are only 
present in the rough endoplasmic reticulum.
Finally, the properties of the signal peptidase which cleaves the 
amino-terminal signal sequence prior to polypeptide chain completion 
are largely unresolved.
The current picture of the initial events involved in secretory 
protein synthesis are illustrated in Fig. 1.2.1. A summary of the 
molecular characteristics of the proteins involved in this system is 
shown in table 1.2.1.
1.3 Iirport of Proteins into Mitochondria
1.3.1 Introduction
A special feature of the mitochondrion is the presence of a double 
membrane system which divides the organelle into two.compartments: 
the intermembrane space and matrix bounded by the outer and inner 
mitochondrial membranes, respectively.. These individual compartments 
each have their own special set of polypeptides (Ernster and 
Kuylenstierna- 1970) which are necessary for the normal functions 
of the organelle.
As previously discussed (Section 1.1) , the mitochondrion has its 
own genetic material which has a very limited protein coding potential.
Fig. 1.2.1
CURRENT PICTURE OF THE INITIAL EVENTS IN SECRETORY- PROTEIN SYNTHESIS
(Reproduced from Meyer et al., 1982b)
Sequence of events in ER-specific translocation of secretory proteins. 
Initiation begins in the cytoplasm on free ribosomes. Translation is 
blocked by SRP (conponent 1) after 70-80 amino acids have been poly­
merized and the signal sequence emerges from the large ribosomal subunit. 
This arrest of translation persists until contact is made with the 
’docking protein' (component 2) which is a 72,000 Mr, ER-specific 
membrane protein. Translation then resumes and translocation proceeds.
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Mast mitochondrial proteins (greater than 95%) are nuclear-encoded 
and thus must be synthesised on cytoplasmic ribosomes before transport 
to the mitochondrion. Both inner and outer mitochondrial membranes 
present a barrier to the passage of most proteins. As a result, how 
do polypeptides destined for one of the inner mitochondrial coirpart- 
ments translocate across one or both membranes? The import process 
must also be highly specific since each compartment contains a defined 
set of protein components.
Incorporation of nuclear-encoded proteins into mitochondria can be 
divided conceptually into five steps:-
1) synthesis of the polypeptide itself, usually as a larger Mr 
precursor;
2) binding of the precursor to the cytoplasmic surface of the 
mitochondrial outer membrane;
3) translocation of the precursor across or into one or both 
mitochondrial membranes, depending on the final suborganeller location
■k
of the protein;
4) cleavage and/or other covalent modifications of the polypeptide 
chain to generate the mature protein;
5) assembly of subunits into functional proteins which may involve 
association with mitochondrially-encoded subunits.
These steps are shown schematically in Fig. 1.3.1 for thep -  
subunit of F^-ATPase and will now be discussed individually in more 
detail.:
SCHEME ILLUSTRATING THE STEPS INVOLVED IN THE SYNTHESIS, IMPORT AND
ASSEMBLY OF THE g-SUBUNIT OF THE F^ATPase 
(Hay et al., 1984)
A tentative scheme for inport of the precursor to p -subunit of 
yeast F^-ATPase. Step 1: a molecule of precursor (P) is translated 
on a cytoplasmic polysome and. released into the cytosol (Cyt.). Step 2: 
the precursor binds by virtue of its amino-terminal recognition sequence 
(r) to a receptor (R) on the outer mitochondrial membrane (CM). Step 3: 
permanent or transient contact between the mitochondrial membranes allows 
the precursor to utilize the transmembrane potential (4pH+) of the 
inner membrane for translocation. Step 4: the amino-terminal recognition
sequence is removed in the matrix by a chelator-sensitive processing 
protease (PP). Step 5: the processed precursor assembles with other
subunits of the nascent F^-ATPase conplex (nF^ ) to form the mature active • 
holoenzyme (F^ ).
©eyt
Matrix
1.3.2 Mechanism of Synthesis of Nuclear-Encoded Mitochondrial Proteins
Determining the subcellular site of synthesis of mitochondrial 
proteins has been central to the question of how mitochondria take up 
proteins in vivo. Two possible mechanisms of synthesis could be 
considered:-
A) if protein inport into mitochondria occurs by the same mechanisms 
as enployed for secretory proteins then the following assumptions 
could be made:-
i) the cytosol should not contain any pools of mitochondrial
proteins since they would be inported into the mitochondrion 
during translation;
ii) inport of polypeptides into mitochondria should be strictly 
coupled to protein synthesi s;
iii) no larger Mr value precursors to nuclear-encoded mitochondrial 
polypeptides should accumulate in intact cells, since 
vectorial translation usually involves the removal of the 
transient amino-terminal signal sequence prior to conpletion 
of the polypeptide chain.
B) On the other hand, mitochondrial proteins may be synthesised on 
free cytoplasmic ribosomes, existing initially as larger M^ precursors 
which are post-translationally taken up into the mitochondria.
These two possibilities have been distinguished from one another 
primarily by adopting two methods of experimental investigation:-
i) in vitro protein translation systems using either cell- 
free homogenates or reticulocyte lysates programmed with 
mRNA to perform protein synthesis;
ii) in vivo pulse-labelling studies of intact cells.
Original data from the laboratory of Butow and Kellems (1972), 
demonstrated the existence of mitochondrially-bound ribosomes in 
several strains of yeast. These ribosomes were shown by electron 
microscopy to be clustered in regions where the mitochondrial outer 
and inner membranes were in close proximity (Kellems et al., 1975). 
These initial findings appeared to support the view of 'vectorial 
translation' of mitochondrial proteins.
In vivo studies on the synthesis of nuclear-encoded mitochondrial 
proteins, however, provided conflicting results. Hallermayer et al.. 
(1977), in an extensive study looked at the kinetics of labelling of 
newly-synthesised mitochondrial proteins in intact N.crassa cells.
They demonstrated the existence of a lag period in the incorporation 
of radioisotope into mitochondrial proteins relative to total cellular, 
ribosomal, microsomal and cytosolic proteins. In addition, the 
delayed appearance of label was also found in immuncprecipitated mito­
chondrial matrix proteins, mitochondrial ribosomal proteins,
■i.
carboxyatractyloside-binding protein and cytochrome c. The post- 
translational nature of the import mechanism was revealed by the fact 
that in the presence of cycloheximide, inport of proteins into 
mitochondria still occurred. This suggested that newly-synthesised 
mitochondrial proteins exist in an extra-mitochondrial pool from which 
they are inported into mitochondria.
A similar study enploying a cell-free homogenate, prepared from 
N.crassa cells, confirmed the above in vivo results (Harmey et al.,
1977) although the actual site of synthesis could not be determined 
(free or membrane-bound ribosomes).
The first insight into the site of synthesis of nuclear-encoded
mitochondrial, proteins actually came from studies performed in the 
algae, Chlamydomonas reinhardtii. Dobberstein et al. (1977) showed
that the chlorcplast enzyme, ribulose-1, 5-bisphosphate.carboxylase 
was synthesised on free polysomes, as a larger Mr precursor, in an 
in vitro translation system. In 1979, the field of mitochondrial 
protein inport took on a new direction owing to the studies of 
Maccecchini et.al. (1979). This group of workers looked at the 
mechanism of import of the three largest subunits (*,£ and#) of the 
yeast F^-ATPase. The three F^-ATPase subunits were synthesised either 
in vitro using a reticulocyte lysate programmed with, yeast mRNA or 
in vivo enploying pulse-labelled yeast sphercplasts. Under both 
experimental conditions, they were able to show that the c<,p and # 
subunits of the F^-ATPase were synthesised as larger precursors. 
Incubation of the in vitro synthesised precursors with isolated yeast 
mitochondria, in the presence of cycloheximide, resulted in their 
conversion to the mature proteins. This conversion, was also demon­
strated in the yeast sphercplasts by 'pulse-chase' experiments. In 
quick succession, several groups illustrated the existence of larger 
Mr precursor molecules for a number of mitochondrial proteins synthesised 
in vitro under the direction of free polysomes (Conboy et al., 1979, 
Neupert et al., 1979; Raymond/and, Shore, 1979).
However, Butow and Ades (1980) questioned the overall importance of 
free polysomes in mitochondrial protein synthesis. They isolated free 
polysomes and membrane bound polysomes associated with the mitochondria 
from yeast sphercplasts, which had been treated with cycloheximide to 
prevent polysome 'run off'. , The proportion of and y subunits of the 
F^-ATPase made by these, two populations of. polysomes was determined 
m  a cell-free translation mixture. It was discovered that the
proportion of the subunits of F^-ATPase was much greater among the 
products of the mi tochondrially-bound polysomes than those synthesised 
on free polysomes. In a more detailed experiment, Suissa and Schatz 
(1982) repeated the above experiments with yeast adopting slightly 
different experimental conditions to extract the mRNA from the 
polyscmal fractions. They showed that of the twelve mitochondrial 
polypeptides studied, none of the translatable mRNAs were predominately 
associated with mi tochondrially-bound polysomes. The previous studies 
of Ades and Butow (1980) may have over-enphasised the function of 
mitochondrial-bound polysomes, as a result of inhibiting protein 
snythesis with cycloheximide prior to polysome preparation. This 
inhibition could result in the increased binding of the nascent 
polypeptide chain together with its attached polysome. In addition, 
it is very difficult to preserve the in vivo distribution of mRNAs 
between free and mitochondria-bound polysomes during breakage and 
fractionation of the cells.
In summary, it is generally believed that mitochondrial proteins 
are synthesised on free, cytoplasmic ribosomes as precursor molecules, 
which are post-translationally taken up by the organelle. The 
existence of mi tochondrially-bound polysomes has been firmly established 
in yeast cells (Ades and Butow, 1980; Suissa and Schatz, 1982) but 
any role that they may play in mitochondrial protein inport, does not 
appear to be obligatory for this process.
1.3.3 Mclecular Characteristics of Precursors
In 1978, Korb and Neupert investigated the biogenesis of the 
mitochondrial intermembrane space protein, cytochrome c. These 
studies were carried out with a cell-free homogenate prepared from
N.crassa cells and a highly specific antiserum to detect the protein.
In the absence of mitochondria, a precursor molecule was synthesised 
which migrated with the same Mr value as the authentic mature protein, 
on SDS-polyacrylamide gel electrophoresis. The precursor protein, 
apocytochrome c, lacked the haem group which was covalently-linked 
to the protein on addition of isolated N.crassa mitochondria. It 
was not until 1979 and the work of Maccecchini et al. that the 
existence of larger precursor molecules was demonstrated. Biploy ing 
in vitro and in vivo systems they were able to shew precursors to the 
three subunits (<*, p and *) of the yeast F^-ATPase that differed in 
Mr fran their mature counterparts by 2000-6000.
Since these studies, the existence of larger polypeptides to 
many cytcplasmically-synthesised mitochondrial proteins has been shown 
(Table 1.3.1). Their sizes are between 500 and 10,000 dal tons 
larger than those of the corresponding mature proteins. In a few 
cases, it has been directly shown that this size difference results 
from an amino-terminal extension of the polypeptide chain. The pre­
cursors to the yeast F^-ATPase p and * subunits, as well as precursors 
to each of the four cytcplasmically-made subunits of cytochrome c 
oxidase, are primary translation products whose amino-termini can be 
labelled with N-fornylmethionine in vitro (Lewin et al., 1980;
Mihara and Blobel 1980). There is no apparent correlation between 
the size of the amino-terminal extension and the final location of the 
mature protein within the mitochondrion.
Tb date, it has been proven difficult to isolate precursors in 
appreciable quantities to investigate the amino acid sequence of the 
amino terminal extension, directly. Recently, however, attention 
has focused on sequencing the genes for nuclear—encoded mitochondrial
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proteins, to overcome this problem. The sequences of the genes coding 
for the proteolipid subunit of the N.crassa ATPase (Viebrock et al.,
1982) and the yeast cytochrome c peroxidase (Kaput et al., 1982), 
have been determined. The pre-sequence of cytochrome c peroxidase 
is an exclusively amincr-terminal extension of 68 amino acids, which 
renders the precursor more basic and more hydrophilic. Similarly, 
the long signal sequence of 66 amino acids of the proteolipid subunit 
of mitochondrial ATPase, is very polar. It has been suggested that 
the presequence is specifically designed to solubilise the proteolipid 
for post-translational uptake into the mitochondria.
So far the enphasis has been placed on the properties of precursor 
proteins whose value is greater than the corresponding mature 
mitochondrial proteins. A few mitochondrial proteins, on the other 
hand, are like cytochrome c, in that they have precursors with the same 
M as the mature protein (Table 1.3.1). There is evidence for some 
of these proteins, that although they lack a transient amino-terminal 
extension, they differ from the mature protein in conformation. For 
example, the extra mitochondrial form of the adenine nucleotide 
translocase binds to hydroxylapatite whereas the mature form does not 
bind (Zimmermannand Neupert, 1980). The precursor to the outer 
membrane protein, porin, of yeast is sensitive to proteinases but once 
it has become integrated into the membrane, it is insensitive to 
proteolysis, even in the presence of detergent (Gasser and Schatz,
1983). Ehrther differences in the tertiary structures of cytosolic 
precursors, have been demonstrated by showing that they form large 
aggregates. The in vitro synthesised adenine nucleotide translocator 
forms aggregates of between 120,000 and 500,000 M , as estimated by 
gel filtration (Zimmermannand Neupert, 1980). It has been proposed
that the post-translational formation of precursor aggregates occurs 
either to protect than fran proteolysis in the cytosol or for prcper 
presentation to the mitochondrial surface.
1.3.4 Receptors Involved, in the Recognition and Binding of Mitochondrial 
Precursors
After translation of the cytoplasmic, precursor forms of mito­
chondrial proteins, it is postulated that an essential step in the 
translocation process is the specific attachment of the precursors 
to the cytoplasmic face of the mitochondrial outer membrane. This 
interaction could involve specialised receptors o r sinply partitioning 
of the precursors into the lipid bilayer. There is no convincing 
evidence for specific receptors playing a role in the insertion of 
mitochondrial outer membrane proteins, although the process has sane 
specificity. Gasser and Schatz (1983) demonstrated that the in vitro 
synthesised 29,000 M protein of the yeast mitochondrial outer membrane 
did not insert into yeast microsomes. However, evidence for the 
uptake of the cytoplasmic forms of mitochondrial proteins destined for 
the intermembrane space, inner membrane and matrix strongly inplicate 
the participation of .receptor molecules.
The most extensive data suggesting a mitochondrial receptor, 
has cane from studies on the biosynthesis and inport of cytochrome c, 
by Neupert and co-workers. As previously discussed (1.3.3) cytochrome 
c is synthesised in the cytosol as a protein with the same Mr as the 
authentic, mature polypeptide but lacks the haem group (Korb and Neupert,
1978). Covalent attachment of the haem group to apocytochrome c occurs 
after migration of the .precursor to the inner membrane.
Hennig and Neupert (1981) examined the, fate of the in vitro
synthesised precursor in a reconstituted inport system prepared from 
N.crassa. This involved incubating the cell-free translation products 
with isolated mitochondria and individually immuncprecipitating the 
apocytochrome c and holocytochrome c forms from:the mitochondrial 
and post-mitochondrial, fractions with non-cross reacting antibodies. 
Radiolabelled apocytochrome c was rapidly cleared from, the supernatant 
fraction and the mature holoenzyme. appeared in parallel fashion in the mito­
chondrial fraction. There was no transient accumulation of the 
apcprotein within the mitochondrion, under these conditions. However, 
when deuterohemin, a. reversible inhibitor of the haem attachment step, 
was added to the reconstituted import system, a large proportion of 
radiolabelled apocytochrome c was.recovered with the mitochondria.
Tb demonstrate that this binding was specific, Hennig and Neupert 
(1981) showed that the precursor could be released, in a . dose-dependent 
manner from the mitochondria by incubation in the presence of excess 
chemically prepared apocytochrome c. This indicated reversible binding 
and conpetition between the two forms of apocytochrome c for sites on 
the mitochondrial surface. The binding ,was shown to be ligand-specific 
by further experiments in which only the apocytochrome. c form and not 
the holocytochrome c form, carpeted,with the uptake of radiolabelled 
precursor into mitochondria. Matsuura et al. (1981) subsequently 
demonstrated that the post-translational uptake of apocytochrome c 
into isolated rat liver mitochondria was inhibited: by a specific segment 
('addressing signal') of the polypeptide chain. This segment, generated 
by cyanogen bromide cleavage of apocytochrome c, extended from residue 66 
to the carboxyl-terminus.
The existence of different receptors for precursor polypeptides
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following conpetition experiments. Excess apocytochrome c does not
inhibit the uptake of precursors to the .adenine nucleotide translocase, 
the ATPase proteolipid subunit, or cytochrome c^, under analogous 
conditions to those enployed above (Zimmermannet al., 1981; Teintze 
et al., 1982). These results taken-together demonstrate many of the 
binding properties of receptors but do,not show that this activity 
resides in a particular protein corponent of the outer, membrane. To 
investigate the nature of the component (s) responsible for binding of 
precursors to mitochondria, RLezman et al. (1983) prepared outer 
membrane vesicles from yeast cells. In this system they were looking 
at the binding of precursor, polypeptides in the absence of protein 
translocation and processing. - When the .outer membrane vesicles were 
treated with trypsin prior to binding, no precursor to cytochrome b£ 
or -ATPase ^ -subunit could be found to be associated with the vesicles.
In contrast, Gasser and Schatz (1983) illustrated that the outer membrane 
protein, porin, could bind to these outer membrane vesicles, after such 
protease treatment. Ligand and.membrane specificity of binding was 
demonstrated with these outer membrane vesicles. In addition, the 
existence of different, receptors was- suggested also from the finding that 
apocytochrome c failed to inhibit the binding of the precursor to cytochrome
It. would appear from these studies on mitochondrial receptors, 
that there exists on the outer membrane a number of different protein 
receptors which interact with different precursor molecules. Until 
the outer membrane conponents responsible are identified in more detail 
and purified, this inportant stage in the inport process remains largely 
unresolved at a molecular level.
Finally, a great deal of interest has recently been generated from
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functional post-translational inport of the precursor to the rat liver
mitochondrial matrix protein, ornithine transcarbamylase (Argan et_al.,
1983). The conponent was retained by gel filtration of the reticulo­
cyte lysate translational mixture on Sephadex G-25. Confirmation of 
these findings was provided by Ohta and Schatz (1984) when studying 
the iirport of the precursor to cytochrome into yeast mitochondria. 
However, they also showed that a cytosolic factor which was trypsin- 
sensitive and whose Mr was about 40,000, as judged by gel filtration, 
was required for the import of pure ATPase f t-subunit precursor into 
isolated yeast mitochondria. This data suggested a role for soluble 
protein(s) of the cytoplasm in the inport pathway. In addition, 
Firgaira et al.. (1984) demonstrated that a cytoplasmic ENA moiety 
was necessary for the post-translational uptake of nuclear-encoded 
mammalian proteins, destined for the mitochondrial matrix. The 
ribonuclease-sensitive conponent showed many properties that are 
characteristic of ribonuclecproteins. Ihis suggests the possibility 
that a similar 1 signal-recognition particle1 to that employed by 
secretory proteins (1.2.3) might function in the recognition and 
targeting of newly-synthesised proteins destined for the mitochondria. 
These findings also open up a conpletely new area of research with 
regard to mitochondrial import of cytcplasmically-synthesised proteins.
1.3.5 Translocation and Processing of Mitochondrial Precursors
1.3.5.1 Energy Dependence of Translocation
Detailed studies of the energy dependence of translocation have 
made use of an import assay in which in vitro synthesised radiolabelled 
precursors were incubated with isolated mitochondria. Translocation 
of polypeptides across the mitochondrial membranes was checked by 
their inaccessibility to externally-added trypsin. Proper proteolytic
processing of the precursors was assayed by immuncprecipitation and 
SDS-gel electrophoresis, to confirm that the inported proteins migrate 
with the same M as the mature mitochondrial polypeptide.
Early work by Nelson and Schatz (1979) utilising intact yeast 
spheroplasts, demonstrated that the inport and cleavage of precursors 
of the F^-ATPasep and 2 subunits, as well as of two subunits of 
the ubiquinol: cytochrome c reductase complex, was energy-dependent.
Addition*of the uncoupler CCCP to respiring yeast spheroplasts or 
specific depletion of the level of matrix ATP in non-respiring yeast 
strains, blocked translocation and processing of the precursors. 
However, it was not possible from these observations to distinguish 
between a requirement for matrix ATP and an electrochemical potential 
across the inner membrane, since the addition of uncoupler makes the 
inner membrane permeable to protons and simultaneously stimulates the 
hydrolysis of ATP by the F^-ATPase (Heytier, 1979). By using 
respiration deficient (rho ) yeast strains which cannot form an 
appreciable membrane potential, Nelson and Schatz (1979) illustrated 
that import from the cytosol, still occurred. They concluded that 
matrix ATP was probably the immediate energy donor for translocation.
Definitive evidence to the contrary has come from experiments 
performed in vitro, using a similar inport assay to the one described 
earlier in this section. Tb discriminate between the two possible 
sources of energy that can be utilised during translocation, the 
following types of inhibitors were added to the inport assay mixture; 
specific inhibitors of the respiratory chain (KCN, antimycin A), 
of the F^F^-ATPase (oligomycin) and ionophores such as valinomycin.
By using various combinations of these inhibitors, it was possible to
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while the electrochemical gradient across the inner membrane was
depleted. Under these conditions, if the direct energy donor for 
translocation of proteins into mitochondria was the membrane potential, 
then the mitochondria would lose the ability to inport precursor proteins 
despite a high concentration of matrix ATP.
Gasser et al. - (1982a) investigated the effects of such inhibitors 
on the translocation and processing of the F^-ATPase ^ -subunit into 
isolated yeast mitochondria. The precursor containing reticulocyte 
lysate was gel-filtered to remove endogenous energy sources and the 
isolated mitochondria treated with KCN to inhibit respiration of 
endogenous substrates. To ensure a high level of matrix ATP, the 
gel-filtered lysate was incubated in the presence of ATP. ATP can 
be transported into the mitochondrial matrix via the adenine nucleotide 
translocase for use either directly as an energy source or hydrolysed 
by the F^Fg-ATPase to generate a proton gradient across the inner 
membrane. In the absence of other inhibitors, the. mitochondria 
efficiently inported and processed the F^-ATPase p  -subunit precursor. 
However, when the mitochondria were also pre-treated with oligomycin, 
translocation was blocked conpletely. Under these conditions, the 
concentration of ATP in the matrix will be high while any electro­
chemical potential across the inner membrane will be very low. When 
KCN was absent from the incubation mixture and respiration re-stimulated 
by the addition of succinate, oligomycin no longer blocked inport of 
the precursor. These findings showed that an electrochemical potential 
was essential for the inport of matrix-located polypeptides.
Schleyer et al.: (1982) further demonstrated the inportance of an
electrochemical potential difference across the mitochondrial inner 
membrane by following the import of F^-ATPase subunit 9 from N.crassa 
into isolated mitochondria. In the presence of oligomycin and
antimycin A, inport was inhibited but could subsequently be restored 
upon the addition of ascorbate and tetramethylphenylenediamine (TMPD) , 
which donates electrons directly to cytochrome c oxidase, thus by­
passing the antimycin A induced block of electron flow.
On a more detailed examination of the energy requirements for 
translocation into the individual mitochondrial compartments, large 
variations are to be found. Inport of proteins destined for the 
mitochondrial outer membrane does not appear to require either ATP 
or an electrochemical potential across the mitochondrial inner membrane 
(Gasser and Schatz, 1983). On the other hand, proteins destined 
for the mitochondrial inner membrane or matrix require an electro­
chemical potential difference for successful transfer across the inner 
membrane (Gasser et al., 1982a/ Schleyer et al., 1982; Gasser et al., 
1982b).
The mitochondrial intermembrane space provides the greatest 
degree of diversity in its requirement of energy for translocation.
An energised inner membrane is not required for the import of cytochrome 
c (Zimmerman et al., 1981) into the intermembrane space whereas 
translocation of cytochromes and c^  are dependent on the membrane 
potential (Daum et al., 1982; Ohashi et al., 1982). In the case of
both cytochromes b^ and c^, which are processed in two stages (see 
section 1.3.5.2), the first cleavage requires an energised inner 
membrane. However, for cytochrome b2, the second processing step 
is probably not dependent on a membrane potential, since the addition 
of valinomycin and K+ to isolated yeast mitochondria, does not block 
the conversion of the intermediate to mature form (Daum et al., 1982). 
The second processing step for cytochrome c^, does appear to require 
an energised inner membrane (Teintse et al., 1382). The intermediate 
form of cytochrome c^  was allowed to accumulate in intact N.crassa
cells during a [^H]-leucine pulse at 8°C. When the teirperature was 
raised to 25°C and the cells incubated for a further 5 min in the 
presence of CCCP, no conversion to mature cytochrome c^  was observed. 
This indicated that the second processing step in the maturation of 
cytochrome c,| was also energy-dependent. In addition, maturation 
of cytochrome c^  from the intermediate form is haem-dependent (see 
section 1.3.5.3).
An electrochemical potential is also required for the translocation 
of polypeptides across the plasma membrane of Escherichia coli 
(Date et al., 1980; Enequist et al., 1981). In bacteria, however, 
the protein translocation occurs from negative to positive potential 
whereas the direction of translocation is opposite in mitochondria.
Thus it is unlikely that the transmembrane potential serves in both 
cases as a sinple electrophoretic gradient. The electrochemical 
potential required is likely to be quite small since the rho mutant 
which lacks a functional ATPase conplex as well as a respiratory chain, 
efficiently inports proteins.
1.3.5.2 Properties of the Yeast Mitochondrial Matrix Protease
After binding and translocation to the correct intra-mitochondrial 
coipartment, the larger Mr precursor proteins are generally cleaved 
by a matrix-located protease. This cleavage results in the formation 
of a polypeptide with the same value as the mature protein, as 
determined by SDS-gel electrophoresis.
The enzyme was first detected in a hypotonic extract of yeast 
mitochondria (Bohni et al., 1980) from its ability to cleave several 
precursors, in a specific manner, to their mature forms. This cleavage 
occurred in the absence of an energy source, such as ATP. Two groups
of workers have recently reported the further purification of the 
yeast enzyme (IVfcAda and Douglas, 1981; Bohni et al., 1983). The 
protease which had a pH optimum of 7.5 was also strongly inhibited 
by a variety of chelating agents including EDTA, GTP and 1,10 —
phenanthroline. This inhibition was reversed by the addition of
2+ 2+ . .Zn or Co ions. The enzyme was insensitive to the serine protease
inhibitors and to sulphydryl modifying reagents* such as N-ethylmaleimide
and iodoacetamide.)
These partially-purified preparations have been used to determine 
the substrate specificity of the enzyme and some of its physical 
characteristics. On gel filtration, the activity exhibits an Mr 
of 110,000 although SDS-polyacrylamide gel electrophoresis of the 
partially purified preparations reveals the presence of approximately 
ten Coomassie Blue stained bands. MoAda and Douglas (1982) have 
reported that the activity correlates best with the presence of a
59,000 Mr subunit.
35Incubation of an [ S] -methionine labelled precursor polypeptide 
with the partially-purified protease, followed by specific immuncprec- 
ipitation and gel electrophoresis have been used to study the specificity 
of the protease. As previously observed with the crude submitochondrial 
extract (Eiohni et al., 1980) , the partially purified enzyme exhibits 
a narrow substrate specificity. It cleaves a variety of in vitro 
synthesised mitochondrial precursors but does not process non- 
mi tochondrial proteins (Bohni et al., 1983). Cytochromes b2 and c^  
located in the intermembrane space, are cleaved by the matrix enzyme 
to intermediate forms whose Mr values are between those of the 
corresponding precursor and mature forms. Cleavage is limited in 
that it proceeds no further than the mature form, even after long 
exposure to the enzyme. The in vitro processing results were confirmed
in vivo, by pulse-labelling yeast spheroplasts in the presence of 
1,10-phenanthroline. Under these conditions, there was rapid 
accumulation of the precursor of the ^ -subunit of the F^-ATPase (Bohni 
et al., 1983).
Cerletti et al. (1983) adopted a slightly different approach to 
illustrate that the precursors were correctly processed to their mature 
forms. This was achieved by looking at the effect of the partially- 
purified protease on the processing of cytochrome c oxidase subunit 
V precursor, by radiochemical sequence analysis of the processed amino- 
terminus of the mature protein. The amino-terminal region generated 
by this protease was in agreement with the amino-terminus of the mature 
polypeptide.
Finally, the yeast matrix protease is coded in the nucleus. This 
was illustrated by Bohni et al. (1983) who prepared a hypotonic extract 
from the mitochondria of a rho mutant strain of S.cerevisiae and 
showed that the extract could convert the precursor of the F^  -ATPase 
p-subunit to the mature size. The protease must be encoded by the 
nucleus and inported into mitochondria, since such mutant organelles 
have no functional mitochondrial protein-synthesising machinery 
(Schatz and Mason, 1974).
1.3.5.3 Processing of Mitochondrial Precursor Polypeptides
Mitochondrial precursor proteins of larger Mr are proteolytically 
processed to generate the mature-sized polypeptide. The processing 
step(s) can involve any one of three different mechanisms. These 
mechanisms have largely been determined by using the in vitro import 
assay (described in section 1.3.5.1) and confirmed in vivo by pulse- 
labelling intact cells for very short times, detecting initial products
of translation by immunoprecipitation.
Protein precursors destined for the mitochondrial outer membrane 
are synthesised in the cytosol as products with the same Mr as the 
mature polypeptides, with one possible exception being the 35,000 
polypeptide from rat liver mitochondria (Shore et al., 1981) (see 
table 1.3.1). In their case, no proteolytic processing is required 
to conplete maturation. Several other nuclear-encoded, mitochondrial 
proteins localised in the inner membrane, intermembrane space and 
matrix also do not appear to undergo proteolytic cleavage, after 
translocation. These include cytochrome c of the intermembrane space, 
the adenine nucleotide translocase of the inner membrane and 2- 
iscprcpylmalate synthase of the mitochondrial matrix (Korb and Neupert, 
1978, Zimmerman and Neupert, 1980; Hanpsey et al., 1983). Cytochrome 
c does, however, require the addition of haem for conplete maturation 
(see section 1.3.3). Interestingly, of all the mitochondrial matrix 
proteins studied to date, 2-iscprcpylmalate synthase is the only 
exanple to show a lack of proteolytic processing during its maturation. 
The remaining mitochondrial proteins, studied so far, are synthesised 
in the cytosol as larger precursors which undergo one of two 
proteolytic processing mechanisms after correct translocation. A 
major role is played by a matrix-located protease in both of these 
processing mechanisms. The properties of the partially-purified 
yeast matrix protease have been described previously (see section 
1.3.5.2).
The first of these processing mechanisms involves a 'one-step' 
proteolytic cleavage and accounts for the majority of proteins listed 
in table 1.3.1. Endcproteolytic removal of the transient amino-
termxnal sequence of the larger M precursor is acconplished by 
proteolytic cleavage at one site and generates the mature protein.
The final mechanism of processing involves cleavage of the precursor 
to the mature protein in two discreet stages. Cytochrome and 
cytochrome c^, located in the intermembrane space and outer surface 
of the inner membrane respectively, have clearly been shown to be 
processed by this 'two-step' mechanism (Teintze et al., 1982, Peid 
et al., 1982b, Gasser et al., 1982b, Ohashi et al., 1982, Daum et al., 
1982; Bohni et al., 1983) (see section 1.3.5.1 for details of first 
proteolytic cleavage).
To investigate the location of the intermediate-sized polypeptide 
generated by the matrix protease, Daum et al. • (1982) studied the 
in vitro import of cytochrome b^ into isolated yeast mitcplasts.
When import of the precursor was allowed to proceed at low temperatures, 
the intermediate polypeptide remained attached to the mitoplasts whereas 
most of the precursor and mature forms of the protein were found in 
the supernatant fraction. In addition, the intermediate protein was 
fully accessible to externally-added protease under conditions where 
the bulk of matrix-located polypeptide was inaccessible. It was 
suggested from these findings, that the intermediate was bound to the 
inner membrane with the major portion exposed to the intermembrane 
space. Therefore, the second proteolytic cleavage, which converts 
the intermediates to their mature forms, would take place on the 
outer surface of the inner membrane.
In yeast, the enzyme responsible for the second cleavage is 
different from the matrix protease, as it is resistant to chelating 
agents such as 1,1O-phenanthroline, although attempts to extract it 
from the mitochondria have proved to be unsuccessful (Daum et al.,
1982).
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intermediate form is required before the second cleavage can take place
(Ohashi et al., 1982). In haem-deficient yeast, mutants, the inter­
mediate accumulates and is only converted to the mature protein upon 
supplementation of the. strain .with the conpound required to restore 
haem biosynthesis. IX&turation of cytochrome from its intermediate 
species does not require haem attachment before .proteolysis (Gasser 
et al., 1982b; Ohashi et al., 1982). A diagram summarizing the inport 
and processing of these proteins.by the 'two-step' mechanism is shown 
in Fig. 1.3.2.
Mere recently, Sadler et al. (1984), sequenced the gene coding for
the precursor to the yeast cytochrome c^. . The deduced amino acid
sequence of the precursor revealed an unusually long transient amino-
terminal pre-sequence of 61 amino acids. This pre-sequence consisted
of a strongly basic amino-terminal region of 35 amino acids, a central
region of 19 uncharged residues .and an acidic carboxy-terminal region
of 7 amino acids. They have suggested from this sequence data, a
model for the orientation of the precursor across the mitochondrial
inner membrane which can .explain the ' two-step' processing mechanism.
The mechanism of processing of the matrix located enzyme, ornithine
transcarbamylase is intriguing. Conboy et al. (1982), demonstrated that
the rat liver protein was initially made as a larger precursor of Mr
39,000 in vitro. Subsequent inport and processing by isolated rat liver
mitochondria not only resulted in the production of the mature polypeptide
(Mr 36,000) but also an intermediate species of M 37,000 .(Merita et al.,
1982a,b). The intermediate-sized polypeptide could also be formed by
incubating the 39,000 precursor form with a partially-purified rat
liver matrix protease (Miura et al., 1982), but could not be detected
in vivo in isolated hepatocytes (Mari et al.,, 1981). Conboy et al.
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rat liver mitochondria were able to suppress production of the intermediate-
Fig. 1.3.2
'TWO-STEP' IMPORT AND PROCESSING MECHANISM FOR.CYTOCHEOMES AND fc>2 
(Reproduced from Hay et al.,. 1984)
Precursors to cytochromes b2 and c^  of.yeast mitochondria are 
depicted as undergoing two separate proteolytic cleavages after entering 
the mitochondrion. Panel 1: each precursor utilises the inner membrane
electrochemical potential to assume a transmembrane conformation.
Panel 2: initial cleavage (arrows), mediated by the matrix protease
yields a membrane-bound. intermediate with a new, amino-terminus (N').
Panel 3: the second cleavage thought to involve a protease at the outer
face of the inner membrane generates the mature amino-terminus (N"). 
flfeture cytochrome b^ is. released in soluble form (with a noncovalently 
bound heme group (semi-circle) into the intermembrane space. Covalent 
attachment, of heme to the intermediate form of, cytochrome c^  (box) 
precedes the second cleavage.
'Two-step' Import pathway model
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sized form and to convert pre-ornithine transcarhamylase to its mature 
form, in vitro. This result suggested that the intermediate species 
and the mature processed forms were generated by two distinct, coirpeting 
enzyme activities and that the 37,000 Mr polypeptide was not a bona fide 
intermediate in vivo.
The overall findings to date.on the mechanism(s) of import of 
cytcplasmically-synthesised polypeptides are. summarized in table 1.3.2.
1.3.6 Assembly of Processed Proteins into Functional Units
The least well characterized step in the inport of nuclear-encoded 
mitochondrial proteins is the assembly of the processed proteins into 
functional units. A major problem so far has been to show experiment­
ally that after in vitro inport, the mitochondrial polypeptides assume 
the structure and physical properties of the native protein. To 
confirm that a nuclear-encoded mitochondrial polypeptide has been 
correctly assembled, the following criteria should be met:-
1) an inported protein should be shown to have reached its correct 
submitochondrial conpartment;
2) in some instances the protein should have associated with identical 
or non-identical subunits to form the structure of the native molecule;
3) imported and assembled subunits should be functional.
To date, only a few experiments have addressed these problems.
In 1982 (a) , Gasser et al. investigated the specificity of localisation 
of mitochondrial precursor proteins by preparing from isolated yeast
fO
00
on
Oia
►-5
H*
01
r fa
H*
3
5?
P
0
00
8
8*
a
n
H-01
M
I
■0
rf
H -
Q i
0oi
I010
H*
•80
ft
•■oQl1Ol
a
H -
rt\
i-h
0
ft
01
£H-
.8
01
cL
S’
013
0l-h
ft
S '
■gH*
3
ft
01
01I
01
ft
0
a
H -
01
0  c
01 
01a
H*
3
H -
M
01 03 01 03 01 03 01 03 
H* 
01 30 a0 Qj H* H*H * H' H* H-
H - Q i < O
H - 0)
St M
H
f t  f t
M
r f  3
M
00
NO
mitochondria, a soluble intermembrane space fraction, a soluble matrix 
fraction and a membrane fraction (inner and outer.). Prior to sub­
fractionation, an in vitro import assay was performed by incubating 
a labelled reticulocyte lysate with isolated yeast mitochondria.
They discovered that the labelled membrane proteins (cytochrome c^  
and cytochrome c oxidase subunit V) were exclusively located in the 
membrane fraction whereas soluble matrix (2-isopropylmalate synthase) 
and intermembrane space proteins (cytochrome b^ ) were recovered to a 
large extent in their respective soluble compartment and in the 
membrane fraction. It was not, however, determined whether these 
membrane-associated cytochrome b£ or 2-isopropylmalate synthase forms 
represented precursors trapped 'in transit' across the membranes or 
non-specific adsorption.
In a study on the import of carbamoyl phosphate synthetase into 
the mitochondria of foetal rat liver (Canpbell et al., 1982), radio­
labelled carbamoyl phosphate synthetase was recovered in a soluble 
fraction when mitochondria were subjected to fractionation following 
an in vitro inport assay. After inport of the precursor into foetal 
rat liver mitochondria, an increase in carbamyl phosphate synthetase 
activity was demonstrated. The precursor itself showed no enzymatic 
activity which inplied that not only inport into the correct conpartment 
but also assembly of the polypeptide into an active holo-enzyme (two 
identical subunits), had taken place. However, it was not ruled out 
that another ccpurifying factor may have stimulated endogenous enzymatic 
activity.
The correct orientation of an inported protein within the 
mitochondrion has been suggested from findings on two membrane proteins. 
Form, cm ouudr juduiuLdiit; pi.cji_ciix in xci, iido been extensively
studied in yeast (Gasser and Schatz, 1983; Mihara et al., 1982)
and N.crassa (Freitag. et al., 1982). The native protein is insensitive 
to protease even in the presence of detergents, whereas the in vitro 
synthesised product, although of the same Mr as the mature protein, 
is highly sensitive to protease. Upon incubation with isolated 
mitochondria, the newly-inported porin was shown to be resistant 
to externally added protease, even in the presence of detergent, 
inplying correct orientation within the membrane. In a similar study, 
Zimmerman and Neupert (1980) were able to demonstrate that the imported 
N.crassa inner membrane adenine nucleotide translocase, resembled the 
native protein in that it was excluded from hydroxylapatite. In 
contrast, in vitro synthesised precursor binds to hydroxylapatite 
although it is of the same M as the native protein. These two studies 
illustrated that the precursor and native forms of a protein exist in 
different conformations which can markedly affect the properties of 
the protein.
Finally, as #yet, no one has directly demonstrated the proper 
assembly of newly-inported subunits into complex holoenzymes in mito­
chondria, although Lewin and Norman (1983) have strong^  evidence in the 
case of the yeast F^-ATPase. They studied the assembly of the F^-ATPase 
complex in isolated mitochondria by initially incubating yeast mito­
chondria with radiolabelled precursors to the-<, yS and 2 subunits. 
Newly-assembled F^-ATPase was detected by autoradiography of the 
isolated enzyme, the criterion being that only polypeptide subunits 
which had been synthesised in vitro and imported into the isolated 
mitochondria, could be radioactive. Incorporation of labelled subunits 
did not occur in the presence of uncouplers or a divalent metal ion 
chelator, nor did it occur in submitochondrial particles. They also 
showed that incorporation of labelled ATPase subunits into the enzyme 
could be conpeted by unlabelled subunits, provided the unlabelled
proteins were added before mitochondria,were incubated with radioactive 
precursor. The latter two findings suggest that, precursors are being 
assembled into new F^-ATPase conplexes rather than exchanging with 
pre-existing subunits.
1.4 Mitochondrial Phosphate Transport Protein
1.4.1 Introduction
A special feature of the mitochondrion is the presence of a double 
membrane system in which the outer membrane displays an unusual 
permeability, allowing non-specific access to molecules up to approx. 
4,000 Mr (Pfaff et al.., 1968). The. inner membrane represents the 
physical permeability barrier to the passage of small molecules into 
the organelle.
]yfeny of the most inportant functions of .the mitochondrion (Krebs 
cycle oxidations, fatty acid, oxidation, ATP synthesis) occur in the 
matrix and substrates and co-factors for these reactions are separated 
from the enzymes by the inner membrane permeability barrier. This 
segregation of reactions in mitochondria suggests that a series of 
carriers must exist for the. transport, of the substrates and products 
across the inner membrane.
There are two main types of transporters in mitochondria; anti­
porters, where a single ion or substrate is moved into the matrix in 
exchange for one of similar charge and synporters where the transport 
of the anion is also electroneutral, as it. is acconpanied by a proton 
to achieve electrical balance. Also present are uniporters where a 
single ion is transported into the matrix (see Fig. 1.4.1). A transport 
system of particular inportance for maintaining mitochondrial functions
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is the inorganic phosphate carrier system. Transport of inorganic 
phosphate into the mitochondrial matrix can occur via two distinct 
carrier system; an electro-neutral phosphate/dicarboxylic acid 
exchange carrier and a phosphate/hydroxyl ion transport protein, which 
catalyses the influx of about 90% of mitochondrial phosphate. These 
two transport systems are particularly inportant because;
i) they supply the inorganic phosphate which is essential for 
maintaining the steady-state oxidative phosphorylation of ADP in the 
organelle.
ii) the latter carrier is directly linked to the pH gradient 
generated by the electron transport chain in the inner mitochondrial 
membrane.
iii) they allow flux of dicarboxylates and tricarboxylates via the 
phosphate/dicarboxylic exchange carrier.
1.4.2 Identification of the Protein
An interesting property of the two phosphate carrier systems is 
their differing sensitivity to sulphydryl group reagents. The phosphate/ 
hydroxyl ion antiporter can be inhibited by low concentrations of 
N-ethylmaleimide, mersalyl and p-mercuribenzoate (Fonyo and Besman,
1968, Tyler, 1969; Coty and Pedersen, 1974a). In contrast, the 
phosphate/dicarboxylate carrier can be blocked by mersalyl and p- 
mercuribenzoate but is insensitive to N-ethylmaleimide (Meyer and 
Tager, 1969, Meijer et al., 1970, Quagliariello and Palmieri, 1972;
Coty and Pedersen, 1974a). The phosphate/dicarboxylate carrier can
(Hoek et al., 1971; Coty and Pedersen, 1974a).
In 1974(b), Coty and Pedersen using the selective inhibitors
N-ethylmaleimide and n-butylmalonate demonstrated that the overall
phosphate transport activity could be resolved into two conponents;
an N-ethylmaleimide sensitive conponent, which catalysed the transport
of about 90% of the phosphate i.e. the phosphate/?H gradient-linked
carrier system and an n-butylmalonate sensitive transport protein
i.e. the phosphate/dicarboxylate exchange carrier.
Identification of phosphate/hydroxyl ion carrier protein (phosphate
transport protein), has been greatly facilitated by its sensitivity to
N-ethylmaleimide. Coty and Pedersen (1975) , on treating rat liver
3mitochondria with a concentration of N-[ H]-ethylmaleimide to produce 
maximum inhibition of phosphate transport, labelled at least 10 poly­
peptide conponents of the inner membrane. A marked increase in the 
specificity of N-ethylmaleimide for conponents of the phosphate trans­
port system, was attained by first protecting with the reversible
sulphydryl group inhibitor p-mercuribenzoate as illustrated in Fig.
31.4.2. Using this technique N-[ H]-ethylmaleimide, labelled five 
proteins, one of which, a 32,000 Mr value protein, contained 40% of 
the bound radioactivity.
3
In 1978, Wohlrab and Greaney Jr. studied the N-[ H]-ethylmaleimide- 
labelling pattern of proteins in sub-mitochondrial particles, prepared 
by sonication of mitochondria purified from the flight muscles of the 
blowfly, Sarccphaga bullata. The reasons for studying phosphate
carrier protein (s) in mitochondria from the flight muscle of the 
blowfly were;
i) mitochondria have a high metabolic capacity which implies a 
high concentration of phosphate transport systems;
THE EFFECT OF p-MERCURIBENZQATE PROTECTION ON THE SPBCIFIIY OF LABELLING
OF THE PHOSPHATE TRANSPORT SYSTEM WITH N- [3H] -ETHmTOEIMIDE 
(Reproduced frcro Coty and Pedersen 1975)
This diagram conpares the labelling of the mitochondrial phosphate
3transport system and other membrane protein with N-[ H]-ethylmaleimide
using two different procedures: direct labelling (upper reaction) and
labelling after p-mercuribenzoate protection and blocking with N-ethyl-
maleimide (lower scheme). If phosphate transport is inhibited by direct 
3
addition of N-[ H] -ethylmaleimide, a number of membrane proteins are 
labelled in addition to the N-ethylmaleimide binding conponent of the 
phosphate transport system. The p-mercuribenzoate protection procedure, 
however, provides means of reducing the extent and increasing the 
specificity of labelling. This procedure consists of the. following four 
steps: (a) Protection of the phosphate transport system -SH group with
p-mercuribenzoate. (b) Blocking of.accessible membrane -SH groups 
with excess ’cold' N-ethylmaleimide. (c) Removal of p-mercuribenzoate 
protecting group with DTT, followed by washing of the mitochondria to 
remove excess reagent. (d) Reinhibition of phosphate transport with
3
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ii) mitochondria appear to possess only one phosphate transport 
system (Van den Bergh and Slater, 1962;. Wohlrab, 1976) and thus 
represent a unique membrane for the study of phosphate transport.
Seven major labelled proteins were observed under the conditions
employed, only two of which, 32,000 and 45,000 Mr value species were
common to the rat liver mitochondria (Coty,and Pedersen, 1975).
Rirther confirmation as to the identity of the protein(s)
responsible for phosphate transport was provided by Wohlrab (1978),
again using mitochondria prepared from the flight muscle of the blowfly.
By comparing the alkylation of proteins in the submi tochondrial
particles with the inhibition of phosphate transport, Wbhlrab found
that the extent of labelling of proteins of M value 45,000 and 32,000
could be correlated closely with the degree of inhibition of transport.
Finally, Wohlrab (1979) presented evidence which, strongly suggested
that only 32,000 Mr protein constituted the phosphate transporter.
3By comparing the N-[ H]-ethylmaleimide labelling patterns of sub- 
mitochondrial particles prepared from rat heart with those of the 
blowfly flight muscle, Wohlrab (1979) illustrated that the 45,000 
M protein was absent from heart sonic submitochondrial particles.
Since both types of mitochondria are energetically active and possess 
a phosphate carrier system, this finding strongly suggested a role 
for the 32,000 protein in phosphate transport.
1.4.3 Purification Studies on the Phosphate Transport Protein
Wohlrab (1980), having identified the protein responsible for 
phosphate transport in mitochondria, partially purified the phosphate 
transport protein from beef heart mitochondria, by taking advantage of its 
low affinity for hydroxylapatite. The purified fraction consisted of the
phosphate transport protein and the carboxyatractyloside binding 
protein (ADP-ATP translocase protein). SDS-polyacrylamide gel 
electrophoresis analysis demonstrated that the phosphate transport 
protein had an Mr of 34,000. Reconstitution experiments, in which 
the phosphate transport protein was incorporated into liposomes, 
suggested a primary role in mitochondrial phosphate transport.
However, the reconstituted system catalysed phosphate-phosphate 
exchange, as determined by ^^Pi efflux or uptake, with a maximal 
exchange rate which was about 2% of the rate in isolated mitochondria 
(Coty and Pedersen, 1974b). This phosphate-phosphate exchange was 
shown to be sensitive to N-ethylmaleimide, mersalyl and p-mercuri­
benzoate but insensitive to the dicarboxylate carrier inhibitor, 
n-butylmalonate or the adenine nucleotide translocase inhibitor, 
carboxyatractyloside.
In 1981, Kolbe et al. . successfully separated the pig heart 
mitochondrial phosphate transport protein from the adenine nucleotide 
translocase, by passing the hydroxylapatite eluate through a Celite 
column. Reconstitution experiments in which this hydroxylapatite/ 
Celite eluate was incorporated into liposomes, demonstrated that the 
rate of exchange of 32px was slightly higher than in the hydroxylapatite 
eluate but still only represented about 2% of the activity in vivo.
The low activity of phosphate transport reported in these two studies 
did not rule out the possibility that a secondary, contaminating 
protein was responsible for this activity and not the primary phosphate 
transport protein.
Kolbe et al. (1981) in the same study as described above, 
demonstrated that the Celite purified protein could be resolved into 
four separate components by SDS-polyacrylamide gradient gel electro­
phoresis (Mr range 35,000-31,500). Three possible explanations were 
proposed to interpret this result:-
i) the phosphate carrier of mitochondria occurs as a complex of 
up to four different polypeptide chains;
ii) some of the four proteins represent proteolytically or other­
wise modified forms of the same protein;
iii) the phosphate carrier is conposed of one protein, the other 
proteins represent different functional proteins, not related to 
phosphate transport.
In recent years, a great deal of attention has been directed 
towards solving this problem and will be discussed in chapter three.
1.5 Etimarase or Rrnarate Hydratase (EC 4.2.1.2)
1.5.1 Introduction
Rimarase or fumarate hydratase (EC 4.2.1.2) catalyses the reversible 
hydration of fumarate to L-malate according to the following reaction:
H COOH COOH
H - C - H
II
COOH
C HO - C - H
Rjmarate
COOH
L-malate
The hydrogen and hydroxyl groups of water are exchanged stereo- 
specifically during the conversion of fumarate and L-malate.
Due to its fundamental role as an essential enzyme of the tri­
carboxylic acid cycle (Fig. 1.5.1), fumarase is found in a wide variety 
of organisms including bacteria (de Mello Ayres, and Lara, 1962; 
Lamartiniere et al., 1970), yeast (Eavelukes.and .Stcppani, 1958), 
moulds (Jacobson, 1931), plants (Shih and Barnett, 1968), invertebrates 
(Clutterbuck, 1928) and mammals (Kuff, 1954; Shepherd, et al., 1955).
In 1952, fumarase was first successfully crystallised from pig 
heart muscle by ftkssey,.who demonstrated that it crystallised from 
ammonium sulphate solutions in an essentially, homogeneous form. 
Subsequent methods for inproving the yield from pig heart muscle, were 
developed by Kanarek and Hill (1964) , enabling many of its molecular 
and catalytic properties to be studied in detail.
The Mr value of the native enzyme as determined by sedimentation 
equilibrium studies was 194,000 (Kanarek and Hill 1964). However, 
the following experimental findings indicated that the native enzyme 
was ccnposed of four identical subunits (Kanarek et al., 1964; Robinson 
et al., 1967):
i) In the presence of 6M urea the was judged to be 48,500 by 
sedimentation equilibrium methods.
ii) Amino-terminal end group analysis revealed 3.6 residues of 
alanine per molecule assuming an of 194,000.
iii) Tryptic peptide maps of fumarase revealed about one-quarter 
of the expected number of peptides based,on the lysine and arginine 
content of the enzyme.
The enzymatically-active form of fumarase appears to be the 
tetrameric structure since, in general, any condition which results
Fig. 1.5.1
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in dissociation of the enzyme leads to a loss of enzymic activity.
In the presence of urea or guanidine hydrochloride the enzyme is fully 
dissociated and inactivated at concentrations greater than 2.0M 
(Robinson et al., 1967; Teipel and Hill, 1971). However, removal of 
these agents by dialysis against phosphate buffer or phosphate buffer 
containing malate, restores over 90% of the fumarase activity.
For many years it was thought that the substrate specificity of 
fumarase was quite rigid and that the enzyme only reacted with its 
natural substrates, fumarate and L-malate. However, several artificial 
substrates have been discovered, the structures of which revealed two 
general requirements for fumarase substrates:-
a) Two negatively charged carboxyl groups are required for a 
substrate, in agreement with earlier findings that this was also a 
structural requirement for conpetitive inhibitors (Massey 1953).
b) The hydroxyl groups in all substrates must have the same con­
figuration as found in L-malate.
The reversible binding of fumarase with its substrates, fumarate 
and L-malate and with two conpetitive inhibitors, citrate and trans- 
aconitate has been examined by equilibrium dialysis (Teipel and Hill 
1968). These studies revealed that there were four substrate or 
inhibitor binding sites per molecule of enzyme or an average of one 
site per polypeptide chain subunit. At low concentrations of substrate 
the hydration of fumarate and dehydration of malate follow Michaelis- 
Menten kinetics but at concentrations more than about five times Km, 
substrate activation is observed (Taraszka and Alberty 1964). The 
substrate activation can be explained by one of the following mechanisms
i) A second molecule of substrate can bind at a site(s) other 
than the active site and thereby increase the reactivity of the active 
site.
ii) Etunarase possesses two or more identical binding sites for 
substrate which display co-operative interactions such that binding of 
substrate to the first site(s) decreases the affinity of substrate 
for the latter site(s). This mechanism is known as 'negative
i /
co-cperativity1 and was originally proposed by Conway and Koshland 
Jr. to explain the kinetic behaviour of glyceraldehyde-3-phosphate 
dehydrogenase (Conway and Koshland Jr. 1968).
iii) The enzyme possesses two or more independent but non-identical 
binding sites, or, alternatively, there are two or more forms of the 
enzyme present which have different affinities for substrate.
1.5.2 Compartmentalisation of FUmarase
It has long been established that fumarase is located in the
■i
mitochondrial matrix where it is an essential enzyme of the tricarboxylic 
acid cycle. However, fumarase has also been reported to be involved 
in many metabolic processes which occur in the cell cytoplasm (Fatner 
et al., 1953, Ravdin and Crandall, 1951; Knox and Lemay-Knox, 1951):-
i) In the urea cycle fumarate is generated by the enzyme 
argininosuccinase which cleaves argininosuccinate into arginine and 
fumarate.
ii) During tyrosine-oxidation, fumarate is generated by the 
hydrolysis of 4-fumarylacetoacetate.
iii) In purine nucleotide biosynthesis, fumarate is derived from 
adenylsuccinate.
In all cases, an extramitochondrial fumarase would be able to 
link these cycles to the mitochondrial matrix tricarboxylic acid cycle, 
by converting fumarate to malate, which could subsequently be taken 
up as a permeant substrate.
In 1976, Nakashima et al. demonstrated that there was as much 
fumarase activity localised in the rat liver cytosol as in the mito­
chondria. This intracellular distribution of hepatic fumarase was 
confirmed in analogous studies in mouse, rabbit, dog, chicken, snake, 
frog and carp (Akiba et al., 1984). In the same report, these workers 
looked at the subcellular distribution of the enzyme in rat kidney, 
brain, heart and skeletal muscle and in hepatoma cells (AH-109A).
Among these tissues, the brain was the only exception having no fumarase 
activity in the cytosolic fraction, all the other tissues showing a 
bimodal distribution of the enzyme.
In recent years, extensive research has been directed towards 
gaining an insight into the structural and physical properties of these 
two rat liver fumarase activities. The first successful purification 
of the mitochondrial and cytosolic fumarases was achieved by Kobayashi 
et al. (1981). They purified the two fumarases from isolated rat 
liver mitochondrial and cytosolic fractions respectively, enplcying 
the method of Kanarek and Beeckmans (1977), which involved affinity 
chromatography on a pyromellitic acid column. The mitochondrial 
fumarase was resolved into two fractions by Whatman DE-52 column 
chromatography, a non-absorbed and an absorbed fraction whereas the 
cytosolic fraction largely passed through this column. The fumarase 
activity contained in these three fractions was then crystallised
with ammonium sulphate. Subsequent studies to characterize the 
physicochemical and catalytic properties of the two separate fumarases 
are summarised in table 1.5.1. It can clearly be seen from this 
table that the two forms of the enzyme are very similar with regard 
to their properties. In addition, the amino acid composition of the 
cytosolic fumarase was shown to be very similar to that of the mito­
chondrial enzyme. Furthermore, immunochemical techniques could not 
differentiate the two enzyme forms from one another, since a single 
precipitin band was formed between the rabbit antiserum against the 
cytosolic fumarase and the cytosolic or mitochondrial fumarase. To 
obtain more conclusive evidence on the identity of the cytosolic and 
mitochondrial fumarases, Kobayashi and Tuboi (1983) examined the 
terminal amino acid residues. The carboxyl-terminal amino acid of 
both enzymes was identified as leucine by using carboxypeptidase A. 
However, the amino-terminal amino acid residue of each fumarase could 
not be identified by classical methods, suggesting that they were 
masked. The N-termini of the mitochondrial and cytosolic fumarases 
were subsequently identified as pyroglutamic acid and N-acetylalanine, 
respectively. In the same study, these workers also compared the 
primary structures of the enzymes in detail by digesting either with 
an arginine-specific protease or with cyanogen bromide. Electro­
phoretic profiles of the digests were indistinguishable from each 
other.
As would be expected from these observations on the molecular 
properties of the mitochondrial and cytosolic fumarases purified from 
rat liver, it has until recently been inpossible to separate them 
from their mixture. However, Hiraga et al. (1984) illustrated that 
the mitochondrial and cytosolic fumarases of rat liver could be
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separated from each other by Bio-gel hydroxylapatite column chromato­
graphy. This showed that there are some conformational differences 
between the native proteins which have been indistinguishable from 
their physicochemical, catalytic and immunochemical properties.
Finally, it has been suggested that the cytosolic and mitochondrial 
fumarases are products of the same gene (Tolley and Craig, 1975;
IVfcKusick and Raddle, 1977). The molecular findings to date would 
certainly confirm such a suggestion, since the two fumarase activities 
have been shown to be very closely related to one another. If the 
mitochondrial and cytosolic fumarases are derived from the same gene, 
the mechanism by which fumarase synthesised on cytoplasmic ribosomes 
is distributed into two different subcellular compartments is an 
extremely important question that has still to be resolved.
GENERAL AIMS
When I started my research in October, 1981, I set out with the 
following objectives:
i) to purify the phosphate transport protein from rat liver 
mitochondria and to further characterize the isolated protein by 
enploying its known sulphydryl group sensitivity properties;
ii) to raise a polyclonal, monospecific antiserum to the isolated 
phosphate transport protein which I could use as a specific tool to 
follow its biosynthesis in vivo, enploying mammalian tissue-culture 
cell lines;
iii) to raise a polyclonal, monospecific antiserum to pig heart 
fumarase and to subsequently utilise this antiserum to gain an insight 
into the mechanism of bimodal distribution of the enzyme, in vivo, 
as above (see ii).
CHAPTER TWO
MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 Biological Materials 
Animals
Female rats of the Wistar strain were bred and obtained from
the Departmental Animal House.
New Zealand white rabbits (4 months old) were purchased from 
• ✓
MRC accredited sources.
Cell Lines
Buffalo rat liver (BRL) cells were a kind gift from Dr. J. Pitts, 
Beatson Institute for Cancer Research, Garscube Estate, Glasgow, U.K. 
Pig kidney (PK-15) cells were supplied by GIBCO Europe, Paisley,
U.K.
Bovine kidney (NBL-1) cells were purchased from Flow Laboratories 
Ltd., Irvine, Ayrshire, U.K.
Yeast
The following yeast'strains were the kind gift of Dr. G. Reid, 
Department of Microbiology, University of Edinburgh:-
Wild type Saccharomyces cerevisiae (S.cerevisiae) 
strain D273-10B (o<, ATCC 25657) and the corres­
ponding rho mutant D273-10B-1
2.1.2 Chemicals for Polyacrylamide Gel Electrophoresis
Acrylamide monomer, N,N’ methylene bis-acrylamide (specially 
purified for gel electrophoresis), ammonium persulphate and sodium 
dodecyl sulphate (SDS) were supplied by BDH Chemicals, Poole, Dorset, 
U.K.
N,N,N',N' tetramethylethylenediainine (TEMED) and Coomassie 
Brilliant Blue R250 were purchased from Sigma (London) Chemical 
Company, Poole, Dorset, U.K.
Pyronin Y dye was supplied by George T. Gurr Ltd., London, U.K.
Low standards were purchased from Pharmacia Ltd., Pharmacia 
House, Midsummer Boulevard, Central Milton Keynes, Buckinghamshire, U.K.
2.1.3 Radiochemicals 
35L-[ S]-methionine (approx. 1100 Ci/mmol) and carrier free
125Na I (approx. 100 mCi/ml) were purchased from Amersham International 
pic, White Lion Road, Amersham, U.K.
3
N-[2- H]-ethylmaleimide (approx. 50 Ci/mmol) was supplied by 
New England Nuclear, Du Pont (U.K.) Ltd., Southampton, U.K.
2.1.4 Chemicals for Fluorography
Dimethyl sulphoxide (DMSO) and 2,5-diphenyloxazole (PPO) were 
obtained from Koch-light Laboratories Ltd., Colnbrook, U.K.
Salicylic acid was supplied by Aldrich Chemical Co. Ltd., 
Gillingham, U.K.
2.1.5 Photographic Materials
Plastic intensifying screen holders (Plast-X cassettes) were 
purchased from Anthony Monk (ENG) Ltd., Sutton-in-Ashfield, U.K.
Du Pont Cronex intensifying screens (18 x 24 cm) were supplied 
by MAS, Springkerse Industrial Estate, Stirling, U.K.
Kodak X-Cmat S film, Kodak XAR-S film, Kodak LX-24-X-ray 
developer and Kodak FX-40 X-ray liquid fixer were obtained from Kodak
(U.K.) Ltd., London, U.K.
2.1.6 Immunochemicals
Freund's adjuvants were obtained frora,Difco Laboratories Ltd., 
Golnbrook, U.K.
Nitrocellulose paper (0.45pm pore size) was supplied by Anderman 
and Co. Ltd., Laboratory.Supplies Division, Kingston-upon-Thames,
Surrey, U.K.
Heat-inactivated horse serum was purchased from GIBCO Europe,
Paisley, U.K.
Anti-rabbit gamma-globulin conjugated to horse radish peroxidase
was supplied by Miles Laboratories Ltd., Stoke Poges, Slough, U.K.
TMFalcon 3912 Microtest III Flexible assay plates were purchased 
from Flow Laboratories Ltd., Irvine, Ayrshire, U.K.
Goat serum .and normal rabbit serum were obtained from the Scottish 
Antibody Production Unit, Carluke, Lanarkshire, U.K.
Pansorbin (Staphylococcus aureus Cowan I strain (S.aureus) 
cell suspension) was supplied by Calbiochem-Behring, Cambridge Bioscience, 
Hardwick, Cambridge, U.K.
Protein A isolated from S.aureus Cowan I strain was.purchased 
from Sigma (London) Chemical Co. Ltd., Poole, Dorset, U.K.
2.1.7 Tissue Culture. Materials
Sterile reagents to prepare Glasgow modification of Eagle's 
medium were supplied.by the Tissue Culture Unit, Department of Bio­
chemistry, University of Glasgow, with the exception, of non-essential 
amino acids (MEAA) , .(-) methionine Eagle's medium and glutamine which
were all purchased from GIBCO Europe, Paisley, U.K.
Yeast
Bacto-peptone and yeast extract were purchased from Difco 
Laboratories Ltd., Golnbrook, U.K.
2.1.8 Chromatographic Media
Hydroxylapatite (Bio-gel HTP) was purchased from BIO-PAD 
Laboratories Ltd., Watford, Hertfordshire, U.K.
Celite type 535 was supplied by Uniscience Limited, Cambridge,
U.K.
Procion Red A was obtained from Amicon Ltd., Scientific Systems 
Division, Upper Mill, Stonehouse, Gloucestershire, U.K.
Sephadex G-50 was purchased from Pharmacia Ltd., Pharmacia House 
Midsummer Boulevard, Central Milton Keynes, Buckinghamshire, U.K.
2.1.9 Enzymes
The following enzyme preparations were purchased from Sigma 
(London) Chemical Co., Poole, Dorset, U.K.:-
Ehmarase (EC 4.2.1.2) from porcine heart 
Citrate synthetase (EC 4.1.3.7) from porcine heart
2.1.10 General Chemicals
Oxaloacetic acid (OAA), acetyl CoA, 2,4 dinitrophenol, digitonin 
L-malic acid, bovine serum albumin (BSA), 1,10-phenanthroline, 5,5'- 
dithio(bis) 2-nitrobenzoic acid (DTNB) , Triton X-100, sodium deoxy- 
cholate (DOC), polyethylene sorbital mono-laureate (TWeen 20),
carbonyl cyanide m-chlorophenylhydrazone (CCCP), D-mannitol, 
o-phenylene diamine, 4-morpholincprcpanesulfonic acid (Mops), 
concanavalin A (con A) and wheat germ agglutinin (WGA) , acetyl-L- 
leucyl-L-leucyl-L-argininal (leupeptin), iodoaeetamide, p-amino- 
benzamidine were all supplied by Sigma (London) Chemical Co. , Poole, 
Dorset, U.K.
EGTA, 2-mercaptoethanol and Fblin and Ciocalteu's phenol reagent
were purchased from BDH Chemicals Ltd., Poole, Dorset,, U.K.
Phenylmethylsulfonylfluoride (PMSF) and Tris were obtained from
Boehringer Mannheim, Boehringer Corporation (London) Ltd., Lewes,
East Sussex, U.K.
Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP)
was purchased from Aldrich Chemical Co., Ltd., Gillingham, U.K.
Sodium azide was purchased from Hopkin and Williams, Chadwell
Heath, Essex, U.K.
Dithiothreitol (DTT) was supplied by Koch-light Laboratories,
Colnbrook, U.K.
TMIodogen was purchased from Pierce Chemical Co., Rockford, 
Illinois, U.S.A.
All the other fine chemicals' and reagents used were of the 
highest available commercial grade.
2.2 GENERAL METHODS
2.2.1 Protein Estimations
The amount of protein in a sairple was measured either by the 
method of Lowry et al. (1951) incorporating the modification of 
Markwell et al. (1976) or by the Biuret method (Gornall et al., 1949).
Calibration curves were constructed from a standard stock 
solution of BSA (10mg/ml).
2.2.2 Enzyme Assays
A) Citrate synthetase (EC 4.1.3.7)
The activity of citrate synthetase was measured by the method 
of Srere (1969). The assay contained in a total vol. of 1ml, 0.4M 
Tris-Hd pH 8.0, 0.5mM DTNB solution, 3mM acetyl CoA and 50-100jug 
of sanple protein. Initiation of. the reaction was achieved by the 
addition of 5mM OAA and the formation of 5-thio-2-nitrobenzoate anion 
monitored at 412nm.
B) FUmarase (EC 4.2.1.2)
The activity, of fumarase was measured by the method of Hill 
and Bradshaw (1969) by .monitoring the formation of. fumarate from 
malate at 240nm. The procedure for performing the assay, in a total 
vol. of 1ml, was as follows:
0.05M L-malic acid solution (dissolved in 0.1M potassium 
phosphate buffer. pH .7.6) was equilibrated to 25°C.. The 
reaction was started by the addition of 1.-5pg of purified 
fumarase or 50-100pg of mitochondrial extract protein.
2.2.3 Radioiodination of Proteins
125In general, lodination of proteins with. Na I was performed 
by the method of Salancinski et al. (1981). 1mg,of protein dissolved 
in 1ml of 20mM Tris-HCl buffer, pH 7.2 containing, 150mM NaCl was added 
to a small glass vial, the bottom surface of which was coated with a
TMthin layer of Iodogen (1ng). Radiolabelling was initiated by
125
the addition of 300-500jjCi of Na I (100m Ci/ml) before allowing 
the reaction to proceed for 15 min at room teirperature. Incorpor­
ation was terminated by transferring the mixture to a centrifuge tube
TMand spinning at 1000g for 5 min to pellet any residual Iodogen .
125 •Free [ I] iodide was removed by subjecting the supernatant fraction
to chromatography on a Sephadex G-50 column (6.5 x 1.4cm), which had
been equilibrated with 20mM Tris-HCl buffer pH 7.2 containing 150mM
NaCl. Void volume aliquots (1ml) were analysed on an LKB Wallac
1251275 mini-gamma counter and those containing the I-labelled protein
6 0 
pooled, dispensed (2 x 10 cpm/fraction) and stored at -20 C. Bio­
rad low M standards and protein A were labelled in a similar manner.
125The lectins, con A and WGA were labelled with Na I by the method 
described in section 3.2.2.
2*2.4 SDS-Polyacrylamide Gel Electrophoresis
2.2.4.1 Preparation of Gels-Electrophoretic Conditions
Polyacrylamide gel electrophoresis was carried out in a dis­
continuous system, according to Laemmli (1970) in the presence of 0.1% 
(w/v) SDS. Slab gels (19 x 9.5cm) were cast between two glass 
plates separated by 1.5mm thick teflon spacers in a perspex box designed 
to accommodate four pairs of glass plates at any one time. To prepare 
the separating gel, acrylamide stock solution, running gel buffer 
and ammonium persulphate (listed in table 2.2.4.1) were mixed and 
degassed under vacuum on a water puitp. Polymerisation was initiated 
by the addition of TEMED to the mixture, the gel solution poured 
immediately and overlaid with isopropanol. When the separating gel
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had set the iscpropanol layer was removed and stacking gel solution 
(see table 2.2.4.1) placed on top of the separating gel. Sairple wells 
were formed by inserting a teflon comb into the stacking gel solution 
(24 wells per gel) prior to polymerisation. Variations on this method 
of casting gels will be described in the appropriate section.
The reservoir buffer contained 0.025M Tris-HCl pH 8.3, 0.192M 
glycine and 0.1% (w/v) SDS. Electrophoresis was performed at 60mA 
per gel until the tracking dye had reached the bottom edge of the gel. 
The gel was maintained at 10-15°C by a circulating cold water system 
which was attached to the electrophoretic apparatus.
2.2.4.2 Preparation of Protein Sanples for Electrophoresis
In general, sanples to be resolved by SDS-polyacrylamide gel 
electrophoresis were precipitated by the addition of 4 vol. of acetone 
and the protein collected by centrifugation at 1500g for 10 min on 
a Beckman model TJ-6 benchtcp centrifuge. The pellet was dissolved 
in Laemmli sanple buffer (0.0625M Tris-HCl pH 6.8, 2% (w/v) SDS, 10% 
(w/v) sucrose, 5% (v/v) 2-mercaptoethanol and 0.001% (w/v) Pyronin Y, 
to act as tracker dye), by boiling for 2 min at 100°C.
2.2.4.3 Staining of Protein(s)
Protein(s) were visualised after, electrophoresis by immersing 
the gel in a solution containing; 0.04% (w/v) Coomassie Brilliant 
Blue R250, 25% (v/v) iscpropanol and 10% (v/v) acetic acid for 8-12h 
at room temperature. Destaining of the gel to reveal protein (s) 
was achieved by washing the gel several times in a solution containing- 
25% (v/v) iscpropanol and 10% (v/v) acetic acid.
Generally, if radiolabelled proteins were being investigated 
the gels were fixed in a solution of 25% (v/v) iscpropanol, 10% (v/v) 
acetic acid for 8-12h at room tenperature before further processing.
2.2.4.4 Estimation of the Relative Molecular Mass (M ) of a Protein
lb calculate the Mr value of a protein on an SDS-polyacrylamide 
gel, the electrophoretic mobility (R^ ) must be defined:-
distance migrated by protein
Rf = --------;---------------------
distance migrated by tracking dye
Ihe R^ value for a protein can be calculated either by directly 
measuring the distance on the stained gel or, more accurately, after 
densitometric scanning of the gel with an LKB 2202 Ultroscan laser 
densitometer. Ihe method has to be calibrated with a set of standard 
proteins of known M values. A plot of R^ value versus log for 
these marker proteins enables the subunit Mr of the sanple protein to 
be determined directly.
A list of the standard marker proteins used and their Mr values 
is given below:-
Phosphorylase b 94,000 ; BSA 67,000 ; ovalbumin 43,000 ;
carbonic anhydrase 30,000 ; soyabean trypsin inhibitor
20,100 ; o<-lactalbumin 14,400.
2-2.4.5 Autoradiography
125Polyacrylamide slab gels containing I-labelled proteins were 
dried down on Whatman 3MM filter paper using a Flexi-dry freeze-
drier (FTS Systems inc., Stone Ridge, New York, U.S.A.). Detection of
radiolabelled proteins was carried out at -80°C using Kodak X-Omat 
S film, enploying Du Pont Cronex intensifying screens to enhance the 
sensitivity of the procedure.
2.2.4.6 Fluorography
Two independent methods, which varied in their, use of chemical
3 35fluor, were utilised to detect [ H] or [ S]-labelled proteins. The 
sensitivity of the two techniques was conparable.
A) This procedure adopted the method of Bonner and Laskey (1974) 
and utilised a water insoluble fluor. After fixing (2.2.4.3), the 
gel was washed twice for 1h at room temperature with DMSO to remove 
any water, then placed in a solution of. DMSO containing the fluor PPO
20% (w/v) . After a 3h incubation at room temperature, the gel 
inpregnated with PPO was washed continuously for 30 min under running 
water, resulting in the precipitation of the fluor in the gel.
B) A.water soluble fluor, sodium salicylate was incorporated into 
the gel by closely following the method of Chamberlain (1979). After 
fixing, (2.2.4.3) the gel was washed several times with distilled water 
to remove any acetic acid, then immersed in a solution of 1M sodium 
salicylate and incubated for a further 30 min at room teirperature.
In both instances the gels were dried down on Whatman 3MM paper before 
exposure to X-ray film as described in section 2.2.4.5..
2.2.5 Subcellular Fractionation Techniques
2.2.5.1 Isolation of Rat Liver Mitochondria
Mitochondria were prepared by the method of Chance and Hagihara
(1963). Female rats of the Wistar strain (180-200g) which had been 
starved overnight to eliminate glycogen storage particles, were killed 
by cervical dislocation, the livers excised and. rinsed 2-3 times with 
ice-cold isolation medium. (0.225M mannitol, 0.O75M sucrose, 500pM 
EGTA, 2mM Mcps buffer pH 7.2). After washing, the livers were chopped 
finely with a pair of scissors;before cell breakage with a tight-fitting 
teflon pestle (clearance 0.004-0.006pm) on a Potter-Elvenhjem homogeniser 
(5 passes). Blood, unbroken cells and nuclei were sedimented by 
centrifugation of the suspension at 8OOg for 7 min. The resulting 
supernatant fraction was decanted into fresh tubes for. centrifugation 
at 6500g for 15 min to pellet the mitochondria. Residual blood and 
nuclei were removed from this pellet by resuspending it in isolation 
medium and centrifuging at 800g for 7 min. Finally, mitochondria 
were pelleted from the above supernatant fraction by centrifugation at 
6500g for 7 min before being washed once in.,isolation, medium to remove 
polysomal and microsomal contamination.
All the centrifugation steps were performed at 4°C and the final 
mitochondrial pellet stored at -20°C until further use.
2.2.5.2 Preparation of Rat Liver .Mitcplasts (Mitochondria with
Outer Membrane Removed)
Purified mitochondria, isolated from.rat liver (2.2.5.1) were 
resuspended in 10mM Tris-phosphate buffer pH 7.5 (swelling medium), 
at a protein concentration of 10mg/ml before incubating on ice for 
5 min. The mitochondria were then shrunk,.by the addition of a solution 
containing 1.8M sucrose, ,2mM ATP and 2mM MgSO^. After, a further 2 min 
incubation on ice, mitcplasts were pelleted by centrifugation at 6500g
for 10 min. The mitcplasts were resuspended in. isolation medium 
(2.2.5.1) and washed twice.
2.2.5.3 Isolation of Subcellular Fractions from Cultured Mammalian 
Cells
Crude subcellular fractions were prepared frcm the three mammalian 
cell lines, BKL, PK-15 and. NBL-1 by the method of Attardi and Ching 
(1979). To isolate subcellular fractions from cultures, cells were 
grown as monolayers in 20 oz. roller bottles at 37°C (2.4.2). On 
reaching confluence, growth medium was decanted, the cell monolayer 
washed 3X with a solution containing 0.13MNaCl, 0.005M KC1, before 
harvesting in 6 vol. of 0.01M Tris-HCl buffer pH 6.7 containing 0.01M 
KC1 and 0.15mM MgCl^. After incubating for 2 min on ice, the cell 
suspension was disrupted with a Potter-Elvenhjem horaogeniser, using a 
sufficient number of strokes (6 or 7) to break greater than 95% of the 
cells. Cell breakage was measured by using a light microscope. On 
addition of 0.25M sucrose, the homogenate was centrifuged at 1100g 
for 3 min to sediment nuclei and unbroken cells. A small fraction 
of the supernatant was retained at this stage to represent cell extract, 
the remainder being subjected to centrifugation at 6500g for 10 min 
to pellet the mitochondria. The post-mitochondrial supernatant 
fraction from this spin represented the cytosol of the cell. The 
mitochondrial pellet was resuspended in 0.01M Tris-HCl buffer pH 6.7 
containing 0.25M sucrose and 0.15mM MgCl^ before repeating the low 
speed centrifugation step to remove any residual nuclei. Finally, 
this supernatant fraction was centrifuged at 6500g for 10 min to 
pellet the mitochondria which were subsequently stored in 0.01M Tris- 
acetate buffer pH 7.0 containing 0.25M sucrose for further analysis.
2.3 IMMUNOLOGICAL TECHNIQUES
2.3.1 Preparation of Antisera
Commercially available pig heart fumarase . (EC 4.2.1.2) was used 
as an antigen. Purity was estimated to be greater than 95% by densito- 
metric scanning of a Coomassie Blue stained polyacrylamide gel.
Rjmarase (1mg) dissolved in 0.9% (w/v) Mad .was mixed thoroughly with 
an equal vol. of Freund*s conplete adjuvant prior to injection 
subcutaneously at various sites in the neck, back and thighs of the 
rabbit. This treatment was repeated at 2-3 week intervals in the 
presence of Freund's inconplete adjuvant. Anti serum was collected 
by bleeding the rabbit from a marginal ear vein, 10-14 days after the 
4th injection of antigen. After allowing the blood to clot overnight 
at 4°C, the antiserum was removed with a pasteur pipette, aliquoted 
(1ml fractions) and stored at -20°C. In some instances the antiserum 
had to be clarified by centrifugation of 2500g for 10 min to remove 
contaminating red blood cells. Before subsequent bleedings, rabbits 
were injected 10-12 days previously with 0.5-1.0mg of fumarase in 
inconplete adjuvant.
A similar regime was followed for the production of the antiserum 
against the phosphate/hydroxyl ion antiport protein.
2.3.2 Characterization of the Antisera
2.3.2.1 Immune-blotting (Immune-replica analysis)
A) Transfer of proteins to nitrocellulose
After SDS-polyacrylamide gel electrophoresis (2.2.4.1) the
resolved proteins were transferred electrcphoretically on to nitro-
TMcellulose paper using the. BIO-RAD Trans-Blot apparatus. A mod­
ification of the method of Towbin et al. (1979) was adopted to perform 
the transfer at 400mA for 3-4h. Ihe electrode buffer consisted of 
0.025M Tris-HCl pH 8.3, 0.192M glycine, 20% (v/v) methanol supplemented 
with 0.02% (w/v) SDS.
B) Immunological detection of proteins on nitrocellulose paper
The procedure of Towbin et al. (1979) was closely followed
although a modification suggested by Batteiger et al. (1982) was
incorporated into the methodology. After electrcphoretic transfer
of the proteins to nitrocellulose, additional binding sites on the
paper were saturated by immersing for 60 min at 37°C or overnight at
4°C in a buffer containing 20mM Tris-HCl pH 7.2, 150mM NaCl, 0.5%
(v/v) Tween 20 and 0.5mg/ml sodium azide (Buffer A). Antiserum,
diluted 1 in 40 in buffer A supplemented with 5% (v/v) heat-inactivated
horse serum was then incubated with the blot for 90 min at room
temperature, after which time the nitrocellulose paper was washed
free of excess antibody by rinsing it five times with 60ml of buffer
A over a period of 30 min. Antigen-antibody conplexes were then 
125decorated with I-labelled protein A (2.2.3) , by incubating the blot
for 90 min at room teirperature in buffer. A plus the labelled protein
6 125A (2 x 10 dpm/50ml). Excess I-labelled protein. A was removed by
washing the paper, as described above. The blot was dried at room
temperature overnight, before.exposure to autoradiography, as described
in section 2.2.4.5
2.3.2.2 Preparation of Cell Lysate for Immune-Precipitation Studies
35L-[ S]-methionine-labelled tissue culture cells (see section 
5.2.1), were washed 3X in ice-cold phosphate-buffered saline (PBS) 
solution (20mM m ^O ^/K ^P O ^ pH 7.4, 0.9% (w/v) Nad) prior to 
solubilisation in 1ml of buffer containing 0.1M Tris-HCl. pH 8.2,
0.1M Kd, 5mM 1 1% (v/v) Triton X-100 and the protease inhibitor 
PMSF (final concentration 1mM). Nuclei were removed by centrifugation 
at 850g for 10 min , DOC and SDS dissolved in above Triton X-100 buffer 
plus 1,1O-phenanthroline (3D-TKM) were added.to the post-nuclear 
supernatant fraction to final concentrations of 1% (w/v) and 0.5%
(w/v) respectively. Insoluble debris, was removed by high speed 
centrifugation (19,000g for 30 min), to yield a clear supernatant 
fraction which was stored at -80°C. Prior to storage a 5ul aliquot 
of the supernatant fraction was counted.in scintillation fluid (65%
(v/v) toluene, 35% (v/v) Triton X-100, 0.023M PPO) on a Beckman LS6800 
liquid scintillation counter.
All the buffers utilised above were sterilised by passing through 
a 0.2pn Nalgene filter (Nalge Company, Division of Sybron Corporation, 
Rochester, New York, U.S.A).
2.3.2.3 Immune-Precipitation
g
10-20pl of antiserum was added to^an aliquot (10-20 x 10 cpm/ 
fraction) of radiolabelled cell lysate (2.3.2.2) and the mixture 
incubated for 1h at room temperature, then overnight at 4°C. Antigen- 
antibody conplexes were then collected by the addition of 20-4Opl 
of a heat-killed, formalin-fixed S.aureus cell.suspension 10% (v/v) . 
After incubating for 1h at room tenperature the bacteria were sedimented 
by centrifugation at 14,000g for 2 min on an MSE EJppendorf Micro-
Centaur centrifuge (MSE scientific .instruments, M&nor Royal, Crawley, 
Sussex, U.K.). Specifically-precipitated radiolabelled material was 
recovered by washing the bacteria, three, times, with 3D-TKM (2.2.3.2), 
once with Triton X-100 buffer (2.2.3.2) and once with 10mM Tris-HCl 
pH 7.4 before resuspending in 50pl of Laemmli sanple buffer (2.2.4.2). 
After boiling for 2-5 min at 100°C the. bacteria were pelleted by 
centrifugation at 14,000g for 2 min.
A 5pl aliquot of the supernatant fraction was counted in 
scintillation fluid, as previously described (2.3.2.2). The immune
precipitated proteins (20-30pl) were .subsequently analysed by SDS- 
polyacrylamide gel electrophoresis (2.2.4.1) and fluorography (2.2.4.6).
2.3.2.4 The Enzyme-linked Immunosorbant Assay (ELISA)
To measure the titres of respective antisera, the antigen in 
100pl of PBS, was bound to the bottom of, a. well of a Falcon microtitre 
plate by incubating overnight at 4°C. Excess antigen was removed by 
immersing the plate in washing buffer (PBS, 0.05% (v/v) TWeen 20). 
Residual binding sites were blocked.by.adding 200pl of washing buffer 
containing 5% (v/v) goat serum to the wells, prior to incubating for 
1h at room tenperature or overnight at 4°C. The plate was rinsed 
again with buffer as before, then serial dilutions of antiserum 
(VlOO to 1/100,000) in 100pl of washing buffer placed in the wells. 
After incubating for 2h at 4°C, the plate was washed in a similar 
manner before adding 100pl of goat anti-rabbit gamma-globulin 
conjugated to horse, radish peroxidase (diluted /500 with washing 
buffer) to each well and incubating for a further 1h at:,4°C. Excess 
conjugate was removed by immersing the plate in washing buffer. The 
quantity of peroxidase activity bound to the plate was determined
spectrcphotometrically using 100pl per well of the following assay 
solution:-
0.04% (w/v). o-phenylene diamine (OPD)
0.04% (v/v)
36mM citric acid 
128mMNa2HP04
After 20 min incubation in the dark at room temperature, the 
reaction was stepped by the addition of 50pl of 4N f^SO^. The 
absorbance at 492nm was .determined for each well using a Titertek 
multiscan spectrophotometer.
2.4 TISSUE CULTURE TECHNIQUES
2.4.1 Growth Media for Cell Lines
BRL, PK-15 and NBL-1 cell lines were grown routinely in Glasgow
modification of Eagle's medium supplemented with;1% (v/v) NEAA,
3 3100 x 10 units/1 penicillin, 37 x 10 units/1 streptomycin and either
10% (v/v) calf serum (BEL), 5% (v/v) foetal calf serum (PK-15) or 10%
(v/v) foetal calf serum (NBL-1).
2.4.2 Routine lyfeintenance of Cells
Cell lines were maintained in their respective media (2.4.1) as 
monolayers at 37°C in Roux or 20 oz. roller bottles in an atmosphere 
of 5% CO2f 95% air. Cells were subcultured 1 in 5 every 3-5 days 
by rinsing the cell sheets once with versene solution (5mM EDTA in PBS) 
and then placing in a small vol. of trypsin solution 0.25% (w/v) 
trypsin, 0.105M NaCl in 0.01M tri-sodium citrate adjusted to pH 7.8
with NaOH). After incubating for a few minutes at 37°C, 20ml of 
warm growth medium was added and a single cell suspension obtained by- 
pipetting gently up and down several times. For radiolabelling studies, 
the cells were grown in small plastic Petri dishes and placed in a 
humidified incubator at 37°C containing a 5% 002/95% air atmosphere.
All the operations described above were carried out under asceptic 
conditions.
2.5 CHARACTERIZATION OF THE PHOSPHATE/HYDPOXYL ION ANTIPORT 
PROTEIN (PHOSPHATE TRANSPORT PROTEIN)
2.5.1 Measurement, of Phosphate Transport by Passive Isotonic Swelling
The transport of phosphate into mitochondria or mitcplasts (2.2.4.1 
and 2) was carried out by the method of Ooty and Pedersen (1975). 
Mitochondria or mitcplasts were diluted to a final concentration of 10rng 
protein/ml in isolation medium (2.2.5.1) and inhibitors of transport, 
where appropriate. After a suitable incubation at 0°C, an 0.1ml aliquot 
was withdrawn and transferred to a cuvette containing 0.9ml of swelling 
medium (0.1M (NH^^HPO^, 1mM EGTA and 5mM K+-Hepes pH 7.4). After 
mixing rapidly, passive swelling was monitored at 750nm on a Uvichem 
spectrophotometer linked to a Servoscribe chart recorder.
In control experiments to monitor the specificity of inhibitors 
for phosphate transport, the swelling media contained 0.125M of either 
NH4C1, NHjOOC CH3 or NH4HCC>3 in place of (NH^HPC^.
32.5.2 N- [2- Hj-Ethylmaleimide Labelling of the Phosphate Transport
Protein
Pat liver mitochondrial protein was precipitated by the addition 
of 4 vol. of acetone and was subsequently collected by centrifugation 
at 1500g for 10 min. The pellet was resuspended in a small vol. of 
20mM Tris-HCl buffer pH 7.2 containing.2% (w/v) SDS before initiation
3
of radiolabelling by the addition of 40pCi of N-[2- H]-ethylmaleimide 
(50 Ci/mmol). After a 30 min incubation at room tenperature the 
reaction was terminated by the addition of 2-mercaptoethanol, to a 
final concentration of 5% (v/v). Thereafter, the protein was pre­
cipitated by the addition of acetone, as described above and the pellet 
solubilised in Laemmli sairple buffer (2.2.4.2). To determine the
extent of incorporation of the label, a 5jj1 aliquot of the above sanple 
was counted, as described previously (2.3.2.3). Padiolabelled proteins
were separated on an SDS-polyacrylamide gel (2.2.4.1) and subsequently 
detected by fluorography (2.2.4.6) . Additional protein fractions 
from the purification procedure (3.2.1) were labelled in an analogous 
manner. Intact rat liver mitochondria were resuspended in isolation 
medium (2.2.5.1) prior to labelling, as described above.
2.5.3 Performic Acid Oxidation of the Isolated Phosphate Transport 
Protein
To estimate the cysteine and methionine content of the protein, 
these residues were oxidised to cysteic acid and methionine sulphone 
using performic acid.
The performic acid was prepared by mixing 1ml. of 30% (w/v) H202 
with 9ml of 88% (v/v) formic acid and incubating at room teirperature 
for 1h before use. After cooling for 15 min on ice, 1ml of performic 
acid was added to the lycphilised protein and the reaction continued 
for 4h at 0°C. To step the reaction, 20ml of distilled water was
added and the sanple lycphilised.. This procedure of resuspension 
in distilled water followed by lycphilisation was repeated. The 
protein sanple was now ready for determination of its amino acid 
conposition.
2.5.4 Amino Acid Analysis
3ml of distilled water was added to, the lycphilised protein 
which was then split into 6 equal fractions and placed in 16.5 x 0.75cm 
test tubes. To each tube was added 10 nmoles of the internal standard 
norleucine and 0.5ml of Aristar HC1, before degassing the mixtures with 
nitrogen.. The samples were frozen in dry ice prior to.the tubes being 
heated and drawn out for sealing. After evacuating, the tubes were 
sealed, then placed on an aluminium block set at 110*1°C. Samples 
were removed after 24, 48 and 72h of hydrolysis (in duplicate) and their 
contents dessicated. Finally, the sanples. were analysed on an LKB 
4400 amino acid analyser operated by Mr.. J. Jardine of the Department 
of Biochemistry, University of Glasgow.
CHAPTER THREE
PURIFICATION AND CHARACTERIZATION 
OF THE PHOSPHATE TRANSPORT PROTEIN
FROM RAT LIVER MITOCHONDRIA
3.1 INTRODUCTION
In recent years, considerable attention has been directed towards 
a better understanding of the operation of the mitochondrial inner 
membrane phosphate transport system. The phosphate carrier plays a 
major role in cellular metabolism since inorganic phosphate must be 
transported continuously into the mitochondrial matrix to maintain 
the steady-state oxidative phosphorylation of ADP. Specific uptake 
of this anion occurs via two distinct transport systems; an electro­
neutral inorganic phosphate/dicarboxylic acid exchange carrier and an 
inorganic phosphate/fcH gradient-linked carrier which catalyses the 
influx of about 90% of the mitochondrial phosphate.
Identification of the phosphate transport protein has been greatly 
facilitated by its sensitivity to the sulphydryl group reagent, 
N-ethylmaleimide, as previously discussed (Section 1.4.2). . Since 
1979 when Wohlrab presented strong evidence on the identity of the 
phosphate transport protein, several groups have attenpted to purify 
the protein, from a variety of tissues including beef heart (Wohlrab, 1980) 
and pig heart mitochondria (Kolbe et al., 1981). However, controversy
has surrounded .the purity of’ the final preparation since the discovery 
by Kolbe et al. (1981) that the pig heart protein consisted of four to 
five major Coomassie-Blue staining bands of similar.M value, when 
resolved on SDS-polyacrylamide .14-20% (w/v). gradient gels. These 
controversial findings will be discussed in detail at a later stage 
in this chapter.
Since the exact nature of the phosphate transport protein (s) had 
not been fully elucidated at that time, an. initial aim of my project 
was concerned with isolating and further characterizing, the rat liver 
mitochondrial protein, as this represented an interesting area of
research in itself.
3.2 METHODS
3.2.1 Procedure(s) for the Purification of the Phosphate Transport 
Protein from Pat Liver Mitochondria
Method (a)
In general terms, a modification of the method of Kolbe et al.
(198-1) was utilised to purify the phosphate transport protein from 
rat liver mitochondria.
Initially, mitochondria were prepared from the livers of four rats 
which had been starved overnight, as described in section 2.2.5.2. The 
mitochondrial pellet was resuspended in a buffer containing 20mM LiCl, 
0.1mM EDTA, 0.5mM DTT, 20mM H^PO^ adjusted to pH 7.0. with LiOH and 
0.5% (v/v) Triton X-100, at a protein concentration of lOirg/ml.
After incubating on ice for 15 min the mitochondrial suspension was 
centrifuged at 105,000g for 1h at 4°C. The resultant pellet was 
subsequently solubilised in the above buffer containing 8% (v/v) Triton 
X-100 at a similar protein concentration and incubated for 15 min 
on ice. Prior to centrifugation at 105,000g for 1h at 4°C, the extract 
was diluted 1:1 with ice-cold distilled f^O. Detergent-solubilised 
mitochondrial protein was then subjected to adsorption chromatography 
on hydroxylapatite followed by a similar treatment with Celite.
The extracted material from the second centrifugation step described 
above, was mixed initially with hydroxylapatite at 0.5g hydroxyl­
apatite per ml of solubilised membrane. This slurry was incubated 
on ice for 15 min before centrifugation at 33,000g for iD nun.
The supernatant fraction was retained at this stage while the pellet-
was washed once with extraction buffer containing 4% (v/v) Triton 
X-100. Subsequent treatment of this suspension, in an analogous 
manner to the initial hydroxylapatite incubation, yielded a second 
supernatant fraction which was bulked with the first hydroxylapatite 
eluate. Clarification of the hydroxylapatite eluates was achieved 
by centrifugation at 1100g for 10 min. All centrifugation steps 
were performed at 4°C.
The hydroxylapatite eluate was finally subjected to adsorption 
chromatography on Celite-type 535 in a similar fashion to that described 
for hydroxylapatite chromatography. The only difference was that the 
Celite was washed with hot water before incubation with the hydroxyl­
apatite eluate. The final Celite eluate was stored at -2Q°C until 
further use.
Method (b)
An alternative procedure has been developed which ccpurifies 
both the phosphate transport protein and the adenine nucleotide 
translocase.
Initially mitochondria, prepared as described previously (2.2.5.1) 
were resuspended in 20mM Msps buffer pH 6.8 containing 0.25M sucrose, 
0.5mM EDTA, 2.5mM MgC^ and incubated with 40pM carboxyatractyloside 
for 10 min on ice to stabilise the adenine nucleotide translocase.
After this incubation, mitochondria were pelleted by centrifugation at 
8,000g for. 10 min before pre-extracting with 20mM Maps buffer pH 7.2 
containing 0.4M NaCl and 0.5% (v/v) Triton X-100 by incubating for 
10 min on ice. After centrifugation for 1h at 105,000g the resulting- 
pellet was solubilised, in a 10mM Msps buffer pH 7.2 containing■ 0.5M 
NaCl and 4% (v/v) Triton X-100 by incubation for 10 min on ice.
Residual, insoluble material was removed by centrifugation at 105,000g
for 1h. The supernatant fraction was subjected.to hydroxylapatite 
chromatography on a 1.75 x 25cm column which had been pre-equilibrated 
with a 0.5% (v/v) Triton X-100, 0.1M NaCl, 10mM Msps pH 7.2 buffer 
solution. The non-absorbed fraction.from this column was collected 
and dialysed against 20mM Tris-HCl pH.7.2 buffer containing 0.5% (w/v) 
Triton X-100, before application to a Procion Red A column ( 8 x 3  cm) 
equilibrated in the same buffer. Differential elution of the two 
proteins from this column was utilised to separate them; the phosphate 
transport protein being eluted with 0.25M NaCl whereas the adenine 
nucleotide translocase.required 3M NaCl for conplete elution. Both 
eluates were stored at -20°C until required.
In both, procedures, fractions were retained for analysis at each 
stage in the purification. Proteins were precipitated by the addition 
of 4 vol. of ice-cold acetone and finally prepared for analysis by 
SDS-polyacrylamide gel electrophoresis, as described in sections 2.2.4.1.
3-2.2 Iodination of Concanavalin A (con A)
125Tyrosine residues of con A. were radio-labelled with Na I by 
incubation with iodogen as follows:-
2mg con A dissolved in 0.5ml of 20mM Tris-HCl buffer. pH 8.0 containing
0.2M methyc*-glucoside was added to a glass vial, the surface of which
had been coated with 200pg of iodogen. Incorporation, of the isotope
125was initiated by the addition of 300pCi Na I (carrier-free) and the 
reaction allowed to proceed for 30 min at room temperature. After 
terminating the reaction by dilution with 20mM Tris-HCl pH 8.0, the 
incubation mixture was removed to another vessel and non-radioactive 
Nal added to give a final concentration of 25mM.
This solution was dialysed subsequently against 20mM Tris-HCl
pH 8.0 buffer, before application to a (8,5 x 1.5 cm) Sephadex G50 column
125equilibrated with dialysis buffer. I-labelled con A was eluted
from the column by washing with 20mM Tris-HCl pH 8.0 buffer containing 
0.2M methy©*-glucoside. Finally, this eluted con A was. dialysed
against 20mM Tris-HCl pH 8.0 and stored at. -20°C in small aliquots 
(0.5ml).
3.2.3 Lectin Overlay Analysis of the.Phosphate Transport Protein
After SDS-polyacrylamide gel electrophoresis, the resolved proteins
were fixed by incubating the gel overnight in 10% (v/v) acetic acid
125and 25% (v/v) isoprcpanol. Prior to incubation with the I-labelled
lectin, the gel was thoroughly washed by rinsing several times in
lectin overlay buffer consisting of 20mM Tris-HCl pH 8.0, 0.12M KC1,
lmM CaO^, 1mM MnCl^/ 1% (v/v) Tween 20, 0.1% (w/v) haemoglobin and
1250.05% (w/v) sodium azide. Incubation of the gel with I-labelled '
con A (see section 3.2.2) was then initiated by the addition of the
lectin to the gel soaked in overlay buffer (approx. 10 x 10 cpm 
125I-labelled con A). After 2 days of incubation at room temperature 
this solution was removed and the gel subsequently washed for 3-5 days 
in lectin-free overlay buffer (5-6 changes), to reduce.the background 
level of radiation. Autoradiography was finally carried out on the 
dried gel, as described previously (see section 2.2.4.5).
3.2.4 Preparation of SDS-polyacrylamide 14-20% (w/v) Gradient Gels
SDS-polyacrylamide gradient gels (18 x 16 cm) were prepared at 
4°C using a Bio-Pad slab gel apparatus (Model NO. Protean 16cm) and a 
gradient gel mixer which consisted of two conpartments (40ml capacity/
compartment) with a connecting flow-line to allow mixing of the two 
stock acrylamide solutions listed in table 3.2.1.
The two acrylamide solutions were degassed under vacuum before 
polymerisation was initiated by the addition of TIMED (6pl) to each 
acrylamide stock solution. Immediately on addition of TEMED, the main 
gel was poured in the following manner:-
A piece of rubber tubing connected to the gradient gel mixer was 
placed between the two glass plates and the flow rate of acrylamide 
solution controlled by a. peristaltic pump (90 ml/h). -The gel was 
carefully overlayed with iscprcpanol before polymerisation was caiplete. 
After polymerisation of the separating gel, a stacking gel containing 
the sanple wells (15 wells/gel) was placed on tcp using the previously 
described procedure (see section 2.2.4.1).
3.3 RESULTS AND DISCUSSION
3.3.1 SDS-polyacrylamide Gel Electrophoresis Analysis of the 
Isolated Phosphate Transport Protein
The Coomassie Blue staining profile of different stages in the 
purification of the phosphate transport protein from intact rat liver 
mitochondria, after separation on an SDS-polyacrylamide gel 10% (w/v) 
is illustrated in Fig. 3.3.1a. A single,, apparently homogeneous 
band can be visualised after both hydroxylapatite and Celite chromato­
graphy. The electrophoretic mobilities of a set of marker proteins 
of known M. value were measured in this gel system and used to construct 
standard curves of electrophoretic mobility against log subunit Mr value 
(Fig. 3.3.2). Coitparison of the electrophoretic mobility of the 
purified phosphate transport protein with these markers gave a value 
of 34,000.
Table 3.2.1
COMPOSITION AND VOLUMES OF SOLUTIONS USED TO CAST SDS-POLYACRYLAMIDE
GRADIENT GELS 14-20% (W/V)
Stock solution
Right-hand conpartment 
14% (w/v) acrylamide 
(Vol.. added)
Left-hand compartment 
20% (w/v) acrylamide 
(Vol. added)
29.2% (w/v) acrylamide 
0.8% (w/v) bis-acrylamide
9.3 ml 13.3 ml
Running gel buffer 5.0 ml 5.0 ml
15% (w/v) sucrose 5.7 ml -
70% (w/v) sucrose - 1.7 ml
0.03% (w/v) ammonium 
persulphate
60 pi 60 pi
The subunit M value of the protein is in agreement with the 
findings of other groups who have purified the beef heart (Wohlrab,
1980) and pig heart (Kolbe et al., 1981) mitochondrial phosphate 
transport protein, respectively. However., the finding that only the 
phosphate transport protein did not adsorb to hydroxylapatite is in 
marked contrast to their data. In both instances, the adenine 
nucleotide translocase (Mr 30,000) was shown to ccpurify with the 
phosphate transport protein after hydroxylapatite chromatography.
However, Kolbe et al. (1981) demonstrated that adsorption chromato­
graphy on Celite effected quantitative removal of the translocase.
Recently, Wehrle and Pedersen (1983) attenpted to purify the 
phosphate transport protein from rat liver mitochondria, essentially 
following the method of Wohlrab (1980). If intact mitochondria were 
utilised as the initial starting material, Triton X-100 extraction 
followed by hydroxylapatite chromatography resulted in purification of 
the phosphate transport protein, the adenine nucleotide translocase 
and a protein of 68,000. This additional 68,000 M protein was 
suggested to represent a subunit of an enzyme found only in liver 
mitochondria, since rat liver mitochondria are more metabolically conplex 
than both bovine heart and blowfly flight muscle mitochondria, used in 
earlier studies. As a result of this finding, Wehrle and Pedersen 
(1983) purified the phosphate transport protein from mitochondrial 
inner membrane vesicles which had been treated with urea. In this case, 
the 68,000 Mr protein was removed but .the two transport proteins still 
ccpurified during hydroxylapatite chromatography. They have attenpted 
subsequently to remove the adenine nucleotide translocase by Celite 
chromatography without success. It is obvious that these findings 
are in marked contrast to our own data, despite the identity of the 
tissue sources, namely rat liver mitochondria.
3.3.2 Lectin Overlay Analysis of the Phosphate Transport Protein
Membranes of eukaryotic cells usually contain between 2% and 10% 
carbohydrate by weight in the form of glycoproteins and glycolipids.
In the plasma membrane of many cell types including red blood cells 
(Nicolson and Singer, 1974) and lynphocyte membranes (Hayman and 
Crunpton, 1972) , this carbohydrate is asymmetrically distributed with 
the sugar moieties protruding out into the extracellular environment.
It has also been demonstrated that many of the glycoproteins are trans­
membrane proteins, which are exposed to both external and internal 
environments providing a means of communication across the bilayer, 
eg. band 3 or the anion channel protein of. the red cell which makes 
it selectively permeable to HCO^ and Cl and glyccphorin A also of 
the red cell plasma membrane whose function is unknown.
It has been reported that isolated mitochondria contain 1-2%
carbohydrate by weight (De Bernard et al., 1971) and that covalently-
associated saccharide, moieties are present on the cytoplasmic surfaces
of both the inner and outer membranes (D’Souza and Lindsay, 1981).
In this connection, it was decided to investigate the possibility that
the integral inner membrane phosphate transport protein from rat liver
mitochondria was glycosylated. This was achieved by using the lectin
125overlay method described m  section 3.2.3 ,and I-labelled con A to
permit detection of covalently-bound mannose, N-acetylglucosamine 
and/or glucose residues. Con A was chosen to determine whether the 
phosphate transport protein was glycosylated or not because it had 
previously been shown in this laboratory that about 80% of rat liver 
mitochondrial glycoproteins bound to con A-Sepharose columns. Conparison 
of the protein staining pattern (Fig. 3.3.1a), in which the phosphate 
transport protein appears to be homogeneous with the corresponding
125 .I-labelled con A overlay autoradiograph (Fig. 3.3.1b), clearly
illustrates the existence of numerous low and high value glycoprotein
contaminants. However, there is no bound label in the region of the
phosphate transport protein (M 34,000) which suggests that it is
unlikely to be glycosylated.
An improved purification procedure was devised to remove con-.
tamination with glycoproteins by extracting the mitochondria initially
with a buffer containing 0.5% (v/v) Triton X-100 before selective
extraction of the phosphate transport protein (see section 3.2.1
method a). These findings are depicted in Figs. 3.3.3(a) and 3.3.3(b)
125which represent the Coomassie Blue and I-labelled con A overlay 
profiles of the purified phosphate transport protein after separation 
on an SDS-polyacrylamide gel 12.5% (w/v). It is apparent that the 
pre-extraction step solubilises about 80% of the mitochondrial protein, 
including the bulk of contaminating glycoproteins.
Fig. 3.3.3(a), track 4 demonstrates that the 0.25M KC1 eluate from 
the Procion Red A column (see section 3.2.1 method b) migrates with 
an identical Mr value of 34,000 when corrpared with the final Celite 
product (see section 3.2.1 method a).
3.3.3 SDS-Polyacrylamide. Gradient Gel Electrophoresis of the 
Purified Protein
In recent years, a great deal of controversy has surrounded the 
nature of the protein conponent(s) that constitute the phosphate carrier 
system. This controversy was initiated in 1981 by Kolbe et al. who 
purified the transport protein from pig heart mitochondria and separated 
the protein conponent(s) on an SDS-polyacrylamide gradient gel 14-20% 
(w/v). They discovered that the Celite purified protein had been
resolved into four separate components which ranged in from 35,000 
to 31,000. Three possible explanations were proposed to interpret 
this result:-
i) the phosphate transporter of mitochondrial inner membrane is 
conposed of four different, polypeptide chains;
ii) some of the four proteins represent proteolytically or other­
wise modified forms of the same protein;
iii) the phosphate transporter is one protein, the other proteins 
represent contaminants which ccpurify with the transport protein.
A subsequent report by. Kolbe et al. (1982) which investigated the 
nature of these additional bands in more detail, led to the proposal 
of a model in which proteolytic processing was suggested to account for 
their existence (Fig. 3.3.4). The phosphate transport protein was 
purified from beef heart and pig heart mitochondria respectively. 
Purification involved using slightly different procedures to the original 
protocol including two successive extractions of mitochondria with 
Triton X-114 instead of Triton X-100. The model was based on the 
findings of three very similar proteins which differed slightly in Mr 
(34,500, 34,000 and 33,000),amino acid composition and could explain 
the contradictory observations of the study. It was assumed in this 
model that the native carrier is conposed of two subunits. The 
occurrence of the active phosphate transport protein as a dimer of two 
identical subunits would be in accordance with other membrane transport 
proteins which were found to consist of two equal subunits in their 
active form; eg. the adenine nucleotide translocase (KLingenberg et al.,
1978).
As a consequence of these findings, the purified rat liver and beef
heart mitochondrial phosphate transport proteins were subjected to 
SDS-polyacrylamide gradient gel electrophoresis 14-20% (w/v) and their 
Coomassie Blue staining profiles compared (Fig. 3.3.5). The beef 
heart protein was purified from mitochondria in an analogous manner to 
the rat liver mitochondrial polypeptide (section 3.2.1 method (a)).
It can clearly be seen that there is a major difference between the 
protein product(s) at the hydroxylapatite stage.in the two preparations. 
One major band is observed in the rat liver sample which migrates with 
an Mr value of 34,000, whereas two major bands with Mr of 34,000 and 
31,000 respectively are detectable in the beef heart preparation.
Wchlrab (1980) previously demonstrated this latter result when purifying 
the phosphate transport protein from the same tissue source and suggested 
that the 31,000 M polypeptide band was likely to be the adenine 
nucleotide translocase. It has subsequently been illustrated that 
there are three possible ways to remove this 31,000 Mr protein involving 
either Celite chromatography (Kolbe et al., 1981), mersalylultrogel
chromatography (Tburaille et al., 1981) or Triton X-114 extraction of 
mitochondria (Kolbe et al., 1982). As depicted in track (6), this was 
shown to be correct when the beef heart hydroxylapatite eluate was 
subjected to adsorption chromatography on Celite.
In marked contrast to the findings of Kolbe et al. (1982), however, 
there is no evidence for the existence of four to five Coomassie Blue 
staining bands in either preparations hydroxylapatite or Celite eluates.
If the proteolytic processing model proposed by these workers to explain 
their results with the beef heart and pig heart mitochondrial phosphate 
transport proteins is correct, .then the rat. liver and beef heart 
mitochondria used in our purifications are less sensitive to proteolytic 
attack.
Confirmation as to the purity of the rat liver mitochondrial protein,
separated on the above gel system, was provided by densitometric scanning 
of the gel using an LKB Ultroscan 2202 laser densitometer. The purity 
of the Coomassie Blue stained protein of M^ 34,000 was estimated to be 
about 95%. Finally, it should be noted that the 0.25M KC1 eluate from the • 
Procion Red A column of the alternative procedure (method b, section 3.2.1) , 
demonstrated the existence of only one polypeptide band when separated and 
stained with Coomassie Blue on the above gradient gel system (track 4).
The SDS-polyacrylamide gradient gel 14-20% (w/v) was prepared as described 
in section 3.2.4.
3.3.4 CHARACTERIZATION OF THE PHOSPHATE TRANSPORT PROTEIN
3.3.4.1 Effect on N-ethylmaleimide on Phosphate Transport into 
Isolated Mitochondria
Initially our aim was to confirm that the protein isolated from rat 
liver mitochondria constituted the phosphate transport system by established 
procedures. It has been well documentated (Fonya and Besman, 1968, Tyler, 
1969; Coty and Pedersen, 1974a), that this transport system is inhibited 
by very low levels of the sulphydryl group reagent, N-ethylmaleimide. It 
is also generally accepted that N-ethylmaleimide reacts specifically with 
an essential sulphydryl group of the phosphate transport system rather than 
non-specifically altering membrane permeability. Preliminary experiments 
were carried out to confirm the susceptibility of this system to N-ethyl­
maleimide. This property can sinply be demonstrated by measuring the 
transport of phosphate into isolated mitochondria utilising the fact that 
mitochondria passively swell in solutions of isotonic ammonium phosphate 
buffer (Chappell and Crofts, 1966).
The swelling of mitochondria in solutions of ammonium salts depends
on the ability of the anion present to penetrate the mitochondrial 
inner membrane, as illustrated in Fig. 3.3.6 (Chappell, 1968). A 
rapid qualitative means of measuring, the swelling process is to monitor 
the decrease in absorbance at 750nm,. when mitochondria are placed 
in such ammonium salt buffers. Fig. 3.3.7(a) confirms the earlier 
findings of Chappell and Crofts (1966) , in that it describes the 
effect of incubating rat liver mitochondria in isotonic solutions of 
ammonium chloride, acetate, bicarbonate and phosphate, respectively.
It can clearly be seen that there is a marked decrease in the absorbance 
at 750nm of the mitochondrial suspension, when incubated in ammonium 
acetate, bicarbonate or phosphate buffers. This indicates that 
swelling has occurred when mitochondria are placed in these respective 
media. However, no swelling is induced in the presence of ammonium 
chloride buffer. These results demonstrate that the three anions, 
phosphate, bicarbonate and acetate can penetrate the mitochondrial 
inner membrane whereas the chloride ion cannot enter into the matrix.
To confirm that phosphate uptake can be inhibited by very low levels 
of the sulphydryl group reagent, N-ethylmaleimide (Coty and Pedersen, 
1974b), isolated rat liver mitochondria were pre-incubated with this 
inhibitor prior to monitoring their passive swelling in isotonic 
ammonium phosphate buffer (Fig. 3.3.7b). It is clear that there is 
no decrease in absorbance over the time-course of the experiment, 
suggesting that N-ethylmaleimide has inhibited phosphate uptake. Pre­
treatment with N-ethylmaleimide did not significantly affect chloride, 
acetate or bicarbonate induced swelling, of mitochondria. Since bi­
carbonate and acetate ions penetrate the mitochondrial inner membrane 
by sinple diffusion, this finding rules out the non-specific alteration 
of membrane permeability by N-ethylmaleimide.
The swelling studies were performed according to the method of
Ooty and Pederson (1974b), as described in section 2.5.1.
33*3-4.2 N-[ H]-Ethylmaleimide Labelling Studies of the Phosphate
Transport Protein
In the past, the phosphate transport protein has been identified 
by several groups as a result of its sensitivity to N-ethylmaleimide.
3
Incorporation of N- [ H] -ethylmaleimide into mitochondrial inner membrane 
proteins at concentrations known to inhibit phosphate transport into 
isolated mitochondria, was the criterion used to achieve such an 
identification (Coty and Pederson, 1975, Wohlrab, 1978; Wohlrab,
3
1979). By coirpanng the.N-[ H]-ethylmaleimide labelling patterns of
blowfly flight muscle mitochondria with rat heart sonic submitochondrial
particles, Wohlrab (1979) was able to identify a protein of Mr 32,000
as constituting the phosphate transport protein. A more detailed account
as to the identification of the protein can be found in section 1.4.2.
In.this section, this property of the phosphate transport system was
utilised to confirm the identity of the isolated rat liver mitochondrial
protein of M 34,000.
It has been established (section 3.3.4.1) that N-ethylmaleimide can
inhibit the transport of phosphate into intact rat liver mitochondria
as measured by the ’ammonium swelling technique1 of Chappell and Crofts
(1966). It was also shown that this effect was specifically due to
interaction with a free sulphydryl group on the transport protein and
not due to non-specific alteration of membrane permeability (Fig. 3.3.7b).
However, when intact rat liver mitochondria or the 8% (v/v) Triton X-100
3extracted material are labelled with N-[ H]-ethylmaleimide, several 
polypeptides can be visualized after fluorography of the resolving 
SDS-polyacrylamide gel (12.5% (w/v) Fig. 3.3.8b). This result is in 
agreement with the earlier findings of several groups including Coty
and Pedersen (1975) , who showed that at least ten polypeptide components
of the rat liver mitochondrial inner membrane could be labelled in an
analogous manner. After subsequent hydroxylapatite chromatography
(track 3), only a protein of Mr 34,000 incorporates the label. This
is in marked contrast to the results of Wohlrab (1980) and Kolbe et al.
(1981), who purified the transport protein from beef heart and pig
heart mitochondria, respectively. They discovered that not only could
3this transporter be labelled with N-[ H]-ethylmaleimide, after adsorption 
chromatography on hydroxylapatite, but that the adenine nucleotide 
translocase (Mr 30,000). also co-labelled with the isotope. The result 
does, however, confirm our earlier observations that after treatment 
of the Triton X-100 extract with hydroxylapatite, only a polypeptide 
band of Mr 34,000 stains with Coomassie Blue. Celite chromatography, 
as expected, results in the labelling of one band of Mr 34,000 in 
agreement with the data of Kolbe.et al. (1981), who showed that this 
treatment removed the adenine nucleotide translocase protein from their 
pig heart mitochondrial preparation. Fig. 3.3.8(a) demonstrates the 
initial Coomassie Blue staining patterns of the proteins prior to 
fluorography.
The above data was confirmed in an experiment where intact rat
3 . .liver mitochondria were initially incubated with N-[ H]-ethylmaleimide
and the phosphate transport protein subsequently purified, as described
in section 3.2.1 method (a). This experiment was performed to rule
out the possibility that labelling of the protein of Mr 34,000 was the
result of a conformational change during its isolation and that in the
3native state the polypeptide reacted with N-[ H]-ethylmaleimide. A 
similar labelling pattern to that achieved in the previous experiment 
(Fig, 3.3.8b) was attained in that only a protein of 34,000 could be 
detected on the fluorograph after hydroxylapatite and Celite chromato-
graphy, respectively (Fig. 3.3.8c).
Ihe evidence presented in this section, as to the nature of the
isolated polypeptide of 34,000, illustrates many of the previously
3
recognised features of. the phosphate transport protein. All N-[ H]- 
ethylmaleimide labelling experiments were performed according to the 
procedure described in section 2.5.2.
3.3.4.3 IMMDNQLOGICAL STUDIES
3.3.4.3.1 Effect of an Anti-Phosphate Transport Protein Serum on
Phosphate Transport
Recent studies to illustrate the role of the purified polypeptide 
of 34,000 have concentrated on reconstitution experiments. In these 
experiments the purified protein, was incorporated into liposomes and 
the rate of phosphate-phosphate exchange measured' by ^^Pi efflux or 
uptake. Wchlrab (1980) and Kolbe et al. (1981) , both demonstrated 
that the reconstituted system prepared from the purified beef heart 
and pig heart mitochondrial proteins respectively, catalysed phosphate- 
phosphate exchange. However, the maximal exchange rate was only about 
2% of the rate in isolated mitochondria (Coty and Pedersen 1974b).
Kolbe et al. (1982) have subsequently demonstrated that if the phospholipid 
cardiolipin is included in the purification procedure, the rate of 
exchange of phosphate can be enhanced 30-fold.
As a result of the generally poor reconstitution exchange rates 
and the fact that I was particularly interested in studying the bio­
synthesis of this protein in vivo, which required the use of a specific 
antiserum, further confirmation as to the identity of the protein 
isolated was provided by the following experiments; phosphate transport
into intact mitochondria and mitochondrial inner membrane vesicles 
(mitcplasts) was studied in the presence of a rabbit, polyclonal antiserum 
directed against the polypeptide of 34,000 (see section 2.3.1). 
Mitochondria or mitcplasts were pre-incubated for 1h at 4°C before 
monitoring phosphate transport, as described in section 2.5.1. Fig. 
3.3.9(a) demonstrates that the antiserum directed against the purified 
protein of Mr 34,000 inhibits phosphate uptake into mitcplasts by about 
50%, whereas control serum, as expected, has no such effect on swelling.
In addition, although not shown here the anti-phosphate transport protein 
serum had no effect on the swelling of mitochondria in NH^HCO^, NH^COOCH^ 
or NH^d. Partial, inhibition of phosphate uptake into mitcplasts can 
be explained by the fact that the substrate for the transport protein 
is a small molecule which may still have access to its binding site even 
in the presence of antiserum and thus cause swelling. Additionally, 
the following factors may contribute to only observing a partial inhibition 
of mitcplast-swelling:
i) Since the antiserum.raised against the purified protein is 
polyclonal in nature, many of the resulting antibody molecules may be 
recognising antigenic determinants (epitcpes) of the protein which do 
not constitute the phosphate binding site and thus do not interfere 
with phosphate binding and mitcplast swelling.
ii) Secondly, a small amount of the outer membrane may still be 
attached to these inner membrane vesicles, particularly at the contact 
points of the two membranes. If the phosphate transport protein is 
located at or near to these junctions then antibody access would be 
limited by. the outer membrane.
As an additional control, phosphate uptake into intact rat liver 
mitochondria which had been pre-incubated with either the antiserum
directed against the polypeptide of 34,000 or control serum, was 
monitored. In this case (Fig. 3.3.9b), no inhibition of swelling was 
observed, as one would expect, since with intact mitochondria immuno­
globulin molecules are too large to penetrate the outer membrane and thus 
block antigenic sites on the transport protein, deeply embedded in the 
inner membrane. Mitcplasts were prepared from intact mitochondria by 
the method described in section 2.2.5.2.
In.summary, the findings of the last two sections (3.3.4.2 and 
3*3.4.3) strongly suggest that the protein isolated from rat liver mito­
chondria with an value of 34,000, is the phosphate transport protein.
3.3.4.4 Amino Acid Analysis.of.the Phosphate Transport Protein
The amino acid conposition.of the purified rat liver mitochondrial 
phosphate transport protein, which had been treated with performic acid 
prior to analysis, was performed according to the method described in 
section 2.5.4. Tto account for the loss of serine and threonine as a 
result of acid hydrolysis the values found at 24, 48 and 72h were extra­
polated to zero-time. Values for valine and isoleucine were estimated 
from sanples taken at 72h, since the recovery of these resisues is not 
conplete until after 72h of acid hydrolysis. When the number of residues 
was calculated from the original amino acid conposition data of the rat 
liver mitochondrial phosphate transport protein, an M value of about 
17,000 was obtained. If the number.of amino acid residues is then 
doubled, the Mr of the phosphate transporter is in accord with the 
previously reported values (M 34,000). The amino acid conposition of 
the rat liver protein was subsequently expressed as moles amino acid 
percentage of total conposition of the protein. Table 3.3.1 conpares 
the amino acid conpositions of the rat liver and beef heart mitochondrial
phosphate transport proteins. The conposition of the beef heart transport 
protein was determined by Kolbe et al. (1982). Clearly, the conpositions 
of the two phosphate transport proteins are in general very similar 
although there are major differences in the contents of cysteine and 
tyrosine. The rat liver mitochondrial phosphate transport protein contains 
at least twice as much cysteine as the beef heart protein. Additionally, 
the rat liver phosphate transport protein does not appear to contain 
tyrosine whereas the beef heart protein contains about 10 residues of 
this amino acid assuming a subunit Mr of 34,000 for the protein. The 
lack of tyrosine in the rat liver mitochondrial phosphate transport 
protein partially confirms the purity of the protein. If the final 
preparation of the protein was contaminated with other polypeptides, it 
is unlikely that these additional polypeptides would not also contain 
tyrosine residues.
Fig. 3.3.1 (a) and (b)
LECTIN OVERLAY ANALYSIS OF. THE PURIFIED PHOSPHATE TRANSPORT PROTEIN 
FROM INTACT RAT LIVER MITOCHONDRIA
The phosphate transport protein was purified from intact rat liver
mitochondria, as described in section 3.2.1 method (a) and initially
resolved on a 10% (w/v) SDS-polyacrylamide gel (gels were cast between
14 x 8cm plates). After electrophoretic separation and detection of
the protein(s) with Goomassie Blue (see section 2.2.4.3), the gel was
125subjected to lectin overlay analysis (see section 3.2.3) with I-labelled 
con A.
a) Coomassie Blue staining profile of different stages in the purifi­
cation of the phosphate transport protein; (1) initial 8% (v/v) Triton 
X-100 extract, (2) hydroxylapatite fraction, (3) Celite-adsorbed 
fraction, (4) low Mr standard proteins.
125b) Tracks (5-8) I-labelled con A overlay profiles of tracks (1 - 4).
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STANDARD CURVE OF ELECTROPHORETIC MOBILITY OF. MARKER-PROTEINS VERSUS
LOG SUBUNIT M VALUE   r-----
Tb estimate the M value of ,the purified.rat liver mitochondrial 
phosphate transport protein on an SDS-polyacrylamide gel (10% (w/v)) , 
a set of standard proteins of known M were resolved on the same gel.
By plotting the electrophoretic mobility (Rf value), of the standard 
proteins versus log subunit Mr value, the Mr of the phosphate transporter 
could then be determined. The low M standard proteins used in this 
calculation are listed in section 2.2.4.4.
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Figs. 3.3.3 (a) and (b)
LECTIN OVERLAY ANALYSIS OF THE PURIFIED PHOSPHATE TRANSPORT PROTEIN 
FFQM TRITON X-100 0.5% (v/v) PRE-EXTFACTED RAT LIVER MITOCHONDRIA
Bat liver mitochondria were initially pre-extracted with a 0.5%
(v/v) Triton X-100 buffer prior to solubilization in an 8% (v/v) Triton 
X-100 buffer and further purification of the phosphate transport protein 
(see section 3.2.1 method a). The phosphate transporter was then 
subjected to analysis by SDS-polyacrylamide gel electrophoresis 12.5% 
(w/v) and subsequent lectin overlay analysis (see section 3.2.3). The 
gels were cast between 14 x 8cm glass plates in a perspex box designed 
to accommodate four pairs of plates.
a) Ooomassie Blue staining profile of (1) 8% (v/v) Triton X-100 extract 
(2) hydroxylapatite eluate (3) Celite-adsorbed fraction (4) 0.25M KC1 
eluate from Procion Ped A column (5) low Mr standard proteins.
125b) Lanes (6-10) I-con A overlay profiles of (1-5).
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Model of the mitochondrial phosphate carrier
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The model is based on the finding of three very similar proteins differing 
slightly in and amino acid conposition. It assumes that the native 
transporter is composed of two subunits and that proteolytic cleavage 
of the native protein occurs at two positions close to the amino and 
carboxyl terminal ends of the polypeptide chain during isolation of 
mitochondria. The cleaved polypeptides remain associated to the protein 
due to hydrophobic, ionic and/or hydrogen bond interactions. The model 
explains why no labelled N-ethylmaleimide was found to be bonded to the 
phosphate transporter fraction in the presence of protecting concentrations 
of mersalyl, although under these conditions the transport of phosphate 
was inhibited. (Reproduced from Kolbe etal., 1982).
Fig. 3.3.5
SDS-POLYACRYLAMIDE GRADIENT GEL ANALYSIS 14-20% (w/v) OF PURIFIED 
PHOSPHATE TRANSPORT PROTEIN FROM RAT LIVER AND BEEF HEART MITOCHONDRIA
Goomassie Blue profile of different stages in the purification of 
the phosphate transport protein (see section 3.2.1 methods a and b).
From rat liver mitochondria; (1) 8% (v/v) Triton X-100 extract,
(2) Hydroxylapatite eluate, (3) Celite-adsorbed fraction, (4) 0.25MNaCl 4 
eluate from Procion Red A column. From beef heart mitochondria,
(5) Hydroxylapatite eluate, (6) Celite-adsorbed fraction, (7) Marker 
proteins 94,000-14,400 M .-
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Phosphate transport 
protein (M 34,000)
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Fig. 3.3.6
POSTULATED MECHANISM OF MITOCHONDRIAL SWELLING IN SOLUTIONS OF
ISOTONIC AMMONIUM SALTS
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Figs. 3.3.7 (a) and (b)
INHIBITION OF MITOCHONDRIAL SWELLING IN. ISOTONIC (NHJ^HPO, MEDIUM IN 
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THE PRESENCE OF N-ETHYLM&LEIMIDE
Rat liver mitochondria (prepared as described in section 2.2.5.1) 
were initially resuspended in isolation medium (section 2.2.5.1) to a 
protein concentration of 10mg protein/ml. N-ethylmaleimide (50pM) was 
added to the supension and incubated on ice for 2 min prior to the 
swelling of mitochondria in isotonic (NH^ ) 2HP04 medium (see section 
2.5.1). In control experiments to monitor the specificity of inhibitors 
for phosphate transport, the swelling media contained 0.125M of either 
NH^Cl, NH4OOC CH3 or NH^HCO^ in the place of (NH^^HPO^.
a) Mitochondrial swelling in the absence of N-ethylmaleimide.
b) Mitochondrial swelling in the presence of N-ethylmaleimide.
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N- [3H] -ethylmaleimide labelling studies of the phosphate transport
PROTEIN FROM RAT LIVER MITOCHONDRIA
3The phosphate transport protein was either labelled with N- [ H]-
ethylmaleimide in intact mitochondria and then purified (Fig. 3.3.8c)
3or labelled at the various stages of its purification with N-[ H]-
. . 3ethylmaleimide (Fig. 3.3.8b). Incorporation of N-[ H]-ethylmaleimide
into the phosphate transport protein was performed according to the 
method described in section 2.5.2.
a) Original Goomassie Blue staining profile of various fractions from 
the purification of the phosphate transporter; (1) low standards,
(2) Celite-adsorbed fraction, (3) hydroxylapatite fraction, (4) 8% 
(v/v) Triton X-100 extract, (5) intact rat liver mitochondria.
b) Fluorographic pattern of (2-5) after labelling with N-[3H]- 
ethylmaleimide (6 - 9).
3
c) N-[ H]-ethylmaleimide labelling pattern of the phosphate transport 
protein when labelled in intact rat liver mitochondria prior to purifi­
cation; (1) intact rat liver mitochondria, (2) hydroxylapatite eluate,
(3) Celite-adsorbed fraction.
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Figs. 3.3.9 (a) and (b)
PARTIAL INHIBITION OF PHOSPHATE UPTAKE IN RAT LIVER MITOPLASTS PRE­
INCUBATED WITH. A SPECIFIC ANTI SERUM TO THE PHOSPHATE TRANSPORT PROTEIN 
AS MEASURED BY THE NH^ -IQN SWELLING TECHNIQUE
Rat liver mitcplasts, prepared as described in section 2.2.5.2, 
or mitochondria (see section 2.2.5.-1), were initially resuspended in 
isolation medium (section 2.2.5.1) at a protein concentration of 10mg/ml. 
An equal volume of anti-phosphate transport protein serum or control serum 
was then added to each suspension and pre-incubated for 1h on ice. Hie 
passive swelling of the suspensions in isotonic (NH^^HPO^ medium (see 
section 2.5.1) was then monitored at 750nm.
a) Swelling of mitcplasts in (NH^ ) 2HP04 medium,- in the presence of anti­
phosphate transport^ protein serum or control serum.
(b) Swelling of mitochondria in (NH^^HPO^ medium, in the presence of 
anti-phosphate transport protein serum or control serum.
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TABLE 3.3.1
COMPARISON OF THE AMINO ACID COMPOSITIONS OF THE RAT LIVER
AND BEEF HEART MITOCHONDRIAL PHOSPHATE TRANSPORT PROTEINS
AMINO ACID MOLES % COMPOSITION (RAT LIVER)
MOLES % COMPOSITION 
(BEEF HEART)
Cysteine 2.39 0.88
Aspartate (+ Asparagine) 11.94 12.27
Methionine 1.30 1.28
Threonine 8.08 9.12
Serine 7.21 7.40
Glutamate (+ Glutamine) 10.56 8.00
Proline 3.55 2.34
Glycine 12.57 12.42
Alanine 8.65 7.29
Valine 6.75 5.64
Isoleucine 4.24 4.30
Leucine 8.74 8.53
Tyrosine 0.00 3.60
Phenylalanine 3.76 4.64
Histidine 0.87 1.24
Lysine 6.22 8.67
Arginine 3.17 2.31
To measure the content of methionine and cysteine in the protein, 
these residues were oxidised to cysteic acid and methionine sulphone 
using performic acid (see section 2.5.3 for further details). The 
amino acid conposition of the phosphate transport protein was sub­
sequently determined by the method described in sections 2.5.4 and
3.3.4.4.
CHAPTER FOUR
CHARACTERIZATION OF ANTI SERA RAISED AGAINST
THE PHOSPHATE TRANSPORT PROTEIN AND FUMARASE
4.1 INTRODUCTION
In the preceding chapter, a detailed account was given of the 
purification and identification of the rat liver mitochondrial phosphate 
transport protein. This protein was also of particular interest from 
a biosynthetic point of view as it is central to energy metabolism within 
the cell and is likely to be a trarismembraneous inner membrane protein. 
There is very little information with regard to the biosynthesis and 
inport of mitochondrial transmembrane proteins although the adenine 
nucleotide translocase protein has been extensively studied in N.crassa 
cells (Zimmerman and Neupert, 1980). In contrast to the general findings 
with mitochondrial proteins (Table 1.3.1), these workers discovered 
that this protein was not made as a larger 14. precursor although there 
was evidence to suggest that the cytosolic form of the protein existed 
in a different conformation to the mitochondrial form. As a result 
of these findings, I was interested in discovering the mode of synthesis 
of the mitochondrial inner membrane phosphate transport protein to see 
if this was the general mode of synthesis of mitochondrial transmembraneous 
proteins.
A second protein of interest with regard to its biosynthesis was 
fumarase which has a bimodal distribution in many tissues (Akiba et al., 
1984). This tricarboxylic acid enzyme is not only found in the mito­
chondrion but also in the cell cytcplasm where it has a role to play in 
the urea cycle and tyrosine catabolism. In studying the biosynthesis 
of this enzyme, an additional problem to be overcome is to determine the 
mechanism by which this enzyme becomes distributed between two cellular 
conpartments.
A prerequisite for studying the biosynthesis of mitochondrial 
proteins is the use of a highly specific probe to detect the protein of
interest from a mixture of labelled polypeptides. This probe can be 
provided by a polyclonal, monospecific anti serum directed against the 
protein(s) of particular interest. Before an antiserum can be utilised 
in such a manner, it must be fully characterized. To characterize an 
antiserum, the antibody titre and precise degree of specificity of 
interaction with the antigen must be determined. The antibody titre can 
be measured by the indirect enzyme-linked imrnunosorbant assay (ELISA) and 
the monospecificity of the anti serum by the recently developed immune- 
blotting technique.
In this chapter, the antisera raised against both the phosphate 
transport protein and fumarase are fully characterized by these methods.
4.2 METHODS
4.2.1 Subcellular Fractionation of Cultured Mammalian Cells
Preparation of a cytosolic fraction from PK-15 cells was performed 
by the method of Mori et al. (1981). Cells, grown to confluence in a 
20oz roller bottle, were washed twice with buffer containing 20mM 
K -Hepes pH 7.4, 0.25M sucrose, 3mM EDTA and 0.1 mM PMSF before resuspending 
in the same buffer at a concentration of 5 x 10 cells/ml. 1 ml aliquots 
(5 x 10 cells) were removed for incubation on ice (2 min) with a range 
of digitonin concentrations (0.5mg/ml suspension) , respectively. After 
this incubation, the mixture was centrifuged at 14,000g for 1 min and 
the supernatant fraction retained to measure both fumarase (see section 
2.2.2B) and citrate synthetase (see section 2.2 .2k) activities. Citrate 
synthetase activity was measured to test the integrity of mitochondria.
4.3 RESULTS
4.3.1 Determination of the Antibody litres of Antisera to the
Phosphate Transport Protein and Rjmarase
The antibody concentrations of the phosphate transport protein 
and fumarase anti sera respectively, were indirectly measured by the 
non-competitive ELISA assay (Voller et al., 1976). As described in 
section 2.3.2.4 antigen-anti body coirplexes can be detected by incubating 
with a horseradish peroxidase-linked second antibody against the IgG 
of the species in which the test antibody was elicited. Subsequent 
incubation of this enzyme-linked conplex with a substrate of the enzyme 
enables direct measurement of the antibody titre by formation of a 
coloured product. The antibody titre can then be obtained by plotting 
a graph of absorbance of product formed versus antibody dilution for 
both a control serum and test antiserum. The point at which there is 
no significant difference in absorbance between the control and immune 
antiserum is called the 'titre-point*. Figs. 4.3.1(A) and 4.3.1(B) indicate
such determinations for the initial bleedings of rabbit, polyclonal 
antisera raised against the phosphate transport protein and the enzyme 
fumarase, respectively. It can clearly be seen that there is no 
significant difference between the antibody titre values of both antisera, 
as they lie in the range of 1 in 10,000. This value is in good agreement 
with the generally accepted value for the initial bleed of any antiserum. 
Antibody titre was increased by subsequent injection of the rabbit with 
purified antigens.
4.3.2 Immune-Blotting Analysis of the Phosphate Transport Protein 
Antiserum
In section 3.3.4.3, this antiserum was shown to partially-inhibit 
(50%) mitoplast swelling in ammonium phosphate buffer in a specific
manner. This result strongly suggested that the protein isolated from 
rat liver mitochondria was indeed the phosphate transport protein. Tb 
confirm that the rabbit polyclonal antiserum was monospecific, it was 
tested by using the highly sensitive immune-replica technique of Tbwbin
et al. (1979). Antigen-antibody conplexes formed were detected by
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incubation of the blot with I-labelled protein A (2 x 10 cpm/blot)
and exposure to autoradiography, as described in section 2.3.2.1(B).
Fig. 4.3.2(B) illustrates such an analysis when the antiserum was tested 
against various quantities of Celite-purified phosphate transport protein. 
After exposing the autoradiograph for two days at -80°C, a band corres­
ponding to the phosphate transport protein (M 34,000) can be seen in 
each track which increases in intensity as the level of purified protein 
increases. This result gives an indication of the sensitivity of the 
technique in that 0.5jug of purified phosphate transport protein can be 
visualized after the above exposure time. Additionally, the result 
confirms that the anti serum recognises the antigen to which it was 
initially raised. However, of interest is the appearance of a doublet 
at 68,000 which is particularly noticeable at the higher levels of 
purified protein. A recent report by Tasheva and Dessev (1983) , strongly 
suggested that this Mr 68,000 doublet was of an artifactual nature owing 
to the presence of 2-mercaptoethanol in Laemmli sanple buffer. Confirm­
ation of their findings was provided by an experiment in which Laemmli 
sanple plus 2-mercaptoethanol or DTT in the absence of protein, was run 
on an SDS-polyacrylamide gel, transferred to nitrocellulose paper and 
incubated with the pho^hate transport protein antiserum (Fig. 4.3.3A, 
tracks 1 and 2). Clearly, the 68,000 doublet is present in both 
these sanples and arises when sulphydryl group reagents are present in 
the buffer. This latter point has been confirmed in an experiment where 
the Celite-purified phosphate transport protein was solubilized by boiling
in Laemmli sanple buffer plus 2-mercaptoethanol and then treated with a 
5-fold excess of the alkylating reagent, iodoacetamide. Iodoacetamide 
was used to alkylate free sulphydryl groups on the excess 2-mercapto­
ethanol. After resolution by SDS-polyacrylamide gel electrophoresis, 
the protein was transferred onto nitrocellulose paper and subsequently 
overlayed with phosphate transport protein antiserum for analysis by the 
immune-replica technique (see section 2.3.2.1B). Although not shown 
here, this treatment of the protein removed the 68,000 M doublet from 
the corresponding autoradiograph. Clearly, this high Mr doublet arises 
as an artifact of the system although its actual nature is unknown.
The next step in the characterization of this antiserum, by the 
immune-replica technique, was to challenge crude mammalian culture cell 
extracts. This approach can be utilised to confirm that the antiserum 
is monospecific in its recognition of antigen, a prerequisite for the 
future biosynthetic studies. In addition, this type of analysis can be 
performed to establish that the protein is present in the various cell 
lines and to show that the anti serum directed against the rat liver protein 
can cross-react with other tissue sources of the protein. Fig. 4.3.3B 
illustrates the autoradiographic profile of such a blot when crude 
cytosolic, mitochondrial and whole cell extracts, prepared from PK-15 
and BRL cells respectively (see section 2.2i5.3) , were treated with the 
phosphate transport protein antiserum. Numerous high M bands can be 
visualized in all three fractions prepared from each cell line. These 
additional, non-specific bands vary markedly in M . In the mitochondrial 
fractions of each, cell line (tracks 4 and 5), a faint polypeptide band 
of Mr 34,000 can be visualized when conpared with track (1) , the Celite- 
purified, rat liver mitochondrial phosphate transport protein. However, 
in contradiction to this finding no polypeptide band of this Mr can be 
seen in the post-nuclear supernatant fractions prepared from these cell
lines (tracks 6 and 7). As expected from its location in the cell, 
no phosphate transport protein band can be shown to exist in the cytosolic 
fractions (tracks 2 and 3).
The faint polypeptide band of Mr 34,000 in the mitochondrial fraction 
prepared from the BRL cells and the lack of this polypeptide in the post- 
nuclear supernatant fraction, suggests that the level of phosphate 
transport protein in these cells is low. In the case of the PK-15 cell 
line, the findings indicate that either the protein is present in low 
levels within the cell or that it does not cross react very strongly with *■ 
the antiserum which is raised against the rat liver mitochondrial phosphate 
transport protein.
Similar results to the above were obtained when rat liver mito­
chondrial subfractions were blotted and treated with this antiserum.
4.3.3 Effect of Rimarase Anti serum on Enzymic Activity
In order to show that an antiserum is directed against a particular 
enzyme or protein, one should be able to show an inhibition of that protein’s 
biochemical activity by the antiserum. This was achieved by assaying the 
activity of the pig heart purified fumarase (EC4.2.1.2) in the presence 
of anti-fumarase serum, as described in the legend to Fig. 4.3.4.
Enzymic activity was calculated from the following equation:
Specific activity (Enzyme units/mg protein) =
A240nm/min x 1000
2.44 x mg protein/reaction mix
= nmoles/min/mg protein
To observe the effect of the rabbit, polyclonal antiserum on 
fumarase activity, the percentage of enzymic activity in the presence of
fumarase anti serum as conpared to control enzymic activity where no 
anti serum was added, was plotted against the vol. of anti serum added to 
the reaction mixture (Fig. 4.3.4). It can clearly be seen from Fig.
4.3.4, that there is a dramatic decrease.in enzymic activity on addition 
of low levels of antiserum (10-20pl), which levels off at about 75% 
inhibition of enzymic activity. In the presence of pre-immune serum no 
inhibition of enzymic activity can be found.
4.3.4 Immune-blot Analysis of Anti-fumarase Serum
The immune-replica technique (Towbin et al., 1979) , was used to 
fully characterize the rabbit, polyclonal fumarase antiserum in a similar * 
manner to that enployed for the phosphate transport protein antiserum. 
Initially, the technique was utilised to confirm that the antiserum 
interacted with the antigen to which it was raised. The effect of 
incubating a fixed quantity of fumarase (5pg). with serial dilutions of 
the fumarase antiserum, by the immune-replica assay, is illustrated in 
Fig. 4.3.5A. There is a very strong interaction of the antiserum with 
enzyme at low antiserum dilutions (ie. 1 in 20), track (1) , which gradually 
decreases with increasing antiserum dilution. However, even at very 
high anti serum dilutions (ie. 1 in .500, track 6), a polypeptide band 
corresponding to fumarase (M^  47,000) can be detected after autoradio­
graphy for two days at -80°C. Apart from demonstrating that the antiserum 
interacts with the purified pig heart enzyme, this result gives an in­
dication of the sensitivity of fumarase anti serum towards its antigen.
Fig. 4.3.5C illustrates the autoradiographic profile obtained when various 
levels of purified fumarase (0.5 - 10pg) are blotted and treated with a 
fixed concentration of anti serum (1 in 40 dilution). After a two day 
exposure at -80°C, a band corresponding,to mature fumarase (M^  47,000) 
can be visualised which in agreement with the analogous phosphate trans-
port protein blot (Fig. 4.3.2), increases in intensity with raised levels 
of purified antigen. Fig. 4.3.5B represents, the original Coomassie Blue 
staining profile of F ig. 4.3.5C prior to immune-replica analysis with the 
fumarase antiserum.
Monospecificity of the fumarase antiserum was demonstrated by showing 
that the antiserum only reacted, with a single conponent when challenged 
with crude mammalian tissue culture cell extracts (2.2.5.3), by the 
immune-replica technique (2.3.2.1B). In this case, the various crude 
cell extracts were prepared from BKL, PK-15 and NBL-1 cell lines, 
respectively. Fig. 4.3.6 demonstrates that fumarase can be detected 
in both the mitochondrial and cytosolic conpartments of BEL and PK-15 
cells (tracks (2), (3), (5) and (6)). This finding is in agreement with 
the earlier work of several groups including Nakashima et al.. (1976) who 
have shown that fumarase is distributed between the .cell cytoplasm and 
mitochondrial matrix conpartments of rat liver, respectively. Interest­
ingly, the BRL cytosolic form of enzyme appears to be of a higher Mr value 
(47,000) than the corresponding mitochondrial form (45,000). In contrast, 
the pig kidney fumarases are of an identical Mr value (47,000). The 
bimodal distribution of fumarase was confirmed in an experiment in which 
intact PK-15 cells were treated with a series of concentrations of the 
detergent-like coirpound, digitonin (see section 4.2.1). The release 
of fumarase from PK-15 cells was measured at all concentrations of 
digitonin used by measuring., enzymic activity as described in section 
2.2.2B. To act as an indicator of mitochondrial breakage, the activity 
of the mitochondrial matrix marker, citrate synthetase, was also assayed 
in each sairple (Fig. 4.3.7). At low levels of digitonin where the cell 
plasma membrane is disrupted preferentially, no measurable citrate synthetase 
activity could be detected. However, under the same conditions the 
release of fumarase from the cytosol was shown. This cytosolic activity
correspond^ to about, 40% of the total cellular activity of fumarase.
The existence of a cytosolic pool of enzymic, activity confirmed the 
previous immune-replica data in. cultured mammalian cells (see Fig. 4.3.6) 
At higher levels of digitonin (2 and 5mg/ml cell, suspension) , citrate 
synthetase activity could be detected in the supernatant fraction also 
indicating breakage of mitochondria. A corresponding rise in fumarase 
activity acconpanied mitochondrial disruption, indicating the presence 
of a second pool of fumarase. in this organelle.
Finally, the immune-replica technique was used to demonstrate that 
the mitochondrial fumarase activity was localized in the matrix conpart- 
ment of the organelle. Beef heart mitochondria, prepared by the method 
of Smith (1967) , were sonicated for 3X 15S (high power and anplitude 
3 settings) on an MSE Ultrasonic disintegrator and the membrane fraction 
pelleted by centrifugation at 100,000g for 1h. Boxer (1975) previously 
demonstrated that such mitochondria are largely devoid of outer membrane 
material. This was shown by assaying the beef heart, mitochondria for 
the outer membrane marker enzyme, monoamine oxidase. When this was 
performed (Boxer, 1975), only 4% of the total mitochondrial protein 
represented outer, membrane material. As a result of these findings, 
sonication of beef heart mitochondria in our studies will result in the 
release of matrix conponents. Fig. 4.3.8 illustrates the autoradio­
graphic profile of the immune^blot from such sanples, after treatment 
with fumarase antiserum. The enzyme (M 47,000) could be detected in 
both the matrix fraction (track. 3) and intact, mitochondria (track 1) but 
not in the membrane. fraction (track 2). These findings are in agreement 
with the known mitochondrial function of the enzyme.
4.4. . DISCUSSION
4.4.1 Immune-replica Assay
In this study, the specificities of rabbit, polyclonal antisera 
raised against the rat liver mitochondrial phosphate transport protein and 
pig heart enzyme fumarase respectively, were largely determined by the 
immune-replica technique (Tbwbin et al., 1979), as described in section 
2.3.2.1(B). This technique is now routinely used in our laboratory 
to characterize many different antisera. By transferring SDS-polyacryl- 
amide gel electrcphoretically separated proteins on to nitrocellulose 
paper one has the following advantages:-
i) wet filters are pliable and easy to handle,
ii) the immobilised proteins are readily and equally accessible
to anti serum,
iii) transfer analysis generally calls for small amounts of reagents,
iv) processing times can be significantly reduced.
It also has the advantage over the conventional gel methods utilised 
in the past to determine the specificity of antisera, in that it enables 
the values of all proteins recognised by the antisera to be calculated 
directly.
The method of Tbwbin et al. (1979) was originally adopted in this
laboratory to determine the specificity of both rabbit, polyclonal
anti sera to the rat liver mitochondrial phosphate transport protein and
to the pig heart enzyme, fumarase. Tb saturate additional protein
binding sites on the electrophoretic blots, they were soaked in a 3% (w/v)
BSA solution (see section 2.3.2.IB), prior to treatment with antiserum.
After incubation with anti serum, the immobilised antigen-antibody complexes
125were decorated with I-labelled protein A (prepared as described in
section 2.2.3) and exposed to autoradiography (section 2.2.4.5). In all 
experiments using BSA as the blocking agent, the backgrounds of the 
blots after exposure to autoradiography were extremely poor and as a 
result difficult to interpret. Tb overcome this problem, the modification 
of Batteiger et al. (1982) was adopted. It involved the use of the 
non-ionic detergent TVeen 20 (0.5% (v/v)) to block additional protein ' 
binding sites on the nitrocellulose paper, instead of BSA. By using 
a non-ionic detergent to block unoccupied sites on the nitrocellulose 
paper, several advantages can be gained:
a) The efficiency of electrophoretic transfer can be determined by 
staining the proteins directly on the blot.
b) Staining for protein after immunological probing enables one to 
determine if the electrophoretic pattern is conserved during antibody 
incubation and washes.
c) Oonparison of the autoradiogram and the stained blot from which
it was derived, allows accurate identification of immunoreactive proteins.
All the immune-blots illustrated in this chapter were treated with 
TWeen 20 and resulted in clearer backgrounds, enabling easier inter­
pretations.
4.4.2 Specificity of the Phosphate Transport Protein Anti serum
Immune-replica analysis of the phosphate transport protein antiserum 
always demonstrated the presence of a doublet of Mr 68,000, although the 
Mr value of the purified protein was 34,000. This doublet was even 
present when the Celite purified rat. liver mitochondrial phosphate 
transport protein was treated to such an. analysis. Densitometric scanning
of a Coomassie Blue stained gel containing the Celite purified carrier 
had previously shown its purity to be greater than 95%.
The possibility that this doublet represented a dimer of the 
phosphate transport protein was ruled out by the findings in our 
laboratory of several, conpletely unrelated antisera reacting with it 
on immune-replica analysis. In 1983, Tasheva and Dessev reported the 
existence of a doublet of similar Mr to that mentioned above when resolving 
a class of proteins bound to DNA by SDS-polyacrylamide gel electrophoresis. 
They showed that when 2-mercaptoethanol was present in Laemmli sanple 
buffer during SDS-polyacrylamide gel electrophoresis, two additional 
bands with electrophoretic mobilities corresponding to Mr values of 
68,000 and 54,000 respectively, were stainable with silver and to a 
lesser extent Coomassie Blue. Closer examination of the Coomassie Blue 
stained polyacrylamide gel used to resolve the phosphate transport protein 
(Fig. 4.3.2A), confirmed these authors' results. They also demonstrated 
that even in the absence of protein, when only sanple buffer was loaded 
on to the gel, these two bands could be detected and thus were of a 
non-protein origin. Fig. 4.3.3(A) illustrated the effect of loading 
Laemmli sanple buffer plus 2-mercaptoethanol or DTT on to a gel and 
analysing by the immune-replica technique with phosphate transport protein 
antiserum. The 68,000 M doublet and a slightly lower band were 
strongly labelled in both instances, confirming the non-protein nature 
of the bands and suggesting that they arise as an artifact of this 
system. Tb overcome, this problem it has recently been shown in our 
laboratory that if the protein samples are treated with an excess of the 
alkylating reagent, iodoacetamide after solubilization in Laemmli sanple 
buffer, the 68,000 doublet can no longer be detected, on the auto­
radiograph. This finding suggests a role for the free sulphydryl groups 
on 2-mercaptoethanol in the artifactual nature of this doublet. However,
it does not explain why the anti serum to the phosphate transport protein 
recognises and binds to the doublet.
When the phosphate transport protein anti serum was tested for 
specificity against tissue culture cell extracts, numerous additional 
high Mr bands could be visualized on the autoradiogram. Purification 
of the IgG fraction from whole anti serum had no effect on the immune- 
replica pattern of these extracts. The following explanations can be 
put forward to possibly esqplain these results:
i) The additional polypeptides of higher Mr which are interacting 
with the antiserum against the phosphate transport protein (Mr 34,000) , 
may have arisen from the presence in the antigenic preparation of proteo­
lytic fragments derived from larger polypeptides. These proteolytic 
fragments may comigrate with the phosphate transport protein during 
SDS-polyacrylamide gel electrophoretic separation and thus will not be 
differentiated from the phosphate transporter by Coomassie Blue, staining. 
During the preparation of cultured mammalian cell extracts, if there is 
no problem with proteolysis, the antibodies elicted against the proteolytic 
contaminants will be able to react with the uncleaved protein giving rise 
to these polypeptide bands of higher Mr value. A similar finding to 
this has been reported previously by Suissa and Reid (1983) , when studying 
the specificity of antisera directed against the ^ -subunit of the yeast 
F^-ATPase. They discovered that the antiserum also cross-reacted with 
the oc-subunit of this complex which has been shown to be particularly 
sensitive to proteolysis. This interpretation of the immune-replica 
data obtained with the antiserum raised against the phosphate transport 
protein is unlikely as the preliminary amino acid conposition data of the 
protein illustrates that it contains no tyrosine (see Table 3.3.1). If 
the phosphate transporter was contaminated with proteolytic degradation 
fragments of polypeptides of higher Mr value, then one would e^ qpect this
to affect the amino acid conposition data. It is unlikely that all of 
the contaminating proteins do not contain.any tyrosine residues.
ii) An alternative explanation is that these additional proteins
are very antigenic contaminants which are present in the phosphate
transporter preparation in low levels and thus are not detectable by
Coomassie Blue staining. In agreement with this explanation are the
results of earlier, findings which showed that the rat liver mitochondrial
125 'phosphate transport protein when overlayed with I-labelled con A 
illustrated numerous high and low glycoprotein contaminants (see 
Fig. 3.3.1B). Although pre-extraction of mitochondria with a 0.5%
(v/v) Triton X-100 buffer (see section 3.2.1 method a) appeared to 
quantitatively remove these glycoproteins, lectin overlay analysis was 
not performed on subsequent purifications of the phosphate transport 
protein. As a result, if the preparations used for injecting the rabbit 
were, contaminated with low levels of glycoprotein, antibodies would also 
be raised against them and they would 'subsequently be detected by 
immune-replica analysis. Again, however, this explanation is unlikely 
because one does not see these additional bands when the purified 
phosphate transport protein is analysed by the immune-replica technique 
(see Fig. 4.3.2).
iii) A third explanation of the immune-replica analysis of cultured 
mammalian cell extracts with the antiserum directed against the phosphate 
transport protein is based on the hydrophobic properties of the trans­
membrane carrier. It is very likely that many of the protein's antigenic 
determinants are also of a hydrophobic nature. These additional bands 
on the autoradiograph may, therefore, arise as a result of the constitutive 
polypeptides exposing similar hydrophobic determinants to those found on 
the phosphate transport protein and thus being recognised by the anti serum.
This interpretation, however, would have to suggest in yeast, where the 
antiserum specifically recognises a protein of 29,000 M , that no other 
polypeptides contain similar hydrophobic determinants to those found on 
the rat liver mitochondrial phosphate transporter (see Fig. 5.3.10a).
iv) Finally, a fourth explanation of the immune-replica findings can 
be given in which the polypeptide bands of higher ,M values represent 
either aggregates of the phosphate transport protein or aggregates of the 
phosphate transport protein with other cellular polypeptides. The 
aggregation of membrane proteins, even in the presence of SDS, has recently 
been reported by Finbow et al. (1983). They were carrying out studies 
on the gap junction protein isolated from a wide variety of tissue sources 
and illustrated that the protein (M 16,000) dimerised when boiled in 
SDS, to give a polypeptide of M 26,000 when resolved by SDS-polyacrylamide 
gel electrophoresis. Tb overcome this problem, Finbow et al. (1983) 
solubilised the gap junction protein in an SDS solution at room temperature. 
The wide range of M values of the additional polypeptides obtained when 
crude cultured mammalian cell extracts are immune-blotted with the anti­
phosphate transport protein serum favours an aggregation of the transporter 
with other cellular polypeptides. In addition, the purified rat liver 
phosphate transport protein did not appear to aggregate (see Fig. 4.3.2B). 
However, once again one has the problem of interpreting the yeast immune- 
replica data in which the anti-rat liver mitochondrial phosphate transport 
protein serum specifically recognises a protein of 29,000 Mr (see Fig. 
5.3.10a). In this case, it is assumed that for some reason the yeast 
phosphate transport protein does not have a tendency , to aggregate with 
other cellular proteins.
In summary, although the antiserum directed against the rat liver • 
mitochondrial phosphate transport protein demonstrates the presence of
numerous polypeptides when challenged with crude cell fractions, we 
believe that this problem is of a technical nature and not due to the 
lack of purity of the isolated protein.
4.4.3 Specificity of the Rabbit, Polyclonal Anti serum to Pig Heart 
Rjmarase
The immune-replica technique confirmed that the rabbit, polyclonal 
antiserum raised against pig heart fumarase was monospecific when crude 
mammalian tissue-culture cell extracts (see section 2.2.5.3) were challenged 
with the anti serum. However, both the PK-15 and BKL cells appeared to 
possess a cytosolic form of the enzyme. In the case of the PK-15 cell 
line, this form of the enzyme was of the same M (47,000) as the mito­
chondrial enzyme, whereas the BEL cytosolic fumarase appeared to be of a 
slightly higher Mr than its corresponding mitochondrial form.
Cytosolic and mitochondrial pools of fumarase have been reported to 
exist in many tissues including rat liver, kidney, heart (Akiba et al.,
1984) and in yeast (Hiraga et al., 1984). The cytosolic fumarase appears 
to play a role in the urea cycle and in the tyrosine-oxidizing system. 
Extensive research in recent years has been directed towards a greater 
understanding of the physiochemical properties of the two forms of the 
rat liver enzyme, in particular (Kobayashi et al., 1981). It appeared 
that the. cytoplasmic and mitochondrial forms of fumarase in rat liver 
were indistinguishable from one another (Table 1.5.1). However, Kobayashi 
and TUboi (1983) subsequently discovered that the N-terminal residues of 
the two enzyme forms differed from each other. The N-termini of the rat 
liver mitochondrial and cytosolic fumarases were identified as pyro- 
glutamic acid and N-acetylalanine, respectively. In 1984, Hiraga et al. 
also demonstrated that the two enzyme forms could be separated . from each 
other by Bio-Gel HTP column chromatography. This indicated that there
were some conformational differences between the. native proteins of the 
mitochondrial and cytosolic fumarases.
In contrast to the earlier work of these Japanese groups, BKL 
cytoplasmic fumarase appears to be of a slightly larger Mr than the 
mitochondrial form, indicating several potential modes of synthesis which 
will be discussed in chapter five. The results obtained from immune- 
replica analysis could initially have been interpreted in terms of a 
contamination of cell cytosol with mitochondrial extracts, since cell 
disruption was inplemented by homogenisation. Confirmation was, however, 
provided by an experiment in which intact PK-15 cells were treated with 
increasing concentrations of digitonin (see section 4.2.1).. This compound 
is one of the saponins, a series of steroid glycosides with detergent­
like properties that are widespread amongst higher plants. At low
concentrations, it can.be selectively used to disrupt membranes rich in
0
cholesterol. In this experiment, at low concentrations (0-1mg/5 x 10 
cells), only the plasma membrane of PK-15 cells would be disrupted. Thus 
high speed centrifugation (14,000g for 1 min) of cells treated in this 
manner would spin down all organelles.including mitochondria. The 
resulting supernatant fraction would consequently be rich in cytosolic 
material. At higher levels of digitonin, the mitochondria which contain 
very low levels of cholesterol (0.24% of total lipid by weight) , will be 
disrupted. This experimental approach was, therefore, utilised to 
demonstrate the existence of two pools of the enzyme, fumarase.
Intactness of PK-15 mitochondria was measured by monitoring the activity 
of the matrix-located marker enzyme, citrate synthetase. The results 
obtained clearly illustrated the presence of a cytosolic pool of fumarase 
in PK-15 cells when no measurable citrate synthetase activity could be 
detected. A similar result was obtained when the experiment was performed 
with BRL cells.
Finally, the immune-replica technique is not only a highly sensitive 
method for demonstrating the monospecificity of an antiserum but it can 
also be utilised as an analytical tool, to illustrate the purity of 
subcellular fractions. Beef heart mitochondrial subfractions were 
prepared by sonication (see section 4.3.4) and the membrane and soluble 
fractions isolated by centrifugation. Immune-blotting with fumarase 
antiserum confirmed that the enzyme was located in the mitochondrial 
matrix where it functions in the tricarboxylic acid cycle.
Figs. 4.3.1 (A) and (B)
ESTIMATION OF THE TITEES OF THE ANTI-PHOSPHATE TRANSPORT PROTEIN SERUM 
AND THE ANTI-FUMARASE SERUM
The titres of the polyclonal, rabbit antisera directed against 
the phosphate transport protein and fumarase, respectively, were estimated 
by the indirect ELISA assay (see section 2.3.2.4). A fixed concentration 
of antigen (phosphate transport protein or fumarase) was incubated at 
room tenperature with serial dilutions of antiserum, ranging from 
1 in 100 to 1 in 100,000. By plotting the absorbance at 492nm of the 
product formed from the horse-radish peroxidase linked conjugate (see 
section 2.3.2.4) against antibody dilution for (o) control serum and (•) 
phosphate transport protein serum (Fig. 4.3.1 A) or fumarase antiserum 
(Fig. 4.3.1B) respectively, the antibody titres could be calculated.
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Figs. 4.3.2 (A) and (B)
IMMUNE-REPLICA ANALYSIS OF PURIFIED PHOSPHATE TRANSPORT PROTEIN VERSUS 
ANTISERUM DIRECTED AGAINST THE PROTEIN
Celite-purified rat liver, mitochondrial phosphate transport protein 
(see section 3.2.1 method a) was resolved by SDS-polyacrylamide gel 
electrcphoresis 12.5% (w/v) (see section 2.2.4.1), transferred onto 
nitrocellulose paper (see section 2.3.2.1 A) and analysed by the immune- 
replica technique (see section 2.3.2.1B).
A) Goomassie Blue staining profile of resolved protein (s) after 
SDS-polyacrylamide gel electrcphoresis; (1) low Mr standards (2) 0.5pg
(3) 1pg (4) 2pg (5) 5pg (6) 10pg Celite-purified phosphate transport 
protein.
B) Autoradiographic profile of above gel after immune-blotting, except 
that no low Mr standards were run. Ihe autoradiograph was exposed for 
two days at -80°C (see section 2.2.4.5).
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Phosphate transport 
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Figs. 4.3.3 (A) and (B)
IMMUNE-REPLICA. ANALYSIS OF MAMMALIAN TISSUE-CULTURE CELL EXTRACTS 
VERSUS PHOSPHATE TRANSPORT PROTEIN ANTI SERUM
After separation by SDS-polyacrylamide gel electrcphoresis 12.5%
(w/v) (see section 2.2.4.1), proteins were transferred onto nitro­
cellulose paper (see section 2.3.2.1A) before subjection to immune- 
blotting (see section 2.3.2.1B) and detection by autoradiography (see 
section 2.2.4.5).
A) To illustrate the artifactual nature of the 68,000 Mr doublet which 
reacts with the anti-phosphate transport protein, the following samples 
were utilised; (1) Laemmli sanple buffer plus 2-mercaptoethanol
(2) Laemmli sanple buffer plus DTT (3) Celite eluate.
B) specificity of this antiserum was determined by challenging the 
following crude mammalian tissue-culture cell extracts; (1) Celite eluate 
(2) 40jig PK-15 cytosolic fraction (3) 40pg BRL cytosolic fraction
(4) 40pg PK-15 mitochondrial fraction (5) 40pg BRL mitochondrial fraction
(6) 40pg PK-15 whole cell extract (7) 40pg BRL whole cell extract
The autoradiographs were exposed for two days at -80°C.
A (-) B (-)
M 68,000 r
M 34,000
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Fig. 4.3.4
EFFECT OF POLYCLONAL, RABBIT ANTI-FUMAEASE SERUM ON PURIFIED ENZYMIC 
ACTIVITY
Pig heart fumarase activity (1-5pg) was measured by the method 
described in section 2.2.2(B), in the presence of increasing levels 
of (o) control serum and (•) fumarase antiserum, respectively. The 
enzyme was incubated for 90 min at room teirperature with either control 
serum or fumarase anti serum, prior to its addition to the reaction 
mixture. A graph was subsequently plotted of the percentage of fumarase 
activity in the presence of anti-fumarase serum, as conpared to control 
enzymic activity where no anti serum was added, against the vol. of 
anti serum added.
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IMMUNE-REPLICA ANALYSIS OF PURIFIED PIG HEART FUMARASE VERSUS ANTI-
FUMARASE SERUM
Purified fumarase, after resolution by SDS-polyacrylamide gel 
electrcphoresis 10% (w/v) (see section 2.2.4.1) was transferred onto 
nitrocellulose paper (see section 2.3.2.1 A) and treated to immune- 
replica analysis (see section 2.3.2.1B) with anti-fumarase serum. 
Visualization of the reactive bands was achieved by autoradiography 
(see section 2.2.4.5). . . -
A) Autoradiographic profile of the titration of a fixed level of 
fumarase (5pg) with a series of dilutions of fumarase antiserum;
(1) 1 in 20 (2) 1 in 40 (3) 1 in 80 (4) 1 in 100 (5) 1 in 200
(6) 1 in 500.
B) Autoradiographic profile of a range of levels of purified fumarase 
versus fixed anti serum dilution (1 in 40); (1) 10pg (2) 5pg (3) 2pg 
(4) 1pg (5) 0.5pg purified fumarase.
C) Coomassie Blue staining profile of B including low M^ standards 
(track 6) (see section 2.2.4.3 for details of standards).
Both autoradiographs were exposed for 24hrs at -80°C.
A (-)
(+)
(1) (2) (3) (4) (5) (6)
B C
(-)
(+) (+) 
(1) (2) (3) (4) (5) (1) (2) (3) (4) (5) (6)
Fig. 4.3.6
IMMUNE-REPLICA ANALYSIS OF CULTURED MAMMALIAN CELL EXTRACTS VERSUS 
ANTI-FUMARASE SERUM
Crude cultured mammalian cell extracts, prepared as described in 
section 2.2.5.3, were initially subjected to SDS-polyacrylamide gel 
electrcphoresis 10% (w/v) (see section 2.2.4.1) followed by immune- 
blotting analysis (see sections 2.3.2.1A and B). specificity of 
the antiserum was determined by exposing the blot to autoradiography 
(see section 2.2.4.5).
The autoradiographic profile of the following sanples is illustrated: 
(1) BRL cell extract (2) BRL mitochondria (3) BRL cytosol (4) 0.2pq 
of purified fumarase (5) PK-15 cell extract (6) PK-15 mitochondria
(7) PK-15 cytosol (8) O.^ig purified fumarase (9) NBL-1 cell extract.
In all cases, 40pg of cell extract was loaded on to the gel. Tracks 
1-3 were exposed for six days whereas tracks 4-9 for two days at -80°C.
(-) (-)
(+) (+)
(1) (2) (3) (4) (5) (6) (7) (8) (9)
Fig. 4.3.7
ESTIMATION OF FUMARASE AND CITRATE SYNTHETASE ACTIVITIES IN DIGITQNIN
TREATED PK-15 CELLS
PK-15 cells were treated with a range of digitonin concentrations 
(0-5mg/ml cell suspension), as described in section 4.2.1, to prepare 
a fraction which represented the cell cytosol. The bimodal distribution 
of fumarase was demonstrated by measuring the release of enzymic activity 
(see section 2.2.2B) at each digitonin concentration. As a control, 
the mitochondrial matrix marker enzyme, citrate synthetase was also 
assayed (see section 2.2.2A) in each fraction to test the integrity of 
the mitochondria.
• - fumarase activity (enzyme units/ml cell extract) 
o - citrate synthetase activity (enzyme units/ml cell extract)
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Figs. 4.3.8 (A) and (B)
IMyiUNE-REPLICA ANALYSIS OF BEEF HEART MITOCHONDRIAL SUBFRACTIONS VERSUS 
ANTI-HJMARASE SERUM
Beef heart mitochondrial subfraction proteins, prepared as described 
in section 4.3.5, were separated by SDS-polyacrylamide gel electrophoresis 
10% (w/v) (see section 2.2.4.1) and then analysed by the immune-blotting 
technique (see sections 2.3.2.1 A and B) with fumarase antiserum (1 in 
40 dilution).
A) Coomassie Blue staining profile of; (1) intact beef heart mito­
chondria (2) mitochondrial membrane fraction (3) mitochondrial matrix
(4) 2jig purified fumarase (5) low Mr standards.
40pg of mitochondrial subfractions were loaded onto each track.
B) Autoradiographic profile of above gel except that track (4) only
contained 0.2pg of purified fumarase and track (5) contained 30,000 cpm 
125of I-labelled low M standards. Ihe autoradiograph was exposed for 
24h at -80°C.
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CHAPTER FIVE
BIOSYNTHETIC STUDIES ON FUMARASE
AND THE PHOSPHATE TRANSPORT PROTEIN
5.1 INTRODUCTION
A detailed account of the present understanding of the mechanism(s) 
of biosynthesis of nuclear-encoded mitochondrial proteins was given in 
section 1.3. The vast, majority, of knowledge gained in this field has 
come from biosynthetic studies carried out in the lower eukaryotes 
S.cerevisiae and N.crassa. In vitro translational systems and in vivo 
studies enploying pulse-labelled cells have shown that the overall mechanism 
of inport, from the synthesis of the precursor in the cell cytoplasm to 
its subsequent uptake and translocation into the correct mitochondrial 
conpartment, occurs as summarized in table 1.3.2.
Attention in higher eukaryotic systems has largely focused on the 
synthesis and inport of nuclear-encoded mitochondrial proteins utilising 
in vitro translational systems. Some work, has, however, been performed 
in vivo including that of Mari et al. (1981) who studied the synthesis 
of the urea cycle enzymes, ornithine transcarbamylase and carbamoyl 
phosphate synthetase in isolated rat liver hepatocytes. Primary rat liver 
cell cultures were used in these studies rather than an established rat 
liver cell line because the urea cycle enzymes are lost on prolonged 
incubation of hepatocytes in culture. They were able to confirm the 
previous results in yeast and N.crassa in that these two proteins were 
made as larger precursors. Little, research has been performed in vivo 
enploying cultured mammalian cells, although the work that has been carried 
out includes that of Mihara et al. (1982) who studied the mechanism of 
synthesis of L-glutamate dehydrogenase and D-^-hydroxybutyrate dehydrogenase. 
Again, these workers were able to demonstrate that these two proteins 
were initially synthesised as larger Mr precursors.
As a result of the lack of in vivo data enploying established cell 
lines to study the biosynthesis of mitochondrial proteins in higher
eukaryotic cells, I decided to concentrate on the synthesis of nuclear- 
encoded mitochondrial proteins in cultured mammalian cells. In addition, 
the in vivo data in higher eukaryotes has concentrated on the mechanism 
of synthesis and inport of .soluble, mitochondrial proteins and has not 
investigated the biosynthesis of integral membrane proteins. By utilising 
pulse-labelled cultured mammalian cells, I..hoped to gain a clearer insight 
into the mechanism of synthesis of mitochondrial proteins destined for 
two different locations within the organelle, in order to support the 
earlier findings in yeast and N.crassa.
In particular, the enzyme fumarase was. of interest as it is not 
only found in the mitochondrial matrix, where it functions in the tri­
carboxylic acid cycle, but also because it is located in the cell cytoplasm 
of most tissues.(see section 1.3.1). The bimodal distribution of this 
enzyme presents an interesting problem in that several potential modes of 
synthesis can be envisaged to occur which would result in this type of 
distribution (discussed in detail.in section 5.4.2). Polyclonal, 
monospecific rabbit antisera raised against this protein, which was fully 
characterized, by the methods described in the previous chapter, was used 
as the specific probe to follow the biosynthesis of the enzyme in pulse- 
labelled cultured mammalian cells.
I was also interested in studying the biosynthesis of the mitochondrial 
integral, inner membrane phosphate transport protein in a similar system 
to the above. This carrier protein is likely to be, transmembraneous as 
has been suggested for the extensively studied adenine nucleotide translocase 
of the mitochondrial inner membrane. Neupert and co-workers (1979, 1980) 
have demonstrated both in vitro and in vivo that the N.crassa adenine 
nucleotide translocator is. synthesised in the cytoplasm as a protein of 
similar Mr to the mature polypeptide. I was, therefore, interested in 
determining whether the phosphate transport protein was synthesised in a
similar fashion. However, as reported in section 4.3.2, immune-replica 
analysis of the polyclonal, rabbit antiserum directed against the rat liver 
phosphate transport protein, showed that the antiserum cross-reacted with 
several polypeptides when challenged with crude mammalian tissue-culture 
cell extracts. As a result of this finding, biosynthetic studies were 
not pursued in cultured mammalian cells, although as will be shown in 
section 5.3.4, the antiserum did cross-react specifically with yeast 
extracts prepared from the rho mutant strain D273-10B-1. A detailed 
account of the synthetic studies performed in the yeast cells will be 
given in section 5.4.3.
5.2 METHODS 
355.2.1 L-[ S]-Methionine Labelling of Cultured Mammalian Cells
The procedure listed below was generally used for incorporation of
35L-[ S]-methionine into cellular protein in BEL, PK-15 and NBL-1 cell lines, 
respectively. Variations on its theme will be discussed in the appropriate 
section.
5
Initially, cells (3 x 10 cells/ml) were grown in plastic Petri dishes 
in normal growth medium (see section 2.4.1) by incubating overnight in a 
humified incubator at 37°C containing a 5% 002/95% air atmosphere. The 
original cell suspension was prepared by the method described in section
2.4.2 and cell numbers determined by using a haemocytometer. Normal growth
medium was then discarded, cell monolayers washed once with low methionine
medium (1 in 20 dilution of normal growth medium with (-) methionine medium)
prior to incubation for 2h at 37°C in this medium. At this stage 5-200juCi 
35[ S]-methionine (1100 Ci/mmol) was added to the dish to initiate radiolabellii 
of cell protein. After appropriate, incubation times (see legends to Figs. 
and Tables), the medium was removed, cells washed 3X with PBS (see section
2.3.2.2) to remove soluble counts and lysed with, either 0.3-1.0ml of a 
1% (v/v) Triton X-100 buffer (see section 2.3.2.2) or. 1ml of 2% (w/v) SDS, 
10mM Tris-HCl pH 8.8 buffer. At this point three different strategies 
were adopted to process the cell extract further, depending on the nature 
of the esqperiment;
i) if cells had been labelled for immune-precipitation studies, the 
Triton X-100 extract was processed according to the procedure described 
in section 2.3.2.2;
ii) if cells were labelled for optimizing growth conditions (see section
5.3.1), the extract was treated in the following manner;
a 25pl aliquot (total vol. 300jul) was spotted onto Whatman 3MM filter discs 
and washed extensively overnight in 10% (w/v) trichloroacetic acid (TCA) at 
4°C, TCA was removed, the discs washed once for 20 min with ethanol and then 
air-dried. Finally, the dried discs were placed in scintillation vials 
and counted by adding 4.5ml of scintillation fluid, as previously described 
(see section 2.3.2.2);
35iii) if cells had been labelled with [ S]-methionine in the presence of 
inhibitors of protein synthesis (see section 5.3.2), after solubilization 
in 2% (w/v) SDS, 10mM Tris-HCl pH 8.8 buffer, they were treated with 4 vol. 
of acetone to precipitate protein and subsequently prepared for SDS- 
polyacrylamide gel electrophoresis (see section 2.2.4.2).
5.2.2 Accumulation of Mitochondrial Precursor Proteins .in Yeast Cells
The yeast rho mutant strain D273-10B-1 was routinely grown at 21°C 
on a rich medium containing 1% (w/v) yeast extract, 2% (w/v) Bacto-peptone 
and 0.1M potassium phosphate buffer pH 6.0.
Tto accumulate large amounts of cytoplasmically-made mitochondrial 
precursor proteins, the mutant strain D273-10B-1 was grown at 21°c on rich
medium supplemented with 2% (w/v) galactose. On reaching the mid-log 
phase of growth, the culture was divided into six equal aliquots and CCCP 
added to five of them at final concentrations of 1,2,5,10 and 20/jM, 
respectively. A sixth fraction to which no CCCP had been added, acted 
as a control culture. The cells were grown for a further 7.5h at 21°C, 
after which time they were cooled and harvested at. 4°C by centrifugation 
at 1500g for 10 min. The pellets were washed twice in 0.1M potassium 
phosphate buffer containing 10pM CCCP, the uncoupler being added to prevent 
processing of the precursor proteins. After washing, the cells were 
resuspended in 8ml of 0.1M potassium phosphate buffer pH 6.0 to which was 
added 2.0ml 100% (w/v) TCA, to precipitate, the protein. Subsequently, 
the protein was collected by centrifugation at 1500g for 10 min and the 
pellets were resuspended in 50mM Tris-HCl pH 7.0 containing 10% (w/v) SDS 
and 2mM EDTA. If necessary, the pH was adjusted to 7.0 with 1M Tris-base 
prior to boiling the sairples at 100°C for 15, min. Insoluble material was 
removed by centrifugation at 1500g for 10 min. Occasionally, this extraction 
procedure was repeated to ensure that protein solubilization was complete.
The solubilized protein was precipitated by the addition of 4 vol. of 
acetone before resuspending in Laemmli sanple buffer minus 2-mercaptoethanol 
and pyronin y, to enable protein estimations to be carried out (see section
2.2.1). After the amount of protein had been determined, the sairples 
were prepared for SDS-polyacrylamide gels (see section 2.2.4.2) and 
subsequent analysis by the immune-replica technique.
Finally, yeast mitochondria were prepared from the wild-type strain 
D273-10B (<*; ATCC 25657) by the method of. Daum et al. (1982). and analysed 
by SDS-polyacrylamide gel electrophoresis ,(see section 2.2.4.1) and 
immune-blotting (2.3.2.1).
5.3 RESULTS
5.3.1 Optimization of Growth Conditions
Etor studies on the biosynthesis of nuclear-encoded mitochondrial
proteins in cultured mammalian cells, the growth conditions had to be
. . . . .  . 35optimized initially to ensure maximal rate of incorporation of [ S]-
methionine into total cellular proteins. BEL cells were utilised with 
regard to these studies although the optimal conditions obtained were 
directly applicable.to PK-15 and NBL-1 cells. Detailed descriptions of 
the labelling procedures are given in the respective legends to Figs. and 
Tables.
The initial radiolabelling experiments were performed in (-) methionine 
(-) serum growth medium, as this medium does not contain any free non­
radioactive methionine. The cells are, however, likely to contain internal
pools of non-radioactive methionine which will reduce the specific activity
35 . .of [ S]-methionine within the cells. It was necessary to optimize the
incubation time in this medium prior to the initiation of incorporation of 
35[ S]-methionine into total cellular protein, so that the levels of the
endogenous cellular methionine pools would be depleted to enhance the rate
35of incorporation of [ S]-methionine. The cells would be expected to
contain intracellular pools of methionine since they can synthesise this
amino acid from cysteine or it can be generated from protein turnover.
Several dishes were cultured in which the cells were pre-incubated in this
labelling medium for various times before the addition of isotope and
subsequent incorporation for 30 min at 37°C (Fig. 5.3.1). The rate of
35incorporation of [ S]-methionine increased linearly up to 2h pre-incubation,
thereafter decreasing slowly. The reduction in the rate of incorporation
of radioisotcpe upon prolonged incubation in this medium is likely to be due
to a deterioration in the condition of the cells in the absence of externally-
35added methionine. Whilst the level of incorporation of. [ S]-methionine 
into BRL cellular protein was sufficient for use in the future immune-
precipitation studies, the above experiment did not demonstrate whether
the rate of protein synthesis was affected by the omission of non-radioactive
methionine from the external, medium. As a result, it was necessary to
investigate the effects of varying, the. concentration of. non-radioactive
methionine in the external growth medium, on. the. extent of incorporation 
35of [ S]-methionine. into cellular protein.
Table 5.3.1 illustrates the effect of varying the composition of
35growth medium pn the extent of incorporation of [ S] -methionine into BEL 
cellular protein, during a 30 min labelling period. This experiment was 
performed in order to determine the optimal growth medium in which the 
specific activity of the intracellular radioactive pools was greatly
35enhanced without limiting drastically the rate of incorporation of [ S]-
methionine into cell protein. No significant difference in the incorpor­
ation of radioisotope into cellular protein was found when either (-) 
methionine or low methionine containing serum was used. The levels of
free methionine in these media are very similar and, therefore, as a result
35one would expect to obtain the same extent of incorporation of [ S] -
methionine. When the cells were labelled in either of these media minus
35serum, however, the levels of incorporation of [ S]-methionine into 
cellular protein were also very similar. The following explanations can 
be given to explain this finding since the methionine concentrations in 
these media vary by about 1000-fold with respect to each other (see table
5.3.1);
either (i) methionine is rate-limiting in the (-) methionine (-) serum 
medium such that the rate of incorporation of radioisotope is dramatically 
reduced,
or (ii) there is a high endogenous intracellular pool of methionine in 
the cells which tends to reduce the effective specific activity of added
35[ S]-methionine to a similar degree m  these respective media.
When cells were labelled.in (+) methionine growth medium, a marked
35decrease m  the extent of incorporation of [ S]-methionine was found.
The free methionine concentration in this medium was greatly increased
(about 7-fold) with respect, to (-) methionine and low methionine media
plus serum. As a result, the endogenous methionine pools would be
35expected to be larger, reducing the effective concentration of [ S]-
methionine and thus lowering the rate of incorporation of the isotcpe.
Additionally, this finding confirms that the levels of methionine in the
(-) methionine and low methionine media plus serum are not rate-limiting,
since there is a conparable increase in the extent of incorporation of 
35[ S]-methionine into BKL cellular protein with a reduction in the free
methionine concentrations of these media. The presence or absence of
serum in the growth medium did not appear to have a significant effect on
the incorporation of the radioisotope into total, cell protein.
35Fig. 5.3.2 illustrates the extent of incorporation of [ S]-methionine
into BRL cellular protein at different times up to 24h. The cells were
labelled in both low methionine plus serum medium and (-) methionine plus
serum medium, respectively. It can .clearly be seen that there is a linear
35
increase m  the incorporation of [ S]-methionine up to about 12h in both
35media, at which point there is no further net incorporation of [ S]-
methionine. The parallel increase .in the rate of incorporation of 
radioactive isotcpe in the two media confirmed the previous data (table
5.3.1). It should be noted that by.12h, 80-100%.of the label was 
incorporated into protein.
In summary, the biosynthetic labelling studies, as a result of the 
findings in this section, were performed in low methionine plus serum medium.
5.3.2 Optimization of Conditions for Accumulating Precursor Polypeptides
In section 1.3.5.1 a detailed account was given of the energy require­
ments involved in the inport of cytcplasmically-synthesised mitochondrial 
proteins. It was shown that a membrane potential must exist across the 
mitochondrial inner membrane for, successful transfer of proteins destined 
for the inner membrane or matrix. Depletion.of the membrane potential 
by the use of uncouplers of oxidative phosphorylation has been utilised 
to accumulate the extramitochondrial precursor forms of many proteins 
destined for location within this organelle.
Initially, conditions had to be established whereby inport would be
blocked by uncoupler without, dramatically inhibiting cellular protein
synthesis. To follow the biological activity of uncoupler in vivo
enploying BRL cells, the effect of uncoupler on the synthesis of proteins
encoded by the mitochondrial genome was studied. Mitochondrially-encoded
35protein synthesis can be measured by labelling cells with [ S]-methionine 
in the presence of cycloheximide (1mg/1ml), an inhibitor of cytoplasmic 
protein synthesis in eukaryotic cells.
After extraction of radio-labelled proteins, as described in section
5.2.1 (iii), SDS-polyacrylamide gel electrophoresis 10% (w/v). was performed
to resolve the proteins (see section 2.2.4.1), which were subsequently
detected by fluorography (see section 2.2.4.6). In. the presence of
cycloheximide alone (Figs. 5.3.3a, b; tracks, 5 and 6 respectively) , four
to six polypeptide bands could be. visualized which ranged in Mr from 42,000
to 23,000. Early studies on the synthesis of proteins encoded by the
mitochondrial genome (reviewed.by Mason and Schatz, 1974) in which yeast
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cells were labelled with [ H]-leucine.in the presence of cycloheximide, also 
demonstrated that six polypeptides could be resolved by. SDS-polyacrylamide 
gel electrophoresis. The identity of some of these proteins was provided 
by immune-precipitation of specific components from mitochondrial
extracts prepared from cells labelled in the above manner. Mason and 
Schatz (1973) utilising this type of approach were able to show that the 
three largest subunits of the cytochrome c oxidase conplex are synthesised 
by the mitochondrial translation system. In conjunction with the yeast 
findings described above and.the M values of the proteins reported from 
the recent DNA sequence data of the human mitochondrial genome (Anderson 
et al., 1981), the BRL cell bands were assigned a function (see table 5.3.2).
The effects of the uncouplers CCCP and FCCP on mitochondrial protein 
synthesis, at final concentrations of 20joM and 10pM respectively, are 
illustrated in Fig. 5.3.3a, tracks 1 and 2. It can clearly be seen that 
at these levels CCCP had little or no effect on the synthesis of mito­
chondrially-encoded proteins whereas 10pM FCCP coirpletely inhibited protein 
synthesis. This result suggests that FCCP is the more efficient uncoupler 
of oxidative phosphorylation, under the conditions enployed in this 
experiment. Subsequently, it. was decided to test the effects of a series 
of concentrations of FCCP on mitochondrial protein synthesis, in order to 
find the optimum level of this uncoupler to utilise in future biosynthetic 
studies (Fig. 5.3.3b, tracks 1 and 2). No inhibitory effect was found 
when 1jjM FCCP was used (track 1) , whereas 10pM FCCP (track 2) completely 
abolished mitochondrial protein synthesis, in agreement with the previous 
result. In addition, although not illustrated here, 3pM FCCP was tested 
and shown not to inhibit protein synthesis. As a control, to confirm that
the uncoupler was inhibiting the synthesis of mitochondrially-encoded
35proteins, BEL cells were labelled with [ S]-methionine in the presence of 
cycloheximide (1mg/ml) and chloranphenicol (300pg/ml) (Fig. 5.3.3a, track 
6). No polypeptide bands could be visualized after treating cultured 
BEL cells in this manner. This finding supported the view that FCCP was 
exerting its biological function, under the conditions employed, by inhibiting 
synthesis of mitochondrially-encoded polypeptides.
As a result of these observations, the effect of the uncoupler, FCCP
35(10pM) on the incorporation of [ S]-methionine into total cell protein
was investigated, over a 4h incubation time-course (Fig. 5.3.4). After
30 min,inhibition of cellular protein synthesis was about.50-70% and
remained at this level up to 4h incubation,, in the presence of this uncoupler.
A second potential method for studying extramitochondrial precursor
polypeptides is to inhibit the activity of the matrix-located processing
protease (see section 1.3.5.2). Raymond and Shore (1981) demonstrated
that treatment of rat liver explants with the protease inhibitor, p-
aminobenzamidine (1mM), interfered with the normal processing of the
precursor to carbamyl phosphate synthetase although no precursor accumulation
in the cytosol took place. In addition, they showed that p-aminobenzamidine
had no effect on protein synthesis. When BRL cells were labelled with .
35[ S]-methionine in the presence of cycloheximide (1 mg/ml) and p-amino-
benzamidine (0.1mM and 1mM respectively), mitochondrial protein synthesis
was markedly inhibited at the higher concentration (Fig. 5.3.3a/, track
4; Fig. 5.3.3b, tracks 3 and 4). Additionally, p-aminobenzamidine
(1mM) dramatically interfered with total cellular protein synthesis. As
a result of these findings, p-aminobenzamidine was no longer utilized to
study mitochondrial protein precursors.
Another reported inhibitor of the rat liver matrix-located processing
protease, leupeptin was investigated in a similar manner to the above
experiment. Although leupeptin, at a final concentration of 2mM, did not
inhibit BRL mitochondrial protein synthesis, it was later discovered
(Oonboy et al., 1982) that this protease activity does not play an
obligatory role in the maturation of mitochondrial precursor proteins of
higher Mr value (discussed in detail in section 1.3.5.3).
In summary, precursor accumulation e^ qperiments were carried out by
35labelling cultured mammalian cells with [ S]-methionine, in the presence :
of 10pM PCCP. It was assumed also that the overall rate of synthesis 
of individual proteins was inhibited to the same extent by the presence of 
uncoupler in that there was no preferential inhibitory effects on particular 
protein(s).
5.3.3 Mechanism of Synthesis of Fhmarase in Mammalian Culture Cells
In the preceding chapter (see section 4.3.3), the greatest degree 
of cross-reactivity of anti serum raised against pig heart fumarase with 
mammalian culture cell extracts, was observed in PK-15 and NBL-1 cells. 
Preliminary biosynthetic labelling experiments were performed with these 
cell lines, in order to establish the mechanism of synthesis of fumarase, 
which has been shown to be bimodally distributed in most tissues (Akiba 
et al., 1984). The M^ of the mitochondrial and cytosolic fumarases have 
been determined in rat liver and both shown to be about 49,000. In order 
to determine the nature of the precursor form of this enzyme, inport into 
mitochondria can be blocked by utilizing the uncoupler, FCCP (see section
5.3.2). FCCP acts by dissipating the electrochemical potential across 
the mitochondrial inner membrane, a requirement for efficient uptake of 
most cytcplasmically-synthesised precursor polypeptides.
Initially, however, PK-15 and NBL-1 cells were labelled overnight with 
3510OpCi [ S]-methionine, m  the absence of uncoupler, after which time a 
soluble cell extract was prepared (see section 2.3.2.2) for analysis by 
immune-precipitation (see section 2.3.2.3) and detection by fluorography 
(see section 2.2.4.6). This experiment was performed in order to illustrate
that the newly-synthesised enzyme could be recognised by the anti serum.
The anti-fumarase serum specifically precipitated a single polypeptide of M
47,000 from both cell lines (Fig. 5.3.5, tracks 2, 3, 6 and 7). The M
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value obtained is m  agreement with the value of N-[ H]-ethylmaleimide 
labelled fumarase (track 1) which was co-electrcphoresed to aid the identifi­
cation of immune-precipitated protein. In addition, the findings support the
immune-replica data, which illustrates that the mitochondrial and cytosolic 
forms of the enzyme are of the same.M (see Fig. 4.3.7). To confirm that 
the polypeptide band of. M 47,000 is specifically recognised by fumarase 
antiserum, a control immune-precipitation was performed with pre-immune 
serum (tracks 4 and 5).
Subsequently, precursor experiments were performed in PK-15 cells 
35by labelling with [ S]-methionine for 4h in the absence or presence of
FCCP. In the absence of uncoupler and in agreement with the previous
data (Fig. 5.3.5) , a polypeptide band of'M 47,000 can be visualized which
corresponds to both the mature mitochondrial and, cytosolic forms of enzyme
35(Fig. 5.3.6, track 5). When the cells were labelled with [ S]-methionine 
in the presence of 10pM FCCP, however, not only could this polypeptide 
band be seen but also a protein of higher (track. 3). The M of this 
precursor form (51,000) was estimated to be about 4,000 larger than the 
mature protein. It is assumed that the large Mr protein is the precursor 
to mitochondrial fumarase whereas the polypeptide of similar Mr to the 
mature enzyme represents cytosolic fumarase.
Finally, the above experiment was essentially repeated in the BRL 
cell line. Although the antiserum raised against, the pig heart enzyme 
cross-reacted weakly with BRL fumarase, it had previously been shown that 
the cytosolic and mitochondrial fumarases were of a different (47,000 
and 45,000 respectively). In the absence of FCCP, two polypeptides could 
be visualized on the fluorograph with.Mr values of 47,000 and 45,000 
respectively (Fig. 5.3.7, track 2). This result, therefore, confirmed 
the immune-replica data and illustrated that these two different fumarase 
forms existed in vivo. In contrast to PK-15 cells, addition of 10juM FCCP 
not only blocked inport of mitochondrial fumarase but also appeared to 
inhibit the synthesis of both fumarase forms (track 4). As a result, 
the level of uncoupler was reduced to 5pM and the cells labelled with
35 . .[ S]-methionine for 4h. A single protein conponent of Mr 47,000 was 
resolved by SDS-polyacrylamide gel electrophoresis, under these labelling 
conditions (track 3). The protein band is likely to be conposed of 
cytosolic fumarase as well as the high precursor form of mitochondrially- 
located fumarase.
The potential mechanisms of synthesis of this enzyme arising from 
these findings are discussed in detail in section 5.4.2.
5.3.4 Precursor Accumulation Studies in Yeast Cells
In 1982(a), Reid and Schatz reported that the yeast rho mutant strain 
D273-10B-1 could be utilized to accumulate large amounts of precursors to 
mitochondrial polypeptides. Incubation of this yeast strain with uncoupling 
concentrations of CCCP for 7. 5h in which cell growth was allowed to continue, 
enabled the precursors to be detected directly by the immune-replica 
technique.
Fig. 5.3.8 illustrates the effect of CCCP on the growth of the rho 
mutant of S.cerevisiae. The turbidity of the cell suspension was measured 
after 7.5h of growth in the absence or presence of increasing levels of 
uncoupler and the resulting absorbance at 540nm plotted against uncoupler 
concentration. It can be seen that with increasing uncoupler levels, 
growth is gradually inhibited and reaches a maximum of 50% with 20pM CCCP, 
in agreement with the findings of Reid and Schatz (1982a). The turbidity
of the initial innoculum of each culture is also shown (Ae,n 0.15).' 540nm '
Cell protein extracts were prepared from each culture, by the method described 
in section 5.2.2 and the proteins initially resolved by SDS-polyacrylamide 
gel electrophoresis (see section 2.2.4.1). After transferring the proteins 
to nitrocellulose paper, they were examined by the immune-replica technique 
with anti-fumarase and anti-^phosphate transport protein sera, respectively.
It was assumed in these experiments that there was a constant amount of 
protein in each yeast cell, under the various inhibitory conditions 
enployed.
Fig. 5.3.9(a) demonstrates the autoradiographic profile of these 
sanples after treatment with anti-fumarase serum. In the absence of 
uncoupler (track 1), a polypeptide of 41,000 can be visualized and it is
assumed that this band corresponds to the mature fumarase in yeast. On
addition of the uncoupler, CCCP (1-20pM) this band disappears gradually 
and a polypeptide of higher (46,000) appears in a parallel fashion 
(tracks 2 and 6). The autoradiograph was subsequently scanned with an 
Ultroscan 2202 laser densitometer to determine the percentage areas of the 
mature and precursor polypeptides. The percentage areas of mature protein 
obtained were then plotted against uncoupler concentration (Fig. 5.3.9b).
The amount of mature fumarase found in cells grown in the absence of CCCP 
is expressed as 100%. In the presence of 1-5pM CCCP, the proportion of 
mature enzyme decreases rapidly, until it reaches a minimum level at 5pM 
CCCP. This point is indicative of an optimization of precursor accumulating 
conditions where there is a maximum inhibition of processing of precursor 
without dramatically affecting protein synthesis. At higher concentrations 
of CCCP (10 and 20pM) , protein synthesis is reduced and as a consequence 
cell growth is inhibited more markedly (up to 50%). Although the amount 
of precursor per g of total cell protein will be the same, the reduction 
in cell growth results in an increase in the proportion of mature poly­
peptide assuming that the mature protein is stable during the period of 
growth (Fig. 5.3.9b). The above result was confirmed when a similar 
analysis of these yeast extracts was performed with anti-pyruvate dehydro­
genase conplex serum. The E2 subunit of this enzyme was shown to be made 
as a larger precursor and the relative proportion of mature E2, in the 
presence of increasing uncoupler, closely resembled that obtained for
fumarase. It has recently been shown (Hiraga et al., 1984) that yeast 
cells like most mammalian cells contain both cytosolic and mitochondrial 
fumarase activity, although the M values of these species are not known.
In addition the distribution of activity between cytosol and mitochondria 
appears to vary markedly with growth conditions. It was not possible from 
the above blots to establish in detail, the mechanism of synthesis of 
these two forms.
On examination of yeast extracts with phosphate transport protein 
antiserum, a specific band of 29,000 could be detected at each concen­
tration of uncoupler (Fig. 5.3.10a). However, in contrast to the enzyme 
fumarase, no higher Mr precursor appeared with increasing uncoupler 
concentration. When the percentage area of mature phosphate transport 
protein was calculated and plotted against uncoupler concentration (Fig. 
5.3.9b), there was little or no decrease in the proportion of the mature 
polypeptides. This result suggests that the phosphate transport protein 
is synthesised in the presence of uncoupler, as a protein of similar Mr 
to the mature transporter. If a larger Mr precursor was being synthesised 
in the presence of uncoupler, but was relatively, unstable, one would have 
expected to obtain a similar result to that for fumarase and the E2 subunit 
of pyruvate dehydrogenase complex.
Finally, one of the problems to arise from the findings with the 
yeast blots was to confirm the identity of the cross-reacting polypqgtides, 
which in both instances differed in M value from the corresponding mammalian 
proteins. In the case of the phosphate transport protein, the identity 
of the polypeptide band of 29,000 was partially provided by an e^ qgeriment 
in which mitochondria were isolated from yeast cells (see section 5.3.3) 
and analysed by the immune-replica technique (see section 2.3.2.1). The 
antiserum raised against the rat liver mitochondrial, transporter, cross­
reacted very strongly with a polypeptide of Mr 29,000, confirming that
this protein was of a mitochondrial origin.
5.4 DISCUSSION
5.4.1 Optimization of Conditions for Studying Mitochondrial Precursors
The existence of precursor polypeptides to nuclear-encoded mitochondrial 
proteins has been demonstrated in several laboratories adopting one of the 
following experimental approaches;
i) in vitro translational systems enploying either cell-free homogenates 
or rabbit reticulocyte lysates programmed with specific mRNA. In the 
absence of mitochondria, only the cytoplasmic, precursor forms are 
synthesised;
ii) in vivo pulse-labelling experiments where intact cells are labelled 
35with [ S]-methionine for very short times. In this case, both precursor 
and mature polypeptides are detected, unless cells are fractionated into 
cytosol and mitochondria, respectively.
One of the problems with these experimental approaches is that very 
small quantities of precursor are synthesised, enabling their detection 
to be quite difficult at times. As a result of this, a third approach 
which generally enhances precursor accumulation in vivo has been utilised, 
whereby the import mechanism is interfered with directly. This type of 
approach assumes that there is, not a feedback mechanism , in operation whereby 
accumulation of precursor molecules in the cytosol represses the expression 
of nuclear-encoded mitochondrial proteins. In addition, this experimental 
approach relies on (a) the accumulated precursor being stable on prolonged 
incubation in the presence of an inhibitor of inport and (b) the antiserum 
raised against the mature enzyme recognising the precursor form of the
protein.
Inport of proteins destined for the mitochondrial inner membrane or 
matrix requires the presence of a membrane potential across the inner membrane 
Although the actual role played by the membrane ..potential in inport is not 
fully understood, its inportance has been demonstrated, by utilising mito­
chondria isolated from N.crassa (Schleyer et al., 1982), rat, (Schleyer et al., 
1982; Kolansky et al., 1982) and yeast (Gasser et al., 1982a) in the 
in vitro inport assay, described in section 1.3.5.1. By using specific 
inhibitors of the respiratory chain, of the Fg-ATPase and ionophores, 
it was possible to maintain a high concentration of, matrix ATP while 
depleting the electrochemical gradient across the inner membrane. Under 
these conditions, mitochondria were no longer able to efficiently import 
and process precursor proteins. A detailed account, of these experiments 
can be found in section 1.3.5.1.
Several groups have utilised this.approach in vivo, whereby inport 
and processing were blocked by interfering with the membrane potential, 
but translation allowed to continue (Nelson and Schatz, 1979; Reid and 
Schatz, 1982a). The most commonly used conpound to block inport by this 
type of mechanism is the uncoupler, CCCP. Uncouplers act by making the 
mitochondrial inner, membrane permeable to protons and thus dissipate the 
electrochemical potential, which is essential for the. transfer of proteins 
across the inner mitochondrial membrane. In yeast, at least, if trans- 
location into mitochondria is blocked but translation allowed to continue, 
the precursor pools are large. . However, it should be noted also that 
there is considerable variation in the stability of precursor molecules 
accumulated in the presence of. uncoupler. Pre-cytochrome c^  (Reid and 
Schatz, 1982a) is rapidly degraded whereas. the precursor to the yg-subunit 
of the yeast F^-ATPase is not only stable, but.also .retains the ability 
to be translocated into the mitochondria for at least 30 min after synthesis
(Reid and Schatz, 1982a).
Prior to performing the biosynthetic studies in cultured mammalian 
cells, conditions had to be established where addition of uncoupler would 
block inport of proteins without dramatically interfering with protein 
synthesis. The rationale behind these experiments was that by inhibiting 
the generation of an electrochemical potential across the mitochondrial 
inner membrane, intra-mitochondrial ATP synthesis would also be inhibited. 
Since mitochondrially-encoded proteins require ATP for their synthesis, at 
optimum levels of uncoupler, one would expect to see an inhibition in the 
egression of these gene products. By labelling cells in the presence 
of cycloheximide, a potent inhibitor of eukaryotic protein synthesis and 
consequently cytoplasmic protein synthesis in cultured mammalian cells, 
it was possible to follow the expression of the mitochondrial genome 
products, in an isolated manner.
In the presence of cycloheximide alone, six polypeptide bands were 
resolved by SDS-polyacrylamide gel electrophoresis .10% (w/v) and detected 
by fluorography. DMA sequence data from,three mammalian mitochondrial 
genomes (Anderson et al., 1981, Bibb et al., 1981,; Anderson et al.,
1982) has predicted that 13 different reading frames exist, each capable 
of synthesising a functional protein. The Mr values of these 13 different 
reading frames, as predicted from the human mitochondrial DNA sequence 
(Anderson et al., 1981), range from 66,000 to 7,500. In contrast to the 
findings reported in this study, Attardi and. Ching (1979) using SDS-urea- 
polyacrylamide gel, electrophoresis 15% (w/v) were able to resolve a 
significantly larger number of these polypeptide bands. The following 
reasons can be put forward to explain the discrepancy in the number of 
bands resolved on.a 10% (w/v) SDS-polyacrylamide gel;
i) the values of four of the mammalian mitochondrial DNA products
are less than 20,000, which on the above gel system are likely to migrate 
to the dye front;
ii) variability in the number of bands may also be due in part to 
differences in the rate of synthesis and/or metabolic stability of different 
polypeptides;
35When BRL cells were labelled with [ S] rmethionme m  the presence 
of cycloheximide and CCCP, at levels of this uncoupler utilised to 
accumulate precursors in yeast (Reid and Schatz, 1982a), no inhibition in 
the synthesis of mitochondrially-encoded polypeptides was found. However, 
the fluoro-derivative FCCP was shown to be an effective inhibitor of 
mitochondrial translation at a concentration of 10pM. Additionally, 
it was illustrated that total cell protein synthesis was inhibited by 
about 50%, in agreement with the findings of several other groups (Reid 
and Schatz, 1982a; Fenton et al., 1984).
Another potential method for accumulating extramitochondrial precursor 
proteins is to inhibit the activity of the matrix-located processing 
protease, which plays a major role in the maturation of larger Mr precursor 
forms. It is assumed in this type of inhibition that as long as no feedback 
mechanism is in operation, events prior to processing will, occur normally.
In 1981, Raymond and Shore investigated the effect of the addition of the 
protease inhibitor, yo-aminobenzamide on the processing of the precursor 
to the mitochondrial matrix enzyme,, carbamyl phosphate synthetase. The 
experiments were per formed, in rat liver explants and it was shown that the 
normal processing of the precursor was inhibited, in that no mature enzyme 
could be found in the mitochondria. In addition, however,.no precursor 
could be detected in the mitochondrion and no accumulation of precursor in 
the cytoplasm was found when compared to cells labelled for 30 min in the 
absence of yp-aminobenzamidine. . It was suggested from.these results that
the precursor to carbamyl phosphate synthetase was rapidly degraded, in 
a non-specific manner, upon reaching the blocked processing protease in 
the mitochondrial matrix. Since the stability of different precursor 
molecules has been shown to vary markedly.under accumulating conditions 
(Reid and Schatz, 1982a) , this type of mechanism of inhibition was pursued.
Initially, as with the uncoupler FCCP, the effect of p-aminobenzamidine 
on both mitochondrial and total cellular protein synthesis was investigated. 
In this case, one would not. expect to see any direct effects on protein 
synthesis. It was shown, however, that at a final concentration of 1mM 
and prolonged incubation time that p-aminobenzamidine interfered dramatically 
with the expression of. both mitochondrially .and nuclearly-encoded proteins. 
Since p-aminobenzamidine has a similar structure to the amino acid arginine, 
it is possible that these effects on, protein synthesis are due to arginine 
and p-aminobenzamidine conpeting for the same site on the tRNA synthetase, 
specific for arginine.
The biosynthetic studies performed to determine whether fumarase 
was initially made as a large M precursor or not, were carried out in 
cultured mammalian cells in the presence of the uncoupler PCCP.
5.4.2 Mechanism of Synthesis of FUmarase in Cultured Mammalian Cells
In 1976, Nakashima et al. discovered that the tricarboxylic acid 
cycle enzyme, fumarase, is not solely located in the mitochondrial matrix 
but can also be found in the cell cytoplasm of.rat liver. Subsequently 
a detailed study of the structural and physical properties of the two rat 
liver fumarase activities was achieved by Kobayashi et al. (1981) and is 
summarized in table 1.5.1. The mitochondrial and cytosolic fumarases 
could not be separated from one another by their physicochemical, catalytic 
and immunological properties. The M values of the two enzymes were shown
to be identical by SDS-polyacrylamide gel electrophoresis (M 49,000). 
Recently, Akiba et al. (1984) discovered that fumarase is bimodally 
distributed between the mitochondrial matrix and cell cytoplasm of most 
tissues. In addition to fumarase, malate dehydrogenase and aspartate 
aminotransferase are conpartmentalized,in the cell cytosol and mitochondria. 
However, in contrast to fumarase, the two enzymic forms of these proteins 
are distinguishable from each other in.terms of their physiochemical and 
immunological properties. The bimodal distribution of these proteins 
raises the question as to their mechanism of biosynthesis.
Extensive studies on the synthesis of the aspartate aminotransferases 
(Sonderegger et al., 1982), using an in vitro, translation system and non­
cross-reacting antibodies, demonstrated that the cytosolic form was made 
as a protein of same Mr as the mature enzyme. The mitochondrial matrix 
isoenzyme was, however, synthesised as a precursor of higher M . The 
synthesis of a high Mr precursor to the matrix-located aspartate amino­
transferase is expected, since the majority of matrix proteins have been 
shown to be synthesised in this manner (see I&ble 1.3.1). The differences 
in the properties of these two forms along with the biosynthetic findings 
suggest that the mitochondrial and cytosolic aspartate aminotransferase 
isoenzymes are encoded by two separate genes. Similarly, the malate 
dehydrogenase isoenzymes have been shown to be encoded by separate genes 
(Van Heyningen et al., 1975). Mihara et al. (1982) illustrated that 
mitochondrial malate dehydrogenase was synthesised as a protein of higher 
when translation was performed in a wheat germ cell-free system programmed 
with rat liver RNA.
In this chapter, preliminary data to determine the mechanism of
synthesis of fumarase was obtained by the in vivo, labelling of cultured
35PK-15 and BRL cells with [ S]-methionine. Information as to the nature
of the biosynthetic intermediates of the mitochondrial and cytosolic enzyme
forms was obtained by blocking iirport of proteins, into mitochondria.
As discussed in the preceding section (see 5.4.2) ,, this can be achieved by
the use of uncouplers of oxidative phosphorylation which act by dissipating
the membrane potential across the mitochondrial;inner membrane, a pre-
35requisite for inport. When PK-15 cells were labelled with [ S]-methionine 
in the absence of uncoupler, a. single specific protein was immune-precipitated 
which had an value of 47,000 corresponding to both the mature mitochondrial 
and cytosolic funerases. On addition of 10pM PCCP, two specific polypeptide
bands were immune-precipitated with anti-fumarase serum (see Fig. 5.3.6).
A protein of 47,000 M and one of 51,000 M could be detected under these 
conditions. Ihe polypeptide of ,47,000 Mr, synthesised in the presence of 
10pM PCCP, can be assumed to be the cytosolic form of fumarase, since its 
mode of synthesis should not be unduly affected by uncoupler. On the other 
hand, the high Mr polypeptide produced by blocking inport into mitochondria, 
is likely to be the cytoplasmic precursor form of the mitochondrially-located 
fumarase. Upon inport into mitochondria, this precursor would, be expected 
to be cleaved at its amino-terminal end by the matrix-located protease 
(MzAda and Douglas 1982) to generate mature mitochondrial fumarase 
(M 47,000).
The above data is in agreement with the recently published findings 
of Ono et al. (1985) who studied the biosynthesis of fumarase in vitro 
enploying a rabbit reticulocyte lysate programmed with total rat liver 
ENA. They were able to demonstrate the existence of two different 
putative precursor polypeptides to rat liver fumarase in this system.
One of the polypeptides was synthesised as a precursor with a larger M 
(50,000) than the mature subunit of fumarase (M 45,000) whereas the other 
protein had the same M as the mature enzyme. Rirther evidence as to 
the identity of these proteins was provided by, showing that the addition 
of 10pg of purified cytosolic fumarase coirpetitively inhibited their
immune-precipitation. In addition, Qno et al. (1985) were able to perform
35
m  vitro inport studies m  which the [ S]-labelled cell-free translation 
products were incubated with isolated rat liver mitochondria at 30°C.
Under these conditions, they illustrated that only the high Mr precursor 
fumarase could bind to and subsequently be inported into mitochondria.
From their findings, Ono et al.. (1985) have suggested that the large Mr 
precursor represents the cytosolic polypeptide of mitochondrial fumarase 
and the protein of similar Mr is the mature, cytoplasmic fumarase.
In marked contrast to the report of Qno et al. (1985) and the findings
with PK-15 cells, when the BEL cell line was preliminary investigated
with regard to the biosynthesis of fumarase, a different result was found.
IWo polypeptides of differing could be detected on the fluorograph
(see Fig. 5.3.7), in the absence of uncoupler. Ihe demonstration that
two different M forms of fumarase existed in BEL cells, under normal r
conditions, was a novel discovery but did support the earlier immune-replica 
data (see^ Fig. 4.3.6). It was shown in those experiments that the BEL 
mitochondrial and cytosolic fumarases differed in Mr, the mitochondrial 
form being of a lower than cytoplasmic fumarase. On addition of FCCP 
(5pM) , a single specific polypeptide conponent (Mr 47,000) could be resolved 
by SDS-polyacrylamide gel electrophoresis 10% (w/v). This polypeptide 
had the same as the cytoplasmic enzyme. One interpretation of this 
result is that the cytcplasmically-located fumarase'in BEL cells is the 
precursor form of the mitochondrial enzyme which arises due to the slow 
uptake of the fumarase precursor. Alternatively, the cytoplasmic precursor 
to mitochondrially-located fumarase is of a similar to the cytosolically- 
located enzyme and is, therefore, hard to resolve on above gel system.
Although both PK-15 and BEL total cell protein synthesis is only 
inhibited by about 50% in the presence of 10>iM FCCP, there were conflicting 
findings when immune-precipitation performed with anti-fumarase serum. It was
originally assumed that the effects of FCCP on protein, synthesis were 
general and did not affect specific proteins. In BRL cells, however, 
no detectable fumarase could be resolved following SDS-polyacrylamide gel 
electrophoresis whereas in PK-15 cells.two proteins, specifically recognised 
by antiserum. These findings suggest that the synthesis of BRL cell 
fumarases is more susceptible to the addition of uncoupler than the PK-15 
cellular fumarases.
As a result of the in vivo biosynthetic studies in PK-15 and BRL cells, 
how does fumarase become distributed, between.the two intracellular conpart- 
ments, cytosol and mitochondria? Two potential modes of synthesis can be 
considered;
i) the mitochondrial and cytoplasmic fumarase activities are encoded 
by two separate nuclear genes. In the PK-15 cell line the nuclear gene 
for the mitochondrially-located enzyme contains additional information to 
encode the amino-terminal signal sequence. On the other hand, in BRL 
cells the genes for mitochondrial and cytosolic fumarases have the same 
coding capacity but the mitochondrial gene encodes an amino-terminal 
sequence that can be recognised and cleaved by the matrix-located protease 
(MoAda and Douglas 1982).
As stated earlier in this section, the existence of separate genes 
for the two forms of malate dehydrogenase has been shown (Van Heyningen 
et al. 1975) and a similar mechanism has been suggested for the aspartate 
aminotransferases (Bonderegger et al., 1982). In both instances the 
two isoenzyme forms have been shown to differ markedly from one another 
with respect to their physiochemical and immunological properties.
However, in the case of rat liver fumarases, Kobayashi et al. (1981) 
clearly demonstrated that these properties were .very similar and the proteins 
in fact had the same M . It was also recently reported (Hiraga et al.,
1984) that rabbit IgG raised against the mitochondrial fumarase'of rat 
liver could equivalently neutralize the fumarase activities in the cytosolic 
and mitochondrial extracts. further evidence to rule out;this mechanism 
of synthesis of fumarase has come from somatic-cell, hybridization studies 
(Tolley and Craig, 1975; MoKusick and Ruddle, 1976). Analysis of the 
segregation of human fumarase in. human-mouse hybrids, demonstrated the 
existence of one gene responsible for, the synthesis,of both mitochondrial 
and cytosolic fumarase. From the last few statements, it would appear 
that this type of mechanism of synthesis of bimodally distributed, fumarase 
is unlikely and a more plausible explanation is as follows:
ii) the mitochondrial and cytosolic fumarases are encoded by a single 
gene which can generate two distinct mRNA species by the mechanism known 
as 'alternative splicing'. Many eukaryotic genes have been shown to be 
conprised of mosaic structures in which intervening sequences(introns) are 
interspersed between protein coding regions (exons). Intervening sequences 
appear in the primary transcript product but are removed by splicing during 
mRNA maturation. The generation of two mRNA species, from a single gene 
has been shown for the synthesis of. immunoglobulin heavy chain polypeptides 
(reviewed by Wall, 1980). The earliest immunoglobulin to appear is of the 
IgM subclass and this molecule can exist either,in a membrane-bound or 
secretory form. Amino-terminal protein sequences of. the two forms are 
identical although their carboxyl terminal sequences are quite different.
The mu {p) mRNAs appear to be generated from a single heavy chain trans­
cription unit by alternative patterns of RNA splicing. It has been 
proposed that develcpmentally regulated polyadenylation determine which 
mRNA will be produced.
Another example of 'alternative splicing' occurs with the mouse 
amylase protein which is synthesised in the liver and salivary gland of
mouse and is encoded by a single gene. The mRNAs.present in each tissue 
are identical in their coding region but differ in the first part of the 
51 nontranslated leader (Young et al., 1981). There are two separate 
exons for the 5' nontranslated leaders which vary in length. One of the 
leader exons is spliced on to the coding region exon depending on the 
tissue.
The generation of two fumarase activities by this type of mechanism 
has been proposed by Ono et al. (1985) from their findings on the synthesis 
of rat liver fumarase. It has recently been illustrated (Kobayshi et al.,
1983) , that the carboxy termini of the rat liver fumarases are identical 
although their amino-termini differ in sequence (Sato et al., 1984) .
From these findings and those in PK-15 cells it can be assumed that there 
are two separate exons for the amino-terminal regions of the two enzyme 
forms. It can be envisaged that these exons were derived from a common 
ancestral gene by gene duplication. They have subsequently evolved 
independently such that one codes for the amino-terminus of cytosolic 
fumarase and the other for mitochondrial fumarase. ’Alternative splicing1 
brings the amino-terminal sequences together with the constant coding region 
containing the carboxyl-terminal sequence. In addition, the mitochondrial 
amino-terminal exon must contain a sequence which is recognised by the 
matrix protease, so that the mature mitochondrial enzyme is of the same 
as the cytosolic form.
In the case of BRL cells, it can. be assumed that the two amino-terminal 
region exons have evolved, in such a manner that the mitochondrial exon 
again contains information to enable this region to be recognised by the 
matrix-located protease. The fact that in this cell line the cytcplas- 
mically located fumarase is of a higher than.the mitochondrial protein, 
would be due to its amino-terminal exon being of a similar size to that of 
the mitochondrial amino-terminal exon, without containing the protease
recognition site (see Fig. 5.4.1).
In BRL cells, a third mechanism of synthesis can be proposed whereby 
only one mRNA species is generated from one, gene for fumarase. In this 
situation, the bimodal distribution of the enzyme may arise due to the 
slow uptake of the precursor into mitochondria, such that a steady-state 
equilibrium of the enzyme is established between the cytosol and mitochondria.
5.4.3 Precursor Studies in Yeast Cells
A more direct approach to study the biosynthesis of fumarase in vivo 
is to follow the experimental procedure, described by Reid and Schatz 
(1982a). They reported that the respiration-deficient yeast rho" mutant 
strain D273-10B-1 could be utilised to accumulate large amounts of precursors 
to mitochondrial polypeptides. The rho” mutants have been shown to lack 
cytochromes aa^, b and c, as well as a functional ATPase conplex (reviewed 
by Mason and Schatz, 1974). This arises because these mutants have lost 
large segments or, in some cases, all of their mitochondrial DNA and, as 
a result, they all seem to have lost a functional mitochondrial protein 
synthesising system. The proteins still present in these defective 
mitochondria are, therefore, made by the cytcplasmic protein synthesising 
system. These proteins include the enzymes of the tricarboxylic acid 
cycle, cytochromes c and b2 and the mitochondrial F^-ATPase subunits. In 
addition, the rho mutant mitochondria possess an apparently normal outer 
membrane and a distinct inner membrane which does not differ greatly from 
that in wild-type mitochondria. In 1979 Nelson and Schatz demonstrated 
that rho mutant strain of S.cerevisiae could inport cytoplasmically- 
synthesised polypeptides into their mitochondria, even although their 
mitochondria lacked a functional. ATPase conplex as well as a respiratory 
chain. Since an electrochemical potential must exist across mitochondrial
inner membrane for inport to occur (Gasser et al., 1982a), this finding 
suggested that rho” mutants generate a modest potential, perhaps via the 
adenine nucleotide translocator (Klingenberg and Rxttenberg, 1977).
Reid and Schatz (1982a) chose the,rho mutant strain in preference 
to wild-type yeast because exploratory experiments indicated that its 
mitochondrial inport system was more sensitive to CCGP than that of wild- 
type yeast cells. The yeast cells were grown on a fermentable carbon 
source, galactose, since they do not. have an operational respiratory 
chain. As a result, ATP is generated by substrate level phosphorylation 
reactions in the glycolytic pathway. This ATP can be partially used to 
maintain a membrane potential across the mitochondrial inner membrane, 
so that cytoplasmically-synthesised polypeptides can be efficiently 
inported into the organelle. Reid and Schatz (1982a) showed that long 
term growth of cells, in the presence of CCCP, was only inhibited by about 
50%, a result confirmed in this study (see Fig. 5.3.8). Therefore, by 
adding CCCP to an early exponential phase culture of respiration-deficient 
rho yeast cells and allowing growth to continue for 7.5h precursors should 
accumulate outside .the mitochondria. Reid and Schatz (1982a) demonstrated 
that the precursors to the ^ -subunit of F^-ATPase and cytochrome c^, 
could be detected directly by the immune-replica technique,.following 
extraction of yeast proteins, as described .in section 5.2.2 . This method 
of analysis of mitochondrial precursor polypeptides has the obvious 
advantage over conventional methods, described in sections 5.3.3 and 
5.4.3, in that it rules out the need for immune-precipitation and thus 
is less time consuming.
A similar series of experiments was performed in this study, eirploying 
antisera raised against pig heart.fumarase and rat liver mitochondrial 
phosphate transport protein. A pre-requisite for these studies is that 
the antisera raised against the mammalian proteins will cross-react with
the yeast proteins. Preliminary experiments with fumarase antiserum, 
indicate that a larger Mr precursor polypeptide is generated with increasing 
uncoupler concentrations and there is a simultaneous decrease in the 
proportion of mature polypeptide (Fig. 5.3.9a). The precursor has an 
M value (46,000) which is about 5,000 greater than the mature polypeptide 
(Mr 41,000). One of the problems with this result is that the specifically 
cross-reacting polypeptides have M values which are lower than the pig 
heart counterpart. Although the chromatographic properties of Baker's 
yeast mitochondrial and cytosolic fumarases have been studied (Hiraga 
et al., 1984), no estimation of the M values of the two yeast fumarases 
has been published.
If it is assumed that the mature yeast fumarase has an Mr value of
41,000 and that the mitochondrial and cytosolic forms are of the same M , 
then the simplest interpretation of immune-replica data is as follows; 
the precursor polypeptide that is being synthesised in the presence of the 
uncoupler CCCP is the cytoplasmic pre-form of the mitochondrial enzyme. 
However, because of the nature of the experiment, it is not possible to 
establish whether cytosolic form of the enzyme is being synthesised as a 
larger precursor or as a polypeptide of the same Mr as the mature sized 
enzyme. In these experiments one is not solely looking at newly-synthesised 
proteins but also at pre-exdsting polypeptides. As a result, you would 
expect to see mature fumarase at all levels of CCCP, unless there is a very 
rapid turnover rate for the protein. The immune-replica data partially 
confirms the biosynthetic data obtained from PK-15 cells (discussed in 
section 5.4.3) , in that a precursor polypeptide of higher Mr value can be 
detected when yeast cells are incubated in the presence of CCCP.
Interestingly, the immune-replica data obtained with the phosphate 
transport protein anti serum, in an analogous experiment to the above, 
reveals a strongly cross-reacting polypeptide of M 29,000 (Fig. 5.3.10a).
On addition of uncoupler (1-20pM), there is no sign of . a higher Mr 
precursor form to this protein and the relative proportion of mature 
phosphate transport protein varies little with increasing CCGP (Fig. 
5.3.9b). This latter result suggests that in the presence of uncoupler, 
precursor to this protein is being synthesised which has.the same Mr value 
as the mature polypeptide. Although this data has to be treated with 
caution because the mammalian anti serum is cross-reacting with a yeast 
protein of lower M , the result conforms to the findings of Neupert and 
coworkers (1979, 1980). They studied the biosynthesis of the N.crassa 
ADP/ATP translocator both in vitro and in vivo and showed that the pre­
cursor polypeptide was of the same Mr as the mature protein. Since both 
transporters are likely to be highly hydrcphobic, transmembrane proteins, 
it may be expected that their biosynthetic pathways follow parallel routes. 
The preliminary findings with the yeast rho mutant strain, indicates 
that this may be the case and that this may also be the general mode of 
synthesis of mitochondrial, inner transmembraneous proteins.
Confirmation as to the identity of the cross-reacting yeast protein 
was suggested by performing an immune-replica analysis of. purified yeast 
mitochondria with the rat liver mitochondrial, phosphate transport protein 
antiserum. In this case, a very strong polypeptide band of 29,000 
was recognised by.the antiserum, confirming at least the mitochondrial 
location of this protein (see Fig. 5.3.10b).
A major dilemma to arise from the yeast immune-replica. data is that 
the antiserum raised against the mammalian protein appears to be very 
specific in its recognition properties, in conflict with the previous 
data (see section 4.3.2). When crude mammalian culture cell extracts 
were challenged with this anti serum, numerous additional polypeptides 
could be visualized on the autoradiograph. .. Why does the anti serum react 
so specifically with yeast phosphate, transport protein? One possibility
is that the yeast phosphate transport protein does not have the same 
tendency as its rat liver counterpart to aggregate with itself or other 
proteins when boiled in SDS. As a. result, there would be a reduction 
in the degree of non-specific binding to these aggregates, which was 
previously proposed to be a potential source of these additional polypeptide 
bands (see section 4.4.2).
Fig, 5.3.1
THE EFFECT OF PRE-INCUBATION TIME IN (-) METHIONINE (-) SERUM MEDIUM
ON THE INCORPORATION OF [ S] -METHIONINE INTO BRL , CELL PROTEIN
5
BRL cells (3 x 10 cells/ml) were initially incubated overnight 
at 37°C in 5.5cm (diameter) plastic Petri dishes containing 3ml of normal 
growth medium (see section 2.4.1). The cells were subsequently trans­
ferred into (-) methionine (-) serum medium and pre-incubated for 
071,2,4,5 and 24h, respectively. After the appropriate pre-incubation
time in the above medium, incorporation of the radioactive amino acid
35was initiated by the addition of 20pCi [ S]-methionine and continued 
for 30 min at 37°C. lb measure the extent of incorporation of radio­
isotope into cellular protein., following termination of the labelling 
reaction, the procedure described in section 5.2.1 (ii) , was closely 
followed.
Dishes were labelled in duplicate and a single aliquot counted 
from each sanple.
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Table 5.3.1
THE EFFECT OF THE COMPOSITION OF LABELLING MEDIUM.ON THE INCORPORATION 
OF [35S] -METHIONINE INTO TOTAL BRL CELL PROTEIN
5
Cells (3 x (10 cells (ml) were incubated overnight in 3.5cm (diameter)
plastic Petri dishes at 37°C (see section 2.4.1), before being transferred
into 1ml of various media (listed in ..table opposite). After a further
1.5h pre-incubation at 37°C, radiolabelling was initiated by the addition 
35of 20pCi [ S]-methionine and continued for 30 min. Incorporation of
radioisotope was then terminated, a cell extract prepared and the extent
35of incorporation of [ S]-methionine into BRL cell protein determined
by the procedures described in section 5.2.1 (ii).
Dishes were labelled in duplicate and two.equal aliquots (25pl)
35taken from each sanple. [ S]-methionine incorporation into BRL cell 
protein was subsequently calculated from four different samples.
Growth Medium Methionine conc. in labelling medium (pM)
Average incorporation 
of [35s]-methionine 
into Cellular Protein 
(dpm/105 cellsi)
(-) methionine (-) serum 0.018 189,290 - 5,069
(-) methionine (+) serum 1.5 198,545 - 5,441
low methionine (-) serum 0.5 162,540 ± 5,076
low methionine (+) serum 2.0 171,666-5,620
(+) methionine (-) serum 10 25,465 -  2,284
(+) methionine (+) serum 11.5 26,725 -  2,394
Fig. 5.3.2
TIME-COJRSE TO MEASURE THE EXTENT OF INCORPORATION OF [35S]-METHIONINE 
INTO BRL CELLUIAR PROTEIN IN (-) METHIONINE AND LCW METHIONINE MEDIA
After an overnight incubation at 37°C in 3.5cm (diameter) plastic
Petri dishes containing 1ml normal growth medium (see section 2.4.1) ,
BRL cells (3'x 105 cells/ml) were transferred to (-) methionine or low
methionine media, respectively and pre-incubated for 1.5h at 37°C.
3510pCi [ S]-methionine was added to each dish (in duplicate) and incubated
for 0,1,2,4,8,12 and 24h, respectively. At the indicated time points,
radiolabelling was terminated by washing the dishes 3X with PBS (see
section 2.3.2.2). Cell extracts were subsequently prepared (see section
355.2.1 n) and the extent of incorporation of [ S]-methionine into 
cellular protein measured as described in section 5.2.1.
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Figs. 5.3.3 (A) and (B)
A STUDY OF THE EFFECTS OF VARIOUS INHIBITORY COMPOUNDS ON THE SYNTHESIS 
OF MITOCHQNDRIALLY-ENCODED PROTEINS
5
BRL cells (3 x 10 cells/ml) were initially incubated overnight at
37°C in 8.5cm (diameter) plastic Petri dishes containing 10ml of normal
growth medium (see section 2.4.1). This medium was discarded and the
cells placed in low methionine medium (see section 5.2.1) for 2h prior
to the addition of various inhibitors of protein synthesis (see below).
o 35After a further pre-incubation of 30 min at 37 Cf [ S]-methionine was~ 
added to each dish (250pCi/dish) and the labelling reaction continued 
for 4h at 37°C. A cell extract was subsequently prepared, according to 
the method described in section 5.2.1 (iii) , before resolving the proteins 
by SDS-polyacrylamide gel electrophoresis 10% (w/v) (see section 2.2.4.1) 
and detecting the radiolabelled polypeptides by fluorography (see section 
2.2.4.6). In this case, polyacrylamide gels were cast between 14 x 8cm 
glass plates, in a perspex box designed to accommodate four pairs of 
plates:
A) (1) Cycloheximide (1ng/ml) + 20pM CCCP (2) Cycloheximide (1ng/ml) + 
10pM FCCP (3) Cycloheximide (1 mg/ml) + leupeptin (2mM) (4) Cycloheximide
(1mg/ml) + p-aminobenzamidine (1mM) (5) Cycloheximide (1ng/ml) (6) Cyclo­
heximide (1mg/ml) + chloranphenicol (300pg/ml).
B) (1) Cycloheximide (1ng/ml) + 1pM FCCP (2) Cycloheximide (1 mg/ml) + 
10pM FCCP (3) Cycloheximide (1mg/ml) + 0.1mM p-aminobenzamidine
(4) Cycloheximide (1mg/ml) + 1mM p-aminobenzamidine (5) Cycloheximide + 
alcohol 1% (v/v) (6) Cycloheximide (1mg/ml).
Ihe fluorographs were exposed for one week at -80°C.
A (-)
ttl ■^  W m
(+)
(1) (2) (3) (4) (5) (6)
*
II
III
IV & V
m* VI
(+)
(4) (5) (6)(1) (2) (3)
Table 5.3.2
FUNCTIONAL ASSIGNMENT OF MITOCHONDRIALLY-ENCODED BRL CELL PROTEINS
BRL proteins encoded by the separate mitochondrial genome were 
35labelled with [ S]-methionine m  the presence of an inhibitor of
eukaryotic cytoplasmic protein synthesis, cycloheximide (see Figs.
355.3.3 A and B). The values of the [ S]-methionine labelled 
polypeptides were estimated by the method described in section 2.2.4.3. 
The proteins were identified by corparing their M values with the 
values obtained from, human mitochondrial DNA sequence and from the 
studies performed by Mason and Schatz (reviewed in 1974). See section
5.3.1 for further details of their experiments.
Polypeptide
Band
M from 
Bfc cells
Functional
Assignment
I 42,000 Cyt b
II 36,000 URF I
III 30,000 CO III
IV 28,000 CO II
V 27,000 ATPase 6
VI 23,000 ‘ URF 6
Fig. 5.3.4
TIME-COURSE OF THE EFFECT OF 10juM FCCP ON THE INCORPORATION OF [35Sj- 
METHIONINE INTO TOTAL BRL CELL PROTEIN
Cells were initially incubated overnight at 37°C in 5.5cm (diameter)
5plastic Petri dishes containing 3ml of a single cell suspension (3 x 10
cells/ml) in normal growth medium (see section 2.4.1). This medium was
subsequently discarded, the cells placed in low methionine medium (see
section 5.2.1) and incubated for 1.5h at 37°C. 5 min, prior to the
. 3 5  .addition of 10pCi [ S]-methionine, FCCP (10pM) was added to duplicate
dishes which were then labelled for 0.5,1,1.5,2 and 4h respectively at
37°C. As a control, a parallel series of dishes were labelled with
35[ S]-methionine, in the absence of uncoupler. Radiolabelling was
terminated at the indicated times, a cell extract prepared and the extent
35of incorporation of [ S]-methionine into total cellular protein determined 
by the methods described in section 5.2.1 (ii).
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Fig. 5.3.5
IMMUNE-PREXTIPimTION OF FUMARASE FROM PK-15 AND NBL-1 CELLS LABELLED 
OVERNIGHT WITH [35S]-METHIONINE
6 oCells (3 x 10 cells/10ml). were grown overnight at 37 C by incubating
them in 8.5cm plastic Petri dishes containing normal growth medium (see
section 2.4.1). In order to enable the immune-precipitation of mature
fumarase, the cells were subsequently placed in low methionine medium
containing serum (see section 5.2.1), pre-incubated for 1.5h at 37°C
35then radiolabelled overnight by the addition of 100jiCi [ S]-methionine.
Incorporation of the radioisotope was terminated by washing the cell
monolayer 3X with PBS (see section 2.3.2.3) and a soluble cell extract
prepared (see section 5.2.1 i) for subsequent immune-precipitation
studies (see section 2.3.2.3).
The immune-precipitated proteins were resolved by SDS-polyacrylamide
gel electrophoresis 10% (w/v) (see section 2.2.4.1) and visualized
3by fluorography (see section 2.2.4.6); track (1) N-[ H]-ethylmaleimide- 
labelled fumarase (2) and (3) mature fumarase from NBL-1 cells (4) and
(5) pre-immune serum (6) and (7) mature fumarase from PK-15 cells.
The fluorographs were exposed for one week at -80°C.
(-)
M 47,-000 r
(+)
(1) (2) (3) (4) (5) (6) (7)
Pig. 5.3.6
BIOSYNTHESIS OF PUMARASE IN PK-15 CELLS LABELLED WITH [35S]-METHIONINE 
IN THE PRESENCE OF AN INHIBITOR OF MITOCHONDRIAL IMPORT
g
PK-15 cells (3 x 10 cells/10ml) were initially grown overnight at 
37°C as described in the legend to Fig. 5.3.5. The cells were sub­
sequently placed in low methionine medium containing serum (see section 
5.2.1) for 1.5h at 37°C, before the addition of PCCP (10pM). Radio­
labelling of cellular proteins was initiated 5 min after the addition
35of uncoupler, by placing 200pCi [ S]-methionine in the dish and
continued for 4h. A separate dish was labelled in the absence of PCCP
(10pM), to act as a control.
Soluble cell extracts, immune-precipitations, SDS-polyacrylamide
gel electrophoresis and fluorography were subsequently performed as
125described m  legend to Fig. 5.3.5; track (1) [ I]-labelled low
3standards (2) N-[ H]-ethylmaleinu.de labelled fumarase (3) 4h label 
plus 10pM PCCP (4) pre-immune serum immune-precipitation (5) 4h label 
in the absence of uncoupler.
Tracks (1) to (4) were exposed to fluorography for three weeks 
at -80°C; track (5) was esqposed for three days at -80°C.
M 94,000 r
M 67,000 r
M 43,000 r
M 51,000
M° 47,000 r
M 30,000 
r (+)
(1) (2) (3) (4) (5)
Fig. 5.3.7
BIOSYNTHESIS OF FUM&EASE IN BRL CELLS LABELTED WITH [35S]-METHIONINE 
IN THE PRESENCE OF AN INHIBITOR OF MITOCHONDRIAL IMPORT
6 35BRL cells (3 x 10 cells/ml) were labelled with [ S] -methionine
in the absence or presence of FCCP (5 and 10pM) , as described in the
legend to Fig. 5.3.6 and following immune-precipitation (see section
2.3.2.3) were analysed by SDS-polyacrylamide gel electrcphoresis (see
section 2.2.4.1) and fluorography (see section 2.2.4.6).
Track (1) pre-immune serum (2) 4h label minus uncoupler (3) 4h
label plus 5pM FCCP (4) 4h label plus 10pM FCCP (5) N-[^Hj-ethylmaleimide
125labelled fumarase (6) [ I]-labelled low standards.
Ihe fluorograph was exposed for one week at -80°C.
L(~ )
M 47,000 
Mr 45,000
(+)
(1) (2) (3) (4) (5) (6)
Fig. 5.3.8
EFFECT OF THE UNCOUPLES. CCCP ON THE GROWTH OF THE. FHO~“ MUTANT STRAIN 
OF S.CEKEVISIAE
The yeast rho mutant strain D273-10B-1 was grown at 21°C on rich 
medium supplemented with galactose 2% (w/v) (see section 5.2.2). On 
reaching the mid-log phase of growth, the culture was divided into six 
equal aliquots and CCCP was added to five.of them at final concentrations 
of 1,2,5,10 and 20pM, respectively. Growth was continued for a further 
7.5h at 21°C. The turbidity of each sub-culture was measured spectro- 
photometrically at a wavelength of 540nm, after this period of growth.
A graph was subsequently plotted of A540nm versus concentration of CCCP.
•--- • Growth curve in the presence of increasing CCCP concentration
o— o Thrbidity of initial innoculum
Effect of the uncouplerCCCP on the growth 
of yeast rho" mutant
0.8
0.6
A540nm
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Fig. 5.3.9 (A) and (B)
A) IMMUNE-REPLICA ANALYSIS OF THE YEAST RHQ~ MUTANT STRAIN TREATED 
WITH INCREASING CONCENTRATIONS OF CCCP (FUMARASE ANTI SERUM)
Ihe rho strain D273-10B-1 was grown in the absence or presence
of CCCP as described in the legend to Fig. 5.3.8 and harvested 7.5h
after addition of CCCP. TCA was added to 20% (w/v), the cells were
broken and proteins were extracted with SDS as described in section 5.2.2.
Aliquots of the cell extracts containing 40pg of protein each were
subjected to SDS-polyacrylamide gel electrophoresis 10% (w/v) (see
section 2.2-4.1) and subsequently transferred to nitrocellulose sheets
for immune-replica analysis (see section 2.3.1) with fumarase antiserum.
Lane (1) OpM CCCP (2) 1pM CCCP (3) 2pM CCCP (4) 5pM CCCP (5) 10pM CCCP
(6) 20yiM CCCP (7) 0.2pg pig heart fumarase (8) [^5I]-labelled low
M standards, r
Ihe autoradiogram, was exposed for five days at -80°C.
B) QUANTITATION OF PRECURSOR ACCUMULATION IN YEAST CELLS AFTER GROWTH 
IN THE PRESENCE OF CCCP
Determined the loss of mature fumarase and phosphate transport 
protein in rho cells grown at various levels of CCCP by scanning the 
respective autoradiographs (see Figs. 5.3.9A and 5.3.10A) with an 
Ultroscan 2202 laser densitometer. The amount of mature protein found 
in cells grown in the absence of CCCP is expressed as 100%.
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Fig. 5.3.10 (A) and (B)
A) IMMUNE-REPLICA ANALYSIS OF THE YEAST RHO~ MUTANT STRAIN TREATED 
WITH INCREASING CONCENTRATIONS OF CCCP (PHOSPHATE TRANSPORT 
PROTEIN ANTISERUM)
A similar procedure to'that described in the legend to Fig. 5.3.9(A)
was utilised to perform the above experiment, the only exception being
that an anti serum directed against the rat liver mitochondrial phosphate
transport protein was used for the immune-replica analysis.
Lanes (1) to (6) 0-2pM CCCP (7) Celite-purified rat liver mitochondrial
125phosphate transport protein (10pl) (8) [ I]-labelled low Mr standards.
The autoradiogram was exposed for five days at -80°C.
B) IMMUNE-REPLICA ANALYSIS OF A YEAST MITOCHONDRIAL EXTRACT WITH 
PHOSPHATE TRANSPORT PROTEIN ANTI SERUM
Yeast mitochondria were prepared from the wild-type strain D273-10B-1 
{u , ATCC 25657) by the method of Daum et al. (1982) and analysed by 
SDS-polyacrylamide gel electrophoresis 10% (w/v) (see section 2.2.4.1) 
and immune-blotting with anti-phosphate transport protein serum (see 
section 2.3.1).
Lane (1) Celite-purified rat liver mitochondrial phosphate transport 
protein (10pl) (2) 80pg (3) 60pg (4) 40pg mitochondrial extract,
respectively.
Autoradiography was performed for five days at -80°C.
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Fig. 5.4.1
GENERATION OF TWO mRNA SPECIES ENCODING THE MITOCHONDRIAL AND CYTOSOLIC 
FORMS OF FUMARASE
The findings from the biosynthetic studies performed on the bimodally 
distributed fumarase in. PK-15 and BRL cells, can be explained by the 
following model. This model proposes that..in both cell lines the 
mitochondrial and cytosolic fumarases are generated from one gene by 
the mechanism of ’Alternative Splicing1. This result in the synthesis 
of two separate mKNAs encoding the mitochondrial and cytosolic forms 
of fumarase (see section 5.4.2 for further details).
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CHAPTER SIX 
GENERAL DISCUSSION
6.1 GENERAL DISCUSSION
Ihe biogenesis of mitochondria requires an input from two genetic 
systems; the mitochondrial and nucleo-cytoplasmic systems. In the case 
of some of the mitochondrial inner membrane respiratory corrplexes, their 
synthesis is dependent on both genetic systems (see section 1.1). One 
such complex is cytochrome c oxidase which consists of at least nine non­
identical subunits. The three largest subunits (I, II, III) are coded 
by mitochondrial DNA, whereas the six small subunits (IV-VII, Vila, VIII) 
are coded by nuclear DNA. Ihe interdependence of the two systems has 
recently been demonstrated by Dowhan et al. (1985) who showed that the 
assembly of cytochrome c oxidase in yeast was dependent on the synthesis 
of cytcplasmically-made subunit . IV. Ihey constructed a S.cerevisiae 
mutant which lacked subunit IV, by using a gene interruption technique. 
This mutant was devoid, of cytochrome c oxidase activity although it still 
contained the other cytochrome c oxidase subunits but they were not 
assembled into a stable conplex.
Ihe majority of mitochondrial proteins are nuclear-encoded and as 
a result a central feature of mitochondrial assembly is the inport of 
nuclear-encoded mitochondrial proteins from their site of synthesis on 
free cytcplasmic polysomes. The key steps in this inport process have 
been identified by isotope-tracer studies with intact cells and by 
incubation of isolated mitochondria or mitochondrial subfractions with 
radiolabelled protein precursors in vitro. Since the preliminary studies 
of Maccecchini et al. (1979) where it was shown that cytoplasmic precursor 
polypeptides of higher Mr were synthesised to F^-ATPase c<,^ andsubunits 
in an in vitro translational system, the field of mitochondrial inport 
has advanced greatly. In.general, the inport of cytcplasmically- 
synthesised mitochondrial proteins destined for location within the
intermembrane space, inner membrane or. matrix, of the organelle involves 
the following steps;
i) specific interaction of the precursors with the mitochondrial 
outer membrane via protease sensitive sites (Riezman et al., 1983;
Gasser and Schatz, 1983);
ii) translocation of polypeptides across one or both mitochondrial 
membranes is energy-dependent. Ihe most likely source of energy involves 
the existence of an electrochemical potential across the mitochondrial 
inner membrane (Gasser et al., 1982a);
iii) processing the large precursors by a matrix-localised protease 
(Bohni et al., 1980; MzAda and Douglas, 1982).
Ihere are several exceptions to .this mechanism of iirport as is 
summarised in table 1.3.2. In addition, to date, the inport of proteins 
distributed in the mitochondrial outer membrane does not appear to involve 
any one of the above three steps.
Extensive research has been performed on the. synthesis of proteins 
located in the mitochondrial matrix (Lewin et al., 1980, Raymond and 
Shore, 1981; Bohni. et al., 1983). In all cases, with the possible 
exception of one (Hanpsey et al., 1983) , these proteins are synthesised 
as larger M precursors which, upon translocation into the mitochondrial 
matrix, are cleaved at their amino-termini by. the matrix-located protease 
(Bohni et al., 1980) to generate the mature protein. In agreement with 
these findings are the preliminary results reported in the last chapter 
on the mechanism of synthesis of fumarase. The mitochondrial location 
of this enzyme is the matrix where it functions in the tricarboxylic acid 
cycle. A larger precursor (2000-4000 greater) was shown to be 
synthesised to fumarase in the PK-15 and BRL mammalian cell lines (Figs.
5.3.6 and 5.3.7) and in the yeast rho mutant strain D273-10-B-1 (Fig. 
5.3.9a). This was achieved by blocking the inport of cytqplasmically- 
synthesised precursor into mitochondria using uncouplers of oxidative 
phosphorylation. In yeast, however, the identity of the enzyme has not 
been firmly established since the antiserum raised against the pig heart 
enzyme cross-reacted with a protein of lower M than its mammalian counter­
part. It should also be noted that the mechanism of synthesis of this 
enzyme is conplicated by the fact that fumarase has been shown to be 
located in the cell cytoplasm (Akiba et al., 1984) of most tissues and 
in yeast (Hiraga et al., 1984). R>r a detailed account of the proposed 
mechanism of synthesis of this bimodally distributed enzyme, see section 
5.4.2.
Additionally, I was interested in studying the biosynthesis of the 
mitochondrial inner membrane phosphate transport protein as it is thought 
to be an integral, transmembrane protein. Tb date, only one other trans- 
membraneous polypeptide has been studied .in detail, this being the
N.crassa ADP/ATP translocator of the inner membrane (Zimmerman and Neupert,
1980). The mechanism of synthesis of this protein is slightly different 
to that enployed for the synthesis of mitochondrial matrix proteins, in 
that the cytoplasmic precursor form is of the same Mr as the mature protein. 
However, the precursor form of the protein does differ from the mito- 
chondrially located polypeptide with respect to its conformational
properties, in that it exists in the cytoplasm as a soluble aggregate of
between 150,000 and 500,000 and binds to hydroxylapatite (Zimmerman 
and Neupert, 1980). The inport mechanism does, on the other hand, appear 
to include an interaction with protease sensitive sites on the mitochondrial 
outer membrane and requires the existence of an inner membrane electro­
chemical potential. As reported in chapter four, the antiserum raised 
against the rat liver phosphate transport protein cross-reacted with
several polypeptides of varying value..when challenged with mammalian 
cell culture extracts (see Fig. 4.3.4). However, the antiserum did appear 
to cross-react specifically with yeast cell extracts. When the yeast 
rho mutant strain D273-10-B-1 was grown in the presence of increasing 
levels of CCCP (0-20pM) , a specific polypeptide of .29,000 was illustrated 
to cross-react with the antiserum (see Fig. 5.3.10a). However, no large 
M precursor could be detected with increasing uncoupler concentration.
If the identity of this protein can be established then the preliminary 
findings will agree with those obtained for the ADP/ATP translocase.
It could then be postulated that this is the general mode of synthesis 
of mitochondrial inner transmembraneous proteins.
6.2 Update on Mitochondrial Biogenesis
As stated earlier (see section 1.3.5.1), the transport of precursors 
into the mitochondrion requires an electrochemical potential across the 
mitochondrial inner membrane and is followed by the removal of the amino- 
terminal precursor extension by a chelator-sensitive protease in the 
matrix (Bohni et al., 1980, 1983, Miura et al., 1982, McAda and Douglas, 
1982). Precursors whose prepiece has been removed in vitro by the 
addition of the solubilised matrix protease can no longer be inported into 
the mitochondria (Gasser et al., 1982b). This observation suggests that 
the transient prepiece has some function in the iirport pathway and in 
recent years a great deal of attention,has been directed towards gaining 
a more detailed understanding of the role of the transient prepiece.
Initial interest has been directed towards studying the structures 
of the amino-terminal presequences of higher Mr precursor polypeptides 
in an attenpt to find common structural elements which may be involved 
in targeting proteins to the mitochondrion. This has been achieved by
utilising recombinant DNA technology to determine, the nucleotide sequences 
of the genes coding for inported mitochondrial proteins and thus enabling 
a prediction of the likely protein sequence. This experimental approach 
was adopted because the methods utilised to study the biosynthesis of 
nuclear-encoded mitochondrial proteins result, in the synthesis of very 
small amounts of precursor. When secretory proteins were examined with 
respect to this property there was little obvious homology among their 
signal sequences although closer examination of primary structure (Garnier 
et al., 1980), revealed a central region of hydrophobic residues with a 
minimum length of nine residues. Several genes have recently been 
sequenced which code for mitochondrial proteins including the proteolipid 
subunit of N.crassa ATPase (Viebrock et al., 1982), yeast cytochrome c 
peroxidase (Kaput et al., 1982), yeast cytochrome c^  (Sadler et al., 1984) 
and yeast cytochrome c oxidase subunit TV (Maarse et al., 1984). In all 
cases, the amino-terminal presequences were shown to render the protein 
more basic and in general more hydrophilic. Interestingly, the presequence 
of cytochrome c peroxidase precursor,. which is processed in a two-step 
manner (see section 1.3.5.2), contains a 23. residue long apolar segment 
(Kaput et al., 1982). It is proposed that this segment integrates the 
protein into the mitochondrial inner membrane, such that the 18 amino- 
terminal residues of precytochrome c peroxidase face the matrix and the 
remainder of the pre and mature sequence are. exposed to the intermembrane 
space.
Tb further characterize the role played by the amino-terminal prepiece, 
Hurt et al. (1984a) studied the inport of subunit IV of yeast cytochrome 
c oxidase into mitochondria after its gene had been altered either by 
deletion or fusion .to another gene. The in vitro transcription-translation 
system first described by Stueber et al. (.1984) was used, to synthesise 
the various protein constructs derived from the wild-type subunit IV gene.
Hurt et al. (1984a) were able to demonstrate by this type of approach that 
the amino-terminal region of the subunit IV precursor directs the polypeptide 
into mitochondria. When the amino-terminal region encoding the first 
53 amino acids of the precursor was fused to the gene coding for the 
cytosolic protein, dihydrofolate reductase, the resulting fusion protein 
was transported into the mitochondrial matrix. The location of the 
fusion protein was confirmed by subfractionating the mitochondria into 
its various conpartments and testing for the presence of radiolabelled 
protein. A subsequent report by Hurt et al. (1984b) found that only the 
region encoding the first 22 amino acids of the 25 amino acid transient 
prepiece of cytochrome c oxidase subunit IV was required for directing 
dihydrofolate reductase to the mitochondrial matrix. Additional evidence 
to confirm the role played by the amino-terminal presequence in the inport 
of proteins into the mitochondrion was provided by Douglas et al. (1984).
They fused the gene coding for the ami no-terminus of the yeast F^-ATPase 
p-subunit to the E.coli p-galactosidase gene and were able to demonstrate 
that this hybrid molecule is targeted to the mitochondria. The actual 
location of the protein was not fully defined, although it was shown to be 
protected from added protease under conditions in which an outer membrane 
enzymatic marker was digested. The results described above suggest the 
following roles for the amino-terminal extension of mitochondrial precursor 
polypeptides of higher Mr:
i) the prepiece renders some hydrcphobic polypeptides more soluble 
(Viebrock et al., 1982).
ii) the prepiece contains the information for targeting the attached 
'mature' polypeptide to its correct intramitochondrial location (Hurt 
et al., 1984a).
So far the enphasis has been placed on studying the signal which 
directs proteins of higher Mr to the mitochondrion. Recombinant DNA 
technology has, however, recently been utilised by. Hase et al. (1984) 
in order to identify the sequences which target the major 70,000 Mr protein 
of the yeast mitochondrial outer membrane, and which permanently anchor it 
to the lipid bilayer of the outer membrane. As stated earlier in this
chapter (see section 6.1), proteins destined for location within the 
mitochondrial outer membrane are not made as larger Mr precursors. By 
manipulating the cloned gene, Hase et al. (1984) deleted 13 different 
regions throughout the polypeptide. All the information for targeting 
and anchoring the 70,000 Mr protein was contained within.the amino-terminal 
41 amino acids. When this entire region was deleted, the protein was 
recovered in the cytosol fraction. However, several restricted deletions 
within this amino-terminal region appeared to affect targeting and 
anchoring differentially; most of the altered protein remained in the 
cytosol but a small fraction was misrouted into the mitochondrial matrix 
space. They have suggested from these findings that targeting is mediated 
by a region which includes the 11 amino-terminal amino acids whereas the 
permanent membrane anchor is provided by a typical transmembrane sequence 
between residues 9 and 38.
Finally, although a basic understanding,of the mechanisms of synthesis 
and inport of nuclear-encoded mitochondrial proteins has been attained in 
the last few years, little is known about how the inport pathway is regulated 
and most of its molecular conponents remain to be identified or isolated.
One approach to solving, these problems has recently been adopted by Yaf fe 
and Schatz (1984) and involves the use of terrperature-sensitive mutants.
The isolation of mutants in mitochondrial protein inport was based on the 
following assumptions:
i) inport is an essential cellular process (Gbelska et al., 1983);
ii) a block in this process would result in the accumulation of precursors 
of some mitochondrial proteins (Reid, and Schatz, 1982a).
Yaffe and Schatz (1984) isolated two mutants (mas 1 and.mas 2) which 
were shown to accumulate the precursor to the ^ -subunit of the mitochondrial 
F^-ATPase at the non-permissive tenperature (37°C). In addition, the 
mutation resulted in the arrest of cellular growth at 37°C. Inport of the 
F^-ATPase p -subunit at 37°C was greatly reduced in both mutant strains 
when compared with wild-type cells. Although the tenperature-sensitive 
step in inport in both mas 1 and mas 2 was not firmly established, it was 
shown to occur before the arrival of the precursors in the mitochondrial 
matrix. This type of experimental approach should facilitate the molecular 
analysis of mitochondrial protein inport as the mutant can be used to 
isolate known proteins of. the inport machinery, to clone the genes coding 
for these proteins and to overproduce these coirponents. The field of 
mitochondrial protein inport has now taken on a new and exciting direction 
which should enable a more detailed understanding of the overall process.
6.3 FUTURE WORK
6.3.A FUmarase
A detailed account was given in chapter five on the preliminary 
findings relating to the mechanism of synthesis of the bimodally distributed 
fumarase in mammalian culture cells. In order to confirm these results, 
future research should initially be directed towards establishing the 
relationship between the precursor and mature fumarases. There are 
several potential methods of achieving this including:
i) pulse-chase experiments in which PK-15 and BEL cells are initially 
35labelled with [ S]-methionine in the presence of uncoupler, as described
previously (see legend to Fig. 5.3.6). Following this labelling period, 
the cells are transferred into normal growth.medium (see section 2.4.1) 
containing cold methionine and chased for various selected times. In 
this type of experiment it should be possible to see the precursor form 
of fumarase being converted into the mature protein, as the period of 
chase increases. In addition to confirming, the relationship between the 
precursor and mature enzyme, this type of experimental approach also gives 
an indication of the stability of the precursor,
ii) competition experiments in which the immune-precipitation reaction 
of a cell extract prepared from cells labelled in the presence of uncoupler 
with fumarase anti serum, is performed in the presence of unlabelled mature 
fumarase. In this case, no polypeptides should be visualized on the 
fluorograph indicating that both the precursor and mature proteins are 
competed out by the unlabelled enzyme and thus are related to each other.
The next step would be to confirm that the large Mr precursor 
synthesised in PK-15 cells blocked in import is the precursor form of 
mitochondrial fumarase whereas the nature sized protein is the cytosolically 
located enzyme. This can be achieved by radiolabelling cells in the 
presence of uncoupler, preparing a cell-free extract from the cells and 
subsequently incubating it with isolated mitochondria. Immune-precipitation 
from the resulting mitochondrial and post mitochondrial supernatant fractions 
should illustrate a decrease in the proportion of precursor in the post- 
mitochondrial supernatant fraction with a. corresponding increase in the 
amount of mature radioactive fumarase in the mitochondria. In addition, 
the amount of mature fumarase in the supernatant fraction should not vary 
under these conditions.
6.3.B Phosphate Transport Protein
As previously discussed (see section 5.4.3), the antiserum raised
against the rat liver mitochondrial phosphate transport protein could
only be shown to cross-react specifically with a protein of 29,000 M in
yeast extracts prepared from intact cells grown in the presence of CCCP
or from mitochondria. Although the cross-reacting protein has been shown
to be of mitochondrial origin in this study, its identity has not been
conclusively proven in yeast. The first priority would be to purify the
phosphate transport protein from yeast cells, possibly by a similar
procedure to that adopted for the rat liver protein (see section 3.2.1
method a). A second approach which may be used to tentatively identify
the protein is to utilise its known sulphydryl group sensitivity. Yeast
3mitochondria could be incubated with N-[ H] -ethylmaleimide before being 
subjected to immune-precipitation with anti-phosphate transport protein 
serum. The specifically precipitated protein would then be visualized 
by fluorography. If the protein can be identified it may be feasible to 
study its mechanism of synthesis in mere detail and to confirm the yeast 
rho mutant immune replica data which suggested that the protein was 
initially synthesised as a precursor of the same Mr as the mature polypeptic 
If the phosphate transport protein can be shown to be synthesised in the 
cytoplasm as a protein of similar M to the mature protein, by incubating 
the purified phosphate transporter in an in vitro inport system, it should 
be possible to study its mechanism of inport in more detail.
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’Purification of the mitochondrial phosphate-hydroxyl ion antiporter 
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Fig. 1. SDS\polyacrylamide-gel electrophoresis o f  (a) cal­
modulin pretreated with either 0 .8mM-Ca2 + ions or 5mM- 
EGTA, and (b) crude synaptic membranes from bovine brain
(a) Tracks contain the following: A, calmodulin, E G TA ; 
B, blank; C, calmodulin, C a2+ ; D, blank; E, F, calmodulin, 
C a2 + ; G, calmodulin, EG TA . (b) M em brane samples were 
dissolved in sample buffer containing either 0.8mM-CaCl2 
or 5mM-EGTA before electrophoresis. T racks: A, B, 
washed membranes, C a2+ ; C, washed m em branes, E G TA ; 
D, blank; E, F, Triton-washed m em branes, C a2+; G, 
Triton-washed m em branes, E G T A ; H, I, blanks; J, K, cal­
modulin, C a2+; L, calmodulin, EG TA .
al., 1979), or not show (Burgess et al., 1980), this differential 
mobility, and thus the uniqueness of this sigmoid pattern  to 
calmodulin is not fully established.
Calmodulin has been observed bound to post-synaptic 
mem branes (Wood et al., 1980) and brain microsomes 
(Sobue et al., 1982). Total release of calmodulin from m em ­
branes was reported to require washing of m em branes with 
detergent (Kakiuchi et al., 1978) and it has been shown 
(Sharm a & W ang, 1981) tha t Triton X-100 bound to cal­
modulin in a C a2 +-dependent m anner and inhibited cal­
modulin activation of phosphodiesterase. However, G rab  et 
al. (1979) have reported calm odulin in post-synaptic den­
sities which had been prepared by washing m em branes w ith 
0.5% Triton X-100.
Synaptic m em branes and Triton-washed (0.05%) m em ­
branes were prepared from bovine brain (Chang etal., 1981) 
and electrophoresed as described for calmodulin. N ative 
membranes showed horizontal protein bands through ad­
jacent tracks, the one exception being a ‘sigm oid’ pattern  
’or one protein band which co-migrated with pure bovine 
Drain calmodulin (Fig. 1 b). O ther proteins m igrating w ith 
:almodulin, either C a2 + -free or -bound, although having 
nobilities unaffected by C a2 + , m asked the positions of cal­
modulin, unless adjacent tracks were subjected to electro- 
)horesis. Using this procedure, however, the sigmoid 
m ttern of calmodulin allowed confident identification of 
he protein. In Triton-washed m em branes, no sigmoid
. : :
B C
multiple bands
Fig. 2. SDS/polyacrylamide-gel electrophoresis o f  (a) cal­
modulin pretreated with Ca2 +, and (b) calmodulin (10 pg) with 
either EGTA (5 m u) or Ca2+ (0.8mu)
(a) T racks contain calmodulin (10 jug) w ith : A, 5mM- 
E G T A ; B, no C a2+; C -G , 5, 10, 15, 20, 600/iM -Ca2 + re­
spectively.
pattern  was observed (Fig. lb), showing th a t Triton- 
washing indeed released calmodulin from m em branes.
M ultiple bands of calmodulin have been reported on 
SDS/polyacrylamide-gel electrophoresis by Burgess et al.
(1980), who concluded tha t these bands represented cal­
modulin that had lost one or more of its C a2+ binding sites 
due to denaturation, and by Sharrard et al. (1983), who sug­
gested that the interm ediate bands may be due to proteo­
lysis.
Three interm ediate bands can be seen a t high protein 
loading (Fig. 2a) w ith all buffers m ade w ith deionized, dis­
tilled water (>15M Q /cm ), the intensity o f these bands 
being increased at interm ediate C a2+ concentrations. 
Continuity of the interm ediate bands w ith the C a2 + - 
free calmodulin band (EG TA  track) suggested th a t these 
bands represented C a2 + -bound calm odulin species (Fig. 
2b). Thus it seems probable that these in term ediate bands 
represent calmodulin that had lost either d ifferent am ounts 
o f C a2+ or C a2+ from different sites on denaturation . The 
high protein concentration being greatly in excess o f the 
m icrom olar dissociation constants for calcium  binding 
would allow most endogenous C a2+ to be protein-bound. 
However, the discrete m ultiple bands suggest that, in 
the absence of E G TA , SDS m ust greatly decrease C a2 + 
dissociation from calmodulin.
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Inorganic phosphate m ust be transported continuously into 
the m itochondrial m atrix to m aintain  the steady-state oxi­
dative phosphorylation of AD P. Specific uptake of this 
anion occurs via at least two distinct transport systems: an 
electroneutral inorganic phosphate-dicarboxylic acid ex­
change carrier and an inorganic phosphate-hydroxyl an ti­
porter which catalyses the influx of about 90% of the m ito­
chondrial phosphate.
An interesting property of these phosphate transporters, 
which has facilitated their identification, is th a t they are in­
hibited by a low concentration of sulphydryl group reagents. 
The phosphate carrier protein is inhibited by A-ethylmale- 
imide, mersalyl and p-chlorom ercuribenzoic acid (Fonyo & 
Besman, 1968; Tyler, 1969; Coty & Pederson, 1974), 
whereas the phosphate-dicarboxylate exchange protein is 
blocked by mersalyl and p-chlorom ercuribenzoic acid but is 
insensitive to A-ethylm aleimide (M eyer & Tager, 1969; 
M eijer et al., 1970; Quagliariello & Palm ieri, 1972; Coty & 
Pederson, 1974).
In rat liver m itochondria, the phosphate carrier protein 
has been purified by modifying the m ethod of Kolbe et al.
(-)
P hospha te  
tran spo rt 
protein 
M,  =  34  0 0 0
(a) (b ) (c) {d) (e) (f) (g )
Fig. 1. Sodium dodecyl sulphate 14-20%  (vv/v)/polyacryla­
mide gradient gel analysis o f purified phosphate hydroxyl anti­
porter from rat-liver and beef-heart mitochondria
Coomassie Blue profile of different stages in the purifica­
tion. From  rat-liver m itochondria: (a) 8% (w/v) T riton X- 
100 extract, (b) hydroxylapatite eluate, (c) Celite-adsorbed 
fraction, (d) 0.25M-NaCl eluate from Procion Red A 
column. From  beef-heart m itochondria: (e) hydroxylapatite 
eluate, ( / )  Celite-adsorbed fraction, (g) m arker proteins 
94 000-14 000 M r.
0.5mM -dithiothreitol, O.lmM-EDTA and 8% (w/v) Triton 
X-100, pH 7.0), and hydroxylapatite chrom atography be­
fore adsorption on Celite. Fig. 1 com pares the Coomassie 
Blue staining pattern of the phosphate carrier purified from 
rat-liver and beef heart m itochondria, on a 14-20% sodium 
dodecyl sulphate/polyacrylam ide gradient gel. The beef 
heart protein has been purified also as described by Kolbe et 
al. (1981). There is a major difference between the protein 
product(s) at the hydroxylapatite stage in the two prepara­
tions. In the rat liver sample, only one major band is ob­
served, which m igrates w ith a M r of 34000, w hereas in the 
beef heart preparation there are two m ajor bands, which 
m igrate w ith M r of 34000 and 31000. The 31000 M x band is 
probably the adenine nucleotide translocase as shown by 
W ohlrab (1980). The translocase protein can be removed by 
adsorption on Celite, as was shown by Kolbe et al. (1981), 
and is illustrated here in Fig. 1. In this laboratory, another 
method for separating the translocase from the phosphate 
carrier protein has also been utilized. This involves the 
differential elution of the proteins from a Procion Red A 
column with NaCl. The phosphate carrier protein can be 
eluted with 0.25M-NaCl, whereas the translocase requires 
3M-NaCl for elution from the column.
The results discussed above, contrast m arkedly with the 
recent findings of Kolbe et al. (1982), who purified the phos­
phate carrier protein from bovine and pig heart m itochon­
dria. The hydroxylapatite eluates, when resolved on 14-20% 
(w/v) sodium dodecyl sulphate/polyacrylam ide gradient 
gels, dem onstrated four to five Coomassie blue staining 
bands, which varied in M x from 34500 to 30000. They ex­
plained their findings in term s of a model, which suggests 
that the phosphate carrier protein is proteolytically de­
graded during its isolation from m itochondria. M ultiple 
banding was not observed in this laboratory. Densitom etic 
scanning of the gel dem onstrated that the protein was 
greater than 90% pure.
An im portant additional step in purifying the phosphate 
carrier proteins from rat liver, by the method of Kolbe et al.
(1981), was the pre-extraction of the m itochondria with
0.5% (w/v) Triton X-100 buffer. Early preparations, al­
though dem onstrating only one major band, when overlayed 
with 125I-labellcd concanavalin A showed the presence of 
numerous low and high M x glycoproteins. This initial ex­
traction in 0.5% (w/v) Triton X-100 buffer solubilized about 
80% of the m itochondrial protein and removed these con­
tam inants.
The sulphydryl group sensitivity of the phosphate carrier 
protein was employed in the identification of the protein. 
Labelling studies w ith [3H]A-ethylmaleim ide showed that 
only the 34000M r band was labelled in both the hydroxyl­
apatite and Celite fractions, when purified from ra t liver 
mitochondria. This result is consistent w ith the known sul­
phydryl group sensitivity of the phosphate carrier protein. 
Further confirmation is provided by prelim inary experi­
ments with an antiserum  directed against the 34000 M x pro­
tein. Partial inhibition of m itoplast swelling in isotonic am ­
monium phosphate buffer (Chappell & Crofts, 1966) was 
achieved when m itoplasts were incubated w ith the specific 
antiserum.
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Organization and distribution of carbohydrate on mitochondrial membranes
J. G O R D O N  LIN D SAY , G O R D O N  P. R E ID  and 
W. D A R L IN G T O N
Department o f Biochemistry, University o f  Glasgow, Glasgow 
G12 8QQ, Scotland, U.K.
All eukaryotic mem branes, including those of intracellular 
organelles, contain small am ounts o f covalently associated 
carbohydrate, mainly in the form of glycoprotein (Hughes, 
1976). In m itochondria, it is clearly im portant to establish 
the presence, nature and topographical distribution of these 
glyco-conjugates, since resolution of these points will pro­
vide valuable inform ation on the origins, mode of synthesis 
and assembly of outer and inner m embranes.
Earlier reports on the presence of carbohydrate (De 
Bernard et al., 1971; Glew et al., 1973) and glycosyl trans­
ferase activities in this organelle (G ateau et al., 1978) have 
not been developed to the stage where we can elim inate the 
possibility that these represent contam inants o f non-mito- 
chondrial origin. Moreover, no well-characterized glycopro­
teins have been isolated from the organelle, although a pro­
tein, M r 33 000, involved in C a2 + uptake, appears to contain 
associated carbohydrate (Panfili et al., 1976). There has also 
be controversy over possible glycosylation of the m itochon­
drial F l-A T Pase (Andreu et al., 1978; N alin et al., 1979).
In our laboratory, we can detect the presence of several 
(10-15) concanavalin A-reactive glycoproteins in highly 
purified m itochondria and derived subfractions. The broad 
specificity of this lectin enables over 70% of mitochondrially 
associated glycoprotein to be isolated by affinity chrom ato­
graphy on concanavalin A -Sepharose 4B.
Interestingly, using W GA, specific for sialic acid and 
G lcNAc, only two major glycosylated species w ith apparent 
M r of 92000 and 105000 are found to interact w ith this 
lectin in rat liver m itochondria. We have concluded that 
these components are located in m itochondrial m em branes 
based on the following observations: (a) rat liver m itochon­
dria or mitoplasts (outer m em brane removed) are readily 
agglutinated by W G A , a reaction which is inhibited by 
G lcN A c; (b) W GA can be employed to isolate sealed ‘in­
side-out’ vesicles containing no accessible carbohydrate 
from a mixed population of inner m em brane fragm ents 
"D’Souza & Lindsay, 1981); and (c) fluoresce in -W G A  
binds specifically to isolated m itochondria.
The external location of sialic acid on the 92000 M r com­
ponent has been confirmed by neuram inidase treatm ent of 
n tact m itochondria or mitoplasts. This band exhibits a de­
creased mobility on SDS/polyacrylamide-gels on removal of 
;ialic acid as revealed by fluorography after incubation with 
25I-labelled W GA. In contrast, the higher M r species is un- 
iffected by neuram inidase and is absent from mitoplasts, 
ndicating a location in the outer membrane.
The unique nature of the major WG A-reactive glycopro­
tein has been confirmed by surface-specific modification of 
accessible galactosyl residues employing the galactose oxi- 
dase/tritiated borohydride procedure o f G ahm berg (1976). 
Fig. 1 shows an SDS/polyacrylamide-gel profile of 3H- 
labelled glycoproteins in in tact m itochondria as detected by 
fluorography. The most striking feature is the presence of 
two prom inent bands with M T of 92000 and 105000 (track 
c). Prior incubation with neuram inidase, w hich exposes 
sub-term inal galactose, leads to a m arked enhancem ent in 
N a3H B H4 labelling (3-5 fold) over control values (track d). 
The effect of this pretreatm ent is confined exclusively to the 
lower M t com ponent which becomes extensively tritiated  
(track b), again exhibiting a slightly decreased mobility. 
However, this novel sialoglycoprotein is not susceptible to 
periodate oxidation as evidenced by its subsequent lack of
(-)
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Abbreviations used: G lcN A c, A-acetylglucosamine; 
odium dodecyl sulphate; W GA, wheat germ agglutinin.
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Fig. 1. External labelling o f  rat liver mitochondrial glyco­
proteins
Sucrose-density purified m itochondria are labelled w ith 
1 mCi N a3H BH4 (5-20C i/m m ol) after p retreatm ent for 
30min at 4°C with neuram inidase and galactose oxidase 
(track b), galactose oxidase only (track c) or no pretreatm ent 
(track d) according to the procedure of G ahm berg (1976). 
For com parison, total m itochondrial sialoglycoprotein is 
oxidized with periodate (Blumenfeld et al., 1972) before tri- 
tiation with borohydride (track a). All sam ples are visualized 
by fluorography after resolution of SDS/polyacrylam ide- 
gels. T .D ., tracker dye front; k, kilodaltons.
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reactivity w ith tritiated borohydride (track a). This insensi­
tivity to periodate treatm ent indicates the presence of a C-8 
substituted neuram inic acid (O -C O C H3 or 0 - C 0 C H 20 H ). 
Removal o f the outer m em brane does not affect the 
92000 M t species while the 105000Afr species is again re­
leased.
The intriguing properties and distribution o f this novel 
W G A -reactive sialoglycoprotein are under further investi­
gation, since it may span the bilayer o f both inner and outer 
m em branes.
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Prostaglandin synthase activity in tissues from guinea pigs fed fatty acid- and aspirin-
supplemented diets
C H R ISTO S H A D JIA G A P IO U , 
C A T H E R IN E  T R IT SC H L E R  and 
M IC H A E L  G. H A R R IN G T O N
Department o f  Biochemistry, University College, Belfield, 
Dublin 4, Ireland
PU FA  supplem entation of the diet o f guinea pigs increased 
the prostaglandin synthase activity in the tissues (M cG rath, 
1980). Aspirin-like drugs have been found to inhibit prosta­
glandin synthase activity (Vane, 1971).
The present work examines the relationship between 
dietary PU FA  and prostaglandin synthase activity in five 
tissues (adipose tissue, brain, kidney medulla, liver, lung) 
and the effect o f sim ultaneously adm inistered aspirin 
thereon. G roups of anim als o f the same age (5 m onths) iso­
lated in cages were m aintained on diets for 4 or 8 weeks. 
They were fed ad libitum on standard laboratory diet (group 
A), laboratory diet supplem ented w ith 12.5% (w/w) sun­
flower oil (group B), or laboratory diet supplem ented w ith 
12.5% (w/w) olive oil (group C). H alf o f each group were 
killed and half were m aintained on the diets for a further 4 
weeks receiving, in addition, aspirin (20 m g/kg per day). 
The anim als were killed, tissues removed, chopped, homo­
genized in 4vol. of 100mM-Tris/HCl buffer, p H 8.2, at 4°C, 
and centrifuged at 12000# for 15min at 4°C. The super­
natan ts were centrifuged a t 200000# for 30m in a t 4°C to 
yield a m icrosomal fraction (Flower et al., 1973). The m icro­
somal fraction was resuspended in buffer. Prostaglandin 
synthase activity was determ ined in incubation a t 37°C for 
15min w ith [ l -14C]arachidonic acid (2.2 pu), adrenaline 
(5mM), reduced glutathione (5mM) in T ris/H C l, pH  8.2. The 
products were extracted w ith ethyl acetate and dried under 
nitrogen. The prostaglandins were separated by t.l.c. using 
chloroform /m ethanol/acetic acid (9 5 :5 :5 ) (Srivastara, 
1978), located by autoradiography, eluted and determ ined 
by liquid scintillation counting.
A lthough the diets were isocaloric, intake by the different 
groups of anim als varied in ad libitum feeding. A nim als fed 
standard  (group A) and sunflower oil (group B) diets have 
sim ilar growth rates as determ ined by gain in body weight; 
slightly higher growth rates were observed in anim als fed 
olive oil (group C).
Total lipid content determ ined by Folch extraction 
(Folch et al., 1957) showed sim ilar patterns in four tissues in 
th a t sunflower oil and olive oil supplem entation progres-
Abbreviations used: P U F A , polyunsaturated fatty acids; t.l.c., 
thin-layer chromatography; IC50, concentration o f inhibitor re­
sulting in 50% inhibition o f prostaglandin synthase.
sively increased the lipid weight per g of wet tissue (group 
A <  group B <  group C). In  the fifth tissue (adipose tissue) 
the lowest lipid content was found in anim als fed sunflower 
oil (group B <  group A <  group C).
Analysis o f extracted lipid using the lipoxygenase m ethod 
(W altking, 1972) showed the PU F A  content o f all tissues, 
expressed as mg of PU F A  per g of wet tissue, to follow the 
series: group B > g ro u p  C > g ro u p  A. Prostaglandin syn­
thase activity was lowest in tissues from animals fed stand- 
dard diet, and highest in those from anim als fed sunflower 
oil diets (group A <  group C <  group B) (Fig. 1).
Aspirin adm inistered for 4 weeks to guinea pigs fed speci­
fied diets did not effect the anim als growth rates, total lipid 
content or P U F A  content. In addition aspirin adm inistra­
tion resulted in decreased prostaglandin synthase activity in 
all tissues (Fig. 1).
The sensitivity of prostaglandin synthase to aspirin 
(Sigma, London) expressed as IC50 varied w ith the tissue: 
adipose tissue 760 pM, brain  133/im, kidney 300 pM, liver 
60 pu and lung 52 pM. These values were not affected by the 
diet nor by aspirin adm inistration.
Changes in the PU F A  content of tissues resulting from 
supplem entation with sunflower and olive oil are consistent 
w ith the PU FA  content o f these oils. Increases in total lipid
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Fig. 1. Microsomal prostaglandin synthase activity in tissues 
from guinea pigs fed  modified diet (pg/mg o f protein)
G uinea pigs fed standard  (group A), sunflower oil (group B) 
and olive oil (group C) diets ad libitum for 4 weeks or for 8 
weeks with aspirin during weeks 5-8. Total prostaglandins 
determ ined by extraction, t.l.c. separation and liquid scintil­
lation counting of products o f incubation. □  G roup A 
without aspirin; H  group B w ithout aspirin ; S  group C 
w ithout aspirin; ID groups A, B and C w ith aspirin.
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